Drug Name,SMILES,molecular_weight,logP,pKa,solubility,permeability,plasma_protein_binding,fm_in_vitro,fu_in_vitro,Clearance,CYP450_Enzyme
dextromethorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,271.401,,,,,0.65,,,1116.5,
benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,424.087,,,,,,,,42.0,
salicylamide,C1=CC=C(C(=C1)C(=O)N)O,137.1373,,,3.3,,,,,,
albuterol (salbutamol),CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,239.31,,,,,,,,6.65,
clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,242.701,,,,,0.49050000000000005,,,0.1,
dextrorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O,257.375,,,,,,,,19.5,
fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,336.476,860.0,8.4,,,0.43,,,0.5,CYP450_3a4_substrate
verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,454.607,,,,,0.46,,,10.5,CYP450_3a4_substrate
sulindac,CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,356.415,,,,,0.94,,,,
cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,261.087,,,,,0.13,,,0.9,CYP450_3a4_substrate
etintidine,CC1=C(N=CN1)CSCCN=C(NCC#C)NC#N,276.3664,,,,,,,,40.85,
pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,226.2742,,,,,0.05,,,,
vecuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,637.738,,,,,0.69,,,4.7,
iproplatin,CC(C)N.CC(C)N.O.O.Cl[Pt]Cl,414.1904,,,,,,,,164.65,
terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,548.6,,,,,0.2,,,2.0,
doxycycline,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.438,,,,,0.465,,,0.355,
diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,250.199,,,0.001,,0.99,,,4.2,
valproic acid,CCCC(CCC)C(=O)O,144.212,,,,,0.47,,,0.065,CYP450_3a4_inhibitor
methoxsalen (8-methoxypsoralen),COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,216.191,1.9,,,,,,,,
mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,241.2885,,,0.004,,0.9,,,21.13,
labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,328.41,3.1,,,,0.5,0.366,,33.0,
cholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,408.57,,,,,,,,9.44,CYP450_3a4_substrate
ranitidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,314.408,,,,,0.09,,,5.75,
nisoldipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,388.418,3.1,,,,0.9973000000000001,,,11.0,
prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,358.4,,,168.2,,0.385,,,2.2,CYP450_3a4_substrate
desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,266.386,,,,,,,,0.7450000000000001,CYP450_2d6_substrate
lormetazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl,335.1888,,,,,,,,225.0,
terfenadine,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,471.681,7.1,13.2,96.3,,,,,5.48,
azlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,461.497,,,,,0.17,,,15.45,
ciprofibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,289.1566,,,,,0.99,,,,
idrocilamide,C1=CC=C(C=C1)/C=C/C(=O)NCCO,191.229,0.9,,,,0.9640000000000001,,,,
primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,259.351,,,,,,,,9.24,
proguanil,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl,253.735,,,,,0.75,,,1.2,
decitabine,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,228.21,,,3.3,,0.01,,,125.0,CYP450_3a4_substrate
hexobarbital,CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2,236.2694,,,,,,,,164.0,
atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,266.34,,9.0,10.0,1.0,0.05,,,,CYP450_3a4_substrate
netilmicin,CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N,475.5829,,,,,,,,38.57,
minocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,457.48,,,,,0.76,,,0.65,
nitrazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,281.2699,,,,,0.067,,,30.965,
antipyrine (phenazone),CC1=CC(=O)N(N1C)C2=CC=CC=C2,188.229,,,,,,,,39.75,
atropine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,289.373,,,,,0.18,,,6.0,
moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,241.6808,,,,,0.07,,,11.0,
enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,376.45,,,,,0.55,,,3.2,CYP450_3a4_inhibitor
lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,234.341,2.44,8.01,,,,,,5.8,
practolol,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O,266.339,,,,,,,,70.5,
xylose,C1[C@H]([C@@H]([C@H](C(O1)O)O)O)O,150.129,,,,,,,,543.0,
clindamycin,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,424.987,,,,,0.469,,,3.0,
progesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,314.5,,,,,0.97,,,,
levothyroxine (thyroxine),C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,776.855,,2.2,,,,,,,
cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,261.7068,,,,,0.46,,,2.6,
roxatidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,306.403,,,,,0.04850000000000001,,,229.5,
viloxazine,CCOC1=CC=CC=C1OCC2CNCCO2,237.297,,,78.0,5.04,0.79,,,73.85,CYP450_3a4_inhibitor
tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,371.5,7.1,9.24,0.00102,,0.98,,,1.4,CYP450_3a4_substrate
indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,357.791,,,,,0.9,,,0.7999999999999999,
azacitidine,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,244.206,,,,,,,,152.0,
ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,204.312,,,,,0.18,,,4.7,
zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133,,,,,0.555,,,21.0,CYP450_3a4_substrate
prednisolone,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,360.4,,,,,0.925,,,0.58,
zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,307.395,,,,,0.92,,,2.6,CYP450_3a4_substrate
fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,306.275,,,,,0.115,,,0.17,
sulbactam,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,233.2429,,,,,0.38,,,254.0,
tranylcypromine,C1[C@H]([C@@H]1N)C2=CC=CC=C2,133.193,,,,,,,,410.5,
bevantolol,CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O,345.436,,,,,0.95,,,9.0,
metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,365.839,,,,,,,,7503.9,
alfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,416.523,,,,,,,,4.55,
misoprostol acid,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,368.51,,,,,0.85,,,170.0,
ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,554.5872,,,,,0.925,,,0.87,
sulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.463,,,0.17,
pirenzepine,CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,351.4079,,,,,0.14,,,255.0,
carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,236.273,,,,,0.385,,,0.9,CYP450_3a4_substrate
stiripentol,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O,234.29,,,,,0.99,,,4.125,CYP450_3a4_substrate
nicotine,CN1CCC[C@H]1C2=CN=CC=C2,162.2346,,,,,0.0385,,,11.95,
bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,361.823,,,,,0.95,,,,
ticarcillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C,384.431,,,,,0.45,,,62.1,
clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,300.7437,,,1.0,,0.85,0.181,,2.2199999999999998,CYP450_3a4_substrate
amdinocillin (mecillinam),CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)O)C,325.431,,,,,,,,281.5,
ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,206.283,,,1.0,,0.99,,,0.475,CYP450_3a4_inhibitor
nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,346.337,2.2,13.0,0.001,,0.485,,,4.4,CYP450_3a4_substrate
picumast,CC1=C(C(=O)OC2=C1C=CC(=C2)OCCCN3CCN(CC3)CC4=CC=C(C=C4)Cl)C,440.9681,,,,,,,,90.5,
cisapride,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,465.95,,,,,0.98,,,4.75,
clofibric acid,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,214.6469,,,,,0.49050000000000005,,,,
medigoxin (beta-methyldigoxin),C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)OC,794.9694,,,,,,,,4.0,
pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,248.7,,,,,0.87,,,,
josamycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,827.999,2.9,,,,,,,,
midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,325.773,2.5,5.5,,42.0,0.97,,,4.2,CYP450_3a4_substrate
danazol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,337.4603,,,,,,,,59.0,
cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,645.6753,,,,,0.9,,,1.5150000000000001,
tolfenamic acid,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,261.7068,,,,,0.997,,,,
ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.368,,,,,0.155,,,2.1,
antipyrine,CC1=CC(=O)N(N1C)C2=CC=CC=C2,188.229,,,,,,,,39.75,
flunarizine,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,404.501,1.97,1.0,0.1,,0.991,,,301.2,
triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,343.216,,,,,0.45799999999999996,,,3.8,CYP450_3a4_substrate
gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,446.908,4.15,1.0,4.0,2.15,0.9,,,2910.0,
allopurinol,C1=NNC2=C1C(=O)NC=N2,136.114,,,,,0.02,,,6.15,
lafutidine,C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3,431.554,,,,,,,,7.210000000000001,
alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N,339.3969,-0.9,8.5,47.0,1.059,0.2,,,14.0,CYP450_3a4_substrate
vigabatrin,C=CC(CCC(=O)O)N,129.158,,,,,,,,93.6,
levothyroxine (thyroxine),C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,776.855,,2.2,,,,,,,
apremilast,CCOC1=C(C=CC(=C1)[C@@H](CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,460.5,,,,,0.68,,,10.0,CYP450_3a4_substrate
sacubitrilat,C[C@H](C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O)C(=O)O,383.4,,,,,0.97,,,,
nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,418.443,,,,,0.98,,,19.0,CYP450_3a4_substrate
propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,178.273,,11.0,,,0.9854999999999999,,,16.0,
ramipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,416.515,,,90.0,,0.375,,,23.0,
avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,649.6646,,,0.0065,,0.96,0.45,,6.9,CYP450_3a4_substrate
rosuvastatin (acid),CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,481.5,,,,,0.88,,,7.6,CYP450_3a4_substrate
desvenlafaxine (O-desmethylvenlafaxine),CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,263.38,,,,,0.21,,,12.45,CYP450_3a4_substrate
deoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576,,,,,0.98,,,,
vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,346.8195,,,,,,,,51.7,
lesinurad,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,404.28,4.7,,,,0.98,,,6.0,CYP450_2c9_inhibitor
lacosamide,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1,250.3,,,,,0.15,,,2.71,CYP450_3a4_substrate
abiraterone acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,391.6,5.12,5.19,0.001,3.69,,,,,CYP450_3a4_substrate
darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,398.8521,,,,,0.92,,,116.0,CYP450_3a4_substrate
ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,230.3092,,,,43.0,,,,,
nalidixic acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,232.238,,,,,0.9,,,,
indinavir,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,613.798,2.8,,,,0.61,,,9.35,CYP450_3a4_substrate
sparfloxacin,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,392.404,,,,,0.4,,,,
tenapanor,CN1C[C@H](C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)[C@@H]5CN(CC6=C5C=C(C=C6Cl)Cl)C,1145.0614,,,,,0.99,,,,CYP450_3a4_substrate
perindopril,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,368.471,,,,,0.6,,,290.5,
sugammadex,C(CSC[C@@H]1[C@@H]2[C@@H]([C@H]([C@H](O1)O[C@@H]3[C@H](O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@@H]6[C@H](O[C@@H]([C@@H]([C@H]6O)O)O[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H](O2)[C@@H]([C@H]9O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)O)O)C(=O)O,2178.01,,,,,,,,88.0,CYP450_3a4_inhibitor
zidebactam,C1C[C@H](CNC1)C(=O)NNC(=O)[C@@H]2CC[C@@H]3CN2C(=O)N3OS(=O)(=O)O,391.4029,,,,,,,,85.95,
doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,425.75,3.0,9.47,0.001,25.0,0.76,,,106.0,CYP450_3a4_substrate
imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,589.7,3.5,,0.1,,0.95,,,2.25,CYP450_3a4_substrate
halofantrine,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,500.429,8.86,,,,,,,0.42,
tipranavir,CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,602.671,6.9,5.96,0.000205,,0.99,,,1.15,CYP450_3a4_substrate
valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,435.525,4.4,1.0,1.0,,0.95,,,0.29,CYP450_3a4_substrate
glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,490.622,,,,,0.995,,,47.8,CYP450_2c9_inhibitor
99mTc-sestamibi,CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.[99Tc+7],,,,,,,,,108.0,
simeprevir,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,749.94,,,,,,,,,CYP450_3a4_substrate
glyburide (glibenclamide),COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,494.009,,,,,0.998,,,0.9,CYP450_3a4_substrate
notoginsenoside R1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,933.131,,,,,0.462,,,121.8,
evacetrapib,CC1=CC(=C2C(=C1)[C@H](CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,638.6534,,,,,,0.9,,12.1,
doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.5,,,,,0.76,,,502.5,CYP450_3a4_substrate
propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,259.347,,,,17.9,,,,10.5,CYP450_2d6_inhibitor
palonosetron,C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5,296.412,,,,,0.62,,,160.0,CYP450_3a4_substrate
simvastatin (lactone),CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,418.7,,,,,0.95,,,7.6,CYP450_3a4_substrate
bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,364.42,,,,,0.97,,,136.5,
everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,958.232,,,,0.975,0.74,,,23.299999999999997,CYP450_3a4_substrate
gosogliptin,C1CN(CC1(F)F)C(=O)[C@@H]2C[C@@H](CN2)N3CCN(CC3)C4=NC=CC=N4,366.4136,,,,,,,,78.4,
capreomycin,C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCNC(=N2)N)CNC(=O)C[C@H](CCCN)N.C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N,651.7057,,,,,,,,3.6350000000000002,
bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,358.2669,,,,,0.95,,,700.0,CYP450_3a4_inhibitor
pefloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,333.361,,,,,0.25,,,3.6,
cefpirome,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-],514.5848,,,,,0.1,,,65.5,
desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,266.386,,,,,,,,0.7450000000000001,CYP450_2d6_substrate
brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,433.2,0.3,7.8,,,,,,15.600000000000001,CYP450_3a4_substrate
carebastine,CC(C)(C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)O,499.647,,,,,0.48950000000000005,,,,
semaglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC6=CN=CN6)N,4113.6119,,,,,0.99,,,0.05,
gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,250.336,,4.7,,,0.99,,,1.05,CYP450_3a4_substrate
vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,489.93,3.0,7.9,0.001,2.9,0.99,,,31.0,CYP450_3a4_substrate
ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.368,,,,,0.155,,,2.1,
falnidamol,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,387.8481,1.83,2.83,,,,0.97,,,
lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,321.162,,,,,0.465,,,0.75,
fexofenadine (terfenadine carboxylate),CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663,,,,,0.65,,,6.800000000000001,
dextropropoxyphene,CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C,339.476,,,,,,,,910.0,
sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,523.32,,,,,0.38,,,697.0,CYP450_3a4_substrate
N-desethylsunitinib (SU12662),CCNCCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,370.4,,,,,0.9,,,,
nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,479.53,3.82,,,,0.9875,,,6.75,
melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,232.2814,0.8,16.51,,,0.32,,,0.016,
encenicline,C1CN2CCC1[C@H](C2)NC(=O)C3=CC4=C(S3)C(=CC=C4)Cl,320.8423,,,,,,,,23.1,
PF-05150122,C1=CC(=C(C=C1C(F)(F)F)C2=CN=NC=C2)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=NN=CS4)F,,,,,,,,,295.0,
brotizolam,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl,393.695,,,,,0.92,,,11.5,
beclomethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C,408.9191,,,,,,,,163.4,
ciclesonide,CC(C)C(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)O[C@H](O2)C6CCCCC6,540.7,,,,,0.99,,,152.0,
gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,323.4149,,5.8,0.001,,0.94,,,18.95,
mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,241.2885,,,0.004,,0.9,,,21.13,
dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,248.305,,,,,0.37,,,0.385,
desmethylselegiline,C[C@H](CC1=CC=CC=C1)NCC#C,173.2575,2.46,9.8,,,0.53,,,,
saxagliptin,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N,333.43,,,,,0.38,,,350.0,CYP450_3a4_substrate
acetaminophen (paracetamol),CC(=O)NC1=CC=C(C=C1)O,151.16,,,,,0.2,,,0.08,CYP450_3a4_substrate
sarpogrelate,CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O,429.51,,,,,,,,92.39999999999999,
naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,335.47,,,,,0.295,,,6.6,CYP450_3a4_substrate
chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,0.483,,,0.017499999999999998,
miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,407.571,,,,,0.98,,,,CYP450_3a4_substrate
naphthoquine,CC(C)(C)NCC1=CC(=C2CCCCC2=C1O)NC3=C4C=CC(=CC4=NC=C3)Cl,409.9582,6.08,,,,,,,458.0,
dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,441.57,0.93,3.96,,,0.64,,,2.765,
daclatasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,738.885,,,,,,,,4.2,CYP450_3a4_substrate
cefepime,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-],480.5676,,,,,0.2,,,64.0,
doripenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O,420.5,,,,,0.08,,,15.9,
contezolid,C1CN(C=CC1=O)C2=C(C=C(C(=C2F)F)N3C[C@@H](OC3=O)CNC4=NOC=C4)F,408.3345,,,,,0.9,,,7.3999999999999995,
abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO,286.337,,,,,,,,13.4,
BMS-690514,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CC[C@H]([C@@H](C4)O)N,368.4386,1.53,4.3,10.0,5.84,,0.338,,7.0,
trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,693.53,4.99,0.25,0.2,1.0,0.9680000000000001,,,4.285,CYP450_3a4_substrate
viloxazine,CCOC1=CC=CC=C1OCC2CNCCO2,237.297,,,78.0,5.04,0.79,,,73.85,CYP450_3a4_inhibitor
tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,492.5802,4.0,9.5,,,0.98,,,23.8,CYP450_3a4_substrate
ampicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,371.39,,,100.0,,0.28,,,156.9,
fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,393.39,4.26,2.78,129.9,2.75,0.47659999999999997,,0.05,9.600000000000001,CYP450_3a4_substrate
pravastatin (acid),CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,424.53,1.6,4.2,0.001,,0.455,,,7.95,CYP450_3a4_substrate
tovorafenib,C[C@H](C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,506.285,3.63,10.29,0.003,43.6,0.975,0.648,,0.73,CYP450_3a4_substrate
meropenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O,437.52,,,,,0.02,,,8.95,
zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],267.244,,,,,0.38,,,1.1,
lusutrombopag,CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl,591.5,,,,,0.9990000000000001,,,1.1,CYP450_3a4_substrate
fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)[C@@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C,524.6,,,,,0.9940000000000001,,,0.75,
irosustat,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,309.3405,,,,,0.987,,,,
"theacrine (1,3,7,9-tetramethyluric acid)",CN1C2=C(N(C1=O)C)N(C(=O)N(C2=O)C)C,224.2188,,,,,,,,1.05,
terfenadine,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,471.681,7.1,13.2,96.3,,,,,5.48,
lenabasum (ajulemic acid),CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,400.5554,1.84,5.13,400.0,8.17,0.99,0.51,,5.1,
sulindac,CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,356.415,,,,,0.94,,,,
oxymorphone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,337.8,,,,,0.3,,,,CYP450_3a4_substrate
agomelatine,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,243.304,,,,,0.95,0.9,,39.95,
enoximone,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,248.305,,,,,0.59,,,11.985,
doxepin,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,279.4,,8.96,0.0466,9.844999999999999,,,,8.5,CYP450_3a4_substrate
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,217.288,,,,,0.25,,,12.0,
bromocriptine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,654.602,,,,,,,,5.5,
bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,361.823,,,,,0.95,,,,
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,263.382,3.9,9.7,,,0.47,,,4.5,CYP450_2d6_inhibitor
dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,519.57,2.9,6.6,0.001,,0.997,,,34.4,CYP450_3a4_substrate
mosapride,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,421.8975,,,,,0.3,,,35.05,
nicotinic acid (niacin),C1=CC(=CN=C1)C(=O)O,123.11,,,,,,,,9.8,
tolrestat,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,357.3506,,,,,0.73,,,17.75,
meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,351.4,3.0,4.08,,,0.9940000000000001,,,0.11,
inclisiran,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4C[C@@H](C[C@H]4COP(=O)(O)O)O)CO)O)O,17284.72,-8.0,,,,0.8740000000000001,,,23.435000000000002,CYP450_3a4_substrate
cefatrizine,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)CSC4=NNN=C4,462.5092,,,,,,,,126.5,
letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,285.3,,,,,,,,,
dexmethylphenidate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,233.3091,1.8,,100.0,,0.47,,,0.4,
ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,319.229,,,,,0.86,,,122.0,
clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,277.1932,,,,,,,,5.515000000000001,
maribavir,CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl,376.24,2.86,5.2,1.49,5.6,0.98,0.664,0.73,2.85,CYP450_3a4_substrate
durlobactam,CC1=C[C@@H]2CN([C@@H]1C(=O)N)C(=O)N2OS(=O)(=O)O,277.2559,2.0,,100.0,,0.1,,,6.535,CYP450_3a4_substrate
nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],329.229,1.6,,0.001,,0.95,,,0.113,
baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,213.663,,,,,0.21,,,180.0,
thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,201.252,2.47,4.64,50000.0,,,,,,
perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,362.9,,3.24,0.47,26.68,,,,12.0,CYP450_3a4_substrate
tucaresol,C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O,272.2548,,,,,,,,1.57,
ginsenoside Rg1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C,801.0168,,,,,0.43449999999999994,,,159.4,
ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,532.56,2.78,6.5,1.0,8.0,,0.52,,35.9,CYP450_3a4_substrate
edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,548.065,,,,,0.55,,,22.0,CYP450_3a4_substrate
budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,430.5,,,0.001,,0.875,,,1.35,CYP450_3a4_substrate
ibrexafungerp,C[C@H](C(C)C)[C@]1(CC[C@@]2([C@H]3CC[C@H]4[C@]5(COC[C@]4(C3=CC[C@]2([C@@H]1C(=O)O)C)C[C@H]([C@@H]5OC[C@@](C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C,730.0443,,,,8.45,0.9969999999999999,,,56.1,CYP450_3a4_substrate
naltrexone,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,341.405,,,,,0.21,,,,CYP450_3a4_substrate
sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,295.405,,,,,0.175,,,13.7,CYP450_3a4_substrate
ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,720.955,3.9,,0.001,,0.985,,,0.8,CYP450_3a4_substrate
ombitasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,894.1203,7.9,,0.001,,0.9990000000000001,,,,
fluticasone propionate,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,500.5749,,,,,0.99,,,1093.0,
pancuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,732.677,,,,,0.045,,,1.1,
bendazac,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,282.298,,,,,0.99,,,53.5,
amrubicin,CC(=O)[C@]1(C[C@@H](C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)O[C@H]5C[C@@H]([C@@H](CO5)O)O)N,483.47,,,,,,,,19.4,
josamycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O,827.999,2.9,,,,,,,,
levetiracetam,CC[C@@H](C(=O)N)N1CCCC1=O,170.2106,,,,,0.1,,,0.96,CYP450_3a4_substrate
binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,441.2305,,,,,0.97,,,20.2,CYP450_3a4_substrate
terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,387.438,,,,,0.92,,,1.15,
minocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,457.48,,,,,0.76,,,0.65,
metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,299.8,,,,,0.22,,,3.75,CYP450_3a4_substrate
dagrocorat,CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)[C@@]4(CC[C@@](C[C@H]4CC3)(C(F)(F)F)O)CC5=CC=CC=C5,494.5541,,,,,7.000000000000001e-05,,,,
levomethadyl acetate,CC[C@@H](C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2)OC(=O)C,353.503,,,,,0.8,,,2.755,
delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,440.76,,,,,0.84,,,11.67,
bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,470.61,,,,,0.9754999999999999,,,,CYP450_3a4_substrate
mezlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C,539.5875,,,,,,,,19.9,
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,428.537,4.1,,,,0.9,,,1.33,CYP450_3a4_substrate
(l)-nebivolol,C1CC2=C(C=CC(=C2)F)O[C@H]1[C@H](CNC[C@@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O,,,,,,0.9784999999999999,,,,
carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],373.2666,,,,,0.0,,,0.9,
nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,266.303,2.5,2.8,,,0.6,,,0.5,CYP450_3a4_substrate
danazol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,337.4603,,,,,,,,59.0,
vecuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C,637.738,,,,,0.69,,,4.7,
dalfampridine (4-aminopyridine),C1=CN=CC=C1N,94.1164,,,,,0.02,,,,CYP450_3a4_substrate
gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,477.599,,,,,0.1,,,0.82,
disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,339.48,,,,,,,,0.8,
domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,425.918,3.96,7.89,,6.19,0.92,,,,
asciminib,C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,449.8432,,1.975,0.124,22.1,0.973,0.36,,6.7,CYP450_3a4_substrate
apatinib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,493.5853,,,,,0.924,0.626,,57.8,
selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,496.62,,,,,0.99,,,35.0,CYP450_3a4_substrate
pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/[C@H]5CCCN5C,583.1,,,,,0.9330000000000002,,,77.45,
tigecycline,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,585.65,0.8,3.17,14550.0,,0.71,,,23.8,
vorapaxar,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C,492.5877,,,,,,,,2.22,CYP450_3a4_substrate
encequidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,688.7,,,,,,,,91.5,
thiotepa,C1CN1P(=S)(N2CC2)N3CC3,189.222,,,,,,,,103.0,
propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,368.494,,,,,,,,79.2,
(S)-acenocoumarol,CC(=O)C[C@@H](C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,353.3285,,,,,,,,12.55,
irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,586.685,,,,,0.49,,,9.4,CYP450_3a4_substrate
pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,248.7,,,,,0.87,,,,
verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,454.607,,,,,0.46,,,10.5,CYP450_3a4_substrate
telaprevir,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,679.8577,3.96,11.86,0.0047,5.7,0.675,,0.41,32.4,CYP450_3a4_substrate
vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,421.3026,2.7,3.8,0.99,,0.99,,,0.0434,CYP450_3a4_substrate
duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,297.42,,,1.0,,0.015,,,94.5,CYP450_1a2_substrate
procyclidine,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,287.444,,,,,0.9259999999999999,,,,
cligosiban,COCC1=NN=C(N1C2=CN=C(C=C2)OC)N3CC(C3)OC4=C(C=C(C=C4)F)Cl,419.8421,,,,,,,,39.0,
moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,241.6808,,,,,0.07,,,11.0,
maraviroc,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,513.67,5.1,7.3,,,0.76,,,47.599999999999994,CYP450_3a4_substrate
lithium,[Li],6.941,,,,,0.0,,,0.22999999999999998,
oxaliplatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)[O-])[O-].[Pt+4],395.2728,,,,,0.9,,,52.5,CYP450_3a4_substrate
darunavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,593.73,,,,,0.95,,,32.8,CYP450_3a4_substrate
ibrutinib,C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,440.5,3.97,3.74,0.001,57.9,0.973,,,62.0,CYP450_3a4_substrate
deflazacort,CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)COC(=O)C,441.517,,,,8.0,,,,,CYP450_3a4_substrate
tedizolid,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F,370.3425,,,,,0.8,,,8.4,
clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,315.715,,,,,0.4325,,,0.915,CYP450_3a4_substrate
cabazitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,835.93,,,,,0.905,0.8,,48.5,CYP450_3a4_substrate
barnidipine,CC1=C([C@@H](C(=C(N1)C)C(=O)O[C@H]2CCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,491.541,,,,,0.9565,,,,
lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,480.5426,4.15,,,,0.9998999999999999,,,0.8099999999999999,
vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl,774.8,,,,,0.94,,,,
thioctic acid,C1CSSC1CCCCC(=O)O,206.329,,,,,,,,1686.41,
alvimopan,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,460.6,,,,,0.8,,,245.5,
cefuroxime,CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,424.388,,,,,0.195,,,0.94,
GSK3179106,CCOC1=CC(=O)NC=C1C2=CC(=C(C=C2)CC(=O)NC3=NOC(=C3)C(C)(C)C(F)(F)F)F,,,,,,0.973,,,,
ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N,404.4676,,,58.0,,0.982,,,192.0,CYP450_3a4_substrate
pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,185.23,,,22.0,,0.58,0.48,,15.0,CYP450_3a4_inhibitor
nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,405.44,,8.5,0.1,,0.98,,,51.6,CYP450_2d6_inhibitor
vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,488.61,,,,,0.94,,,56.0,CYP450_3a4_substrate
mirodenafil,CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC,531.6743,2.2,,,,,,,,
celiprolol,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,379.498,,,,,0.275,,,,
cholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,408.57,,,,,,,,9.44,CYP450_3a4_substrate
acetaminophen glucuronide,CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,327.287,,,,,,,,1.8,
recainam,CC1=C(C(=CC=C1)C)NC(=O)NCCCNC(C)C,263.383,,,,,0.1425,,,0.265,
valproic acid,CCCC(CCC)C(=O)O,144.212,,,,,0.47,,,0.065,CYP450_3a4_inhibitor
flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,276.2129,,,,,0.95,,,280.0,CYP450_3a4_substrate
methyldigoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)OC,794.9694,,,,,,,,4.0,
foscarnet,C(=O)(O)P(=O)(O)O,126.004,,,,,0.155,,,1.4,
romidepsin,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,540.7024,,,,,0.93,,,16.05,CYP450_3a4_substrate
tegaserod,CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC,417.47,,,,,0.98,,,11.0,
Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,398.3976,2.5,3.23,,,0.993,,,0.24,
tamsulosin,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,408.516,2.3,9.93,3.3,,0.965,,,0.46499999999999997,
amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,408.879,,8.6,1.0,,0.47,,,3.7,CYP450_3a4_substrate
isavuconazole,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,437.4723,3.5,,,,0.99,,,2500.0,CYP450_3a4_substrate
alpelisib,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,441.4758,2.96,3.26,0.02,3.84,0.89,,,9.2,CYP450_3a4_substrate
albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,265.336,,,,,0.7,,,,
memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,179.305,,,,,0.45,,,7.5,CYP450_3a4_inhibitor
montelukast,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,586.2,7.7,4.3,,,0.99,,,0.435,CYP450_3a4_substrate
bremelanotide,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C,1025.1752,,,,,0.21,,,3.75,
bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,348.483,,,,,0.99,,,,
99mTc-mebrofenin,CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C.[99Tc],,,,,,,,,72.7,
carboxyamidotriazole,C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl,424.674,,,,,,,,9.115,
ensartinib,C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N,561.4,3.6,,4.21,2.0,0.934,,,42.0,CYP450_3a4_substrate
ginsenoside Rb1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C,1109.2978,,,,,0.006999999999999999,,,0.9,
propiverine,CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C,367.4861,,,,,0.925,,,422.0,CYP450_3a4_substrate
teicoplanin,CCCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@@H](C7=C(C(=CC(=C7)O)OC8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)Cl)CO)O)O,1879.65828,,,,,,,,8.5,
carisbamate,C1=CC=C(C(=C1)[C@@H](COC(=O)N)O)Cl,215.635,,,,,0.44,,,1.75,
baicalein,C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O,270.24,,,,,,,,1938.0,
mitragynine,CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.5,,,,,,,0.039,186.85,
capivasertib,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,428.9,2.5241,6.15,0.19,10.3,0.777,0.54,0.622,38.1,CYP450_3a4_substrate
anacetrapib,C[C@H]1[C@H](OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,637.5115,,,,,,,,4.567,
oteseconazole,C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F,527.3984,4.41,,0.0657,,0.49779,,,0.253,CYP450_3a4_inhibitor
albuterol (salbutamol),CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,239.31,,,,,,,,6.65,
gatifloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,375.4,,,,,0.125,,,2.85,
quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.45,,,3.25,
cisplatin,N.N.Cl[Pt]Cl,302.0632,,,,,,,,3.75,
flupentixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,434.523,,,,5.7,0.9840000000000001,,,,
(+)-mefloquine,C1CCN[C@@H](C1)[C@@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,378.314,,,,,,,,2.7815,
tenofovir disoproxil,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,519.445,,,,,0.006999999999999999,,,,
inotersen,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@@H]5[C@H](O[C@H]([C@@H]5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)O[C@@H]8[C@H](O[C@H]([C@@H]8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,7183.08,,,,,0.94,,,3.185,CYP450_3a4_inhibitor
luseogliflozin,CCOC1=CC=C(C=C1)CC2=CC(=C(C=C2C)OC)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O,434.55,,,,,,,,1.6324999999999998,
entecavir,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N,295.3,,,,,0.13,,,,
atorvastatin (acid),CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,558.6,3.66,4.6,0.27,,0.98,,,29.0,CYP450_3a4_substrate
nateglinide,CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O,317.4,3.2,,0.001,,0.98,,,,CYP450_3a4_substrate
aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,448.38,,7.6,,20.5,0.99,,,0.5,CYP450_3a4_substrate
cefixime,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O,453.454,,,,,0.34,,,0.75,
losartan carboxylic acid,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl,436.9009,5.0,,,,0.998,,,50.0,
(-)-tramadol,CN(C)C[C@@H]1CCCC[C@]1(C2=CC(=CC=C2)OC)O,263.379,,,,,,,,0.7,
quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,560.6758,2.33,4.75,0.93,,0.9906,0.652,0.985,2.23,CYP450_3a4_substrate
leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,270.209,,,,,0.9940000000000001,,,0.012,
dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,471.5,,4.0,,,0.35,,,1748.0,
docetaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,807.885,,,,,0.94,,,15.15,CYP450_3a4_substrate
"(R,R)-labetalol (dilevalol)",C[C@H](CCC1=CC=CC=C1)NC[C@@H](C2=CC(=C(C=C2)O)C(=O)N)O,328.41,,,,,0.5,,,13.2,
vesnarinone,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,395.457,,,,,,,,0.284,
mavatrep,CC(C)(C1=CC=CC=C1C2=CC3=C(C=C2)N=C(N3)/C=C/C4=CC=C(C=C4)C(F)(F)F)O,422.4479,,,,,,,,3.8,
methoxyphenamine,CC(CC1=CC=CC=C1OC)NC,,2.6,10.45,,,,,,,
lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)C)C,455.548,4.5,,,,0.925,,,66.0,
loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,477.045,5.5,1.0,,,,,,,
milnacipran,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,246.35,,,,,0.129,,,20.65,CYP450_3a4_substrate
lormetazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl,335.1888,,,,,,,,225.0,
promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,284.425,,,,,0.91,,,5.055499999999999,CYP450_3a4_substrate
ethinylestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,296.408,3.7649999999999997,10.33,3.0,,0.97,,,2.079,
minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,209.251,,,,,0.0,,,24.0,
clorazepate,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,314.727,,,,,0.975,,,0.095,CYP450_3a4_substrate
genaconazole,C[C@H]([C@](CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)S(=O)(=O)C,331.3415,,,,,,,,12.4,
PF-04457845,C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4,455.438,,,,,,,,0.0341,
zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,575.683,,,0.001,,0.99,,,6.8,
bufuralol,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,261.363,,,,,0.9,,,26.0,
glycopyrronium,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,318.431,,,,,,,,422.0,
ritlecitinib,C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3,285.34,,,35.6,,0.14,,0.86,92.56,CYP450_3a4_substrate
PF-05186462,C1=CC(=C(C=C1C(F)(F)F)C2=CN=NC=C2)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=NN=CS4)F,,,,,,,,,94.0,
mibefradil,CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,495.635,,,,,,,,6.6,
prednisolone,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,360.4,,,,,0.925,,,0.58,
nicergoline,CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br,484.391,3.3,,,,,,,,
droxidopa,C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O,213.19,,,,,0.75,,,,CYP450_3a4_inhibitor
avosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC=NC=C3)OC)OC4=CC=CC=C4OC,479.5149,,,,,0.9998,,,2.05,
tranylcypromine,C1[C@H]([C@@H]1N)C2=CC=CC=C2,133.193,,,,,,,,410.5,
levocabastine,C[C@@H]1CN(CC[C@@]1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,420.525,,,,,0.55,,,1.8,
zimeldine,CN(C)C/C=C(/C1=CC=C(C=C1)Br)\C2=CN=CC=C2,,,,,,0.667,,,,
"3,3'-diindolylmethane",C1=CC=C2C(=C1)C(=CN2)CC3=CNC4=CC=CC=C43,246.3116,,,,,,,,146.5,
roxatidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,306.403,,,,,0.04850000000000001,,,229.5,
dexmedetomidine,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C,200.28,,,,,0.94,,,0.318,
sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,464.829,,,,,0.99,,,,
conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,498.583,,,,,0.99,,,15.2,CYP450_3a4_substrate
lopinavir and ritonavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,,5.9,,,,0.98,,,,
rasagiline,C#CCN[C@@H]1CCC2=CC=CC=C12,171.24,,,,,0.92,,,0.34500000000000003,CYP450_3a4_inhibitor
encainide,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC,352.4752,,,,,0.36,,,10410.0,
osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,596.0,3.7,4.4,3.0,2.0,0.95,,,14.3,CYP450_3a4_substrate
formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,344.4086,,,,,0.61,,,150.0,
triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,343.216,,,,,0.45799999999999996,,,3.8,CYP450_3a4_substrate
p-cresol,CC1=CC=C(C=C1)O,,,,,,0.935,,,,
tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,294.3,,,5.0,,,,,,
BI 201335,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)O[C@@H]4C[C@H](N(C4)C(=O)[C@H](C(C)(C)C)NC(=O)OC5CCCC5)C(=O)N[C@@]6(C[C@H]6C=C)C(=O)O,,,,,,0.996,,,,
ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,427.54,117.49,7.2,,,0.9,,,557.0,
enfuvirtide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)NCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NNC(=O)C,4492.0,,,,,0.92,,,1.68,
nefazodone,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,470.014,4.3,,1.0,,0.99,,,,CYP450_3a4_substrate
ursodeoxycholic acid (ursodiol),C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576,,,,,0.7,,,52.0,
solifenacin,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5,362.4704,,,100.0,,,,,10.0,CYP450_3a4_substrate
laropiprant,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F,435.9,,,,,0.996,,,,
pacritinib,C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,472.5858,3.8,,,15.5,0.988,,0.69,2.09,CYP450_3a4_substrate
MK-2206,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,407.4749,,,,,,,,19480.86,
etonogestrel (3-keto-desogestrel),CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.9670000000000001,,,,
hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,160.179,,,,,0.87,,,34.5,
trabectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,761.84,,,,,0.975,,,39.1,CYP450_3a4_substrate
amsacrine,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,393.465,,,,,0.97,,,0.26,
esaxerenone,CC1=C(N(C=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C)CCO)C3=CC=CC=C3C(F)(F)F,466.4779,,,,,,,,3.96,
ipragliflozin,C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F,404.4559,3.38,,0.09,5.92,0.9555,,,6.55,
octreotide,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N[C@H](CO)[C@@H](C)O)O,1019.2,,,,,0.65,,,212.5,
lamivudine,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,229.2589,,,,,0.36,,,2.85,
solriamfetol,C1=CC=C(C=C1)C[C@H](COC(=O)N)N,194.2326,,,,,0.1635,,,19.5,CYP450_3a4_substrate
pimecrolimus,CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C,810.4592,,,,,,,,48.5,
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,416.579,,,,,0.9,,,93.0,
AZD1305,CC(C)(C)OC(=O)NCCN1CC2CN(CC(C1)O2)CCOC3=C(C=C(C=C3)C#N)F,434.5089,3.24,9.9,,,0.0053,,,113.1,
thioridazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,370.5824,5.9,9.5,33.6,,,,,0.565,
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,312.37,1.15,5.07,100.0,0.01,0.4,,,21931.4,CYP450_3a4_substrate
enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,320.3223,,,,,,,,11.625,
sulfadoxine and pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.9,,,,
gabapentin,C1CCC(CC1)(CC(=O)O)CN,171.238,,,,,0.03,,,0.9500000000000001,
azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,456.456,2.5,2.5,0.001,,0.99,,,1.5,CYP450_2c9_inhibitor
ribavirin,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,244.206,,,,,0.0,,,3.0,
buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,385.509,,,,,0.95,,,19.3,CYP450_3a4_substrate
cefetamet,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,397.435,,,,,0.22,,,192.5,
lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,256.095,,,,,0.56,,,0.495,
allopurinol,C1=NNC2=C1C(=O)NC=N2,136.114,,,,,0.02,,,6.15,
meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,247.33,,,,,0.335,,,11.0,CYP450_3a4_substrate
ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,378.106,,,,,,,,37.995,
nicotinic acid (niacin),C1=CC(=CN=C1)C(=O)O,123.11,,,,,,,,9.8,
perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,277.492,,,,,0.9,,,,
clavulanic acid,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O,199.1611,,,,,,,,1.9200000000000002,
itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,705.643,5.66,,,,0.998,,,278.0,CYP450_3a4_substrate
haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,375.869,,,0.01,,0.47,,,7.3500000000000005,CYP450_3a4_substrate
glyburide (glibenclamide),COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,494.009,,,,,0.998,,,0.9,CYP450_3a4_substrate
terbinafine,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,327.9,5.715,7.1,0.63,,0.99,,,,CYP450_3a4_substrate
sulfaphenazole,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,,1.52,6.82,1500000.0,,,,,,
tetracycline,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.4376,,,,,0.34,,,0.955,
5-fluorouracil,C1=C(C(=O)NC(=O)N1)F,130.078,,,,,0.1,,,11.5,
cefmenoxime,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,511.566,,,,,,,,112.0,
cilastatin,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,358.4564,,,,,0.4,,,115.05,
gabapentin,C1CCC(CC1)(CC(=O)O)CN,171.238,,,,,0.03,,,0.9500000000000001,
triamterene,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,253.268,,,,,0.315,,,41.5,
digitoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,764.944,,,,,0.484,,,0.0295,
sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,272.367,,,,,,,,2.6,
guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,282.55,,,,,0.7,,,414.4,CYP450_3a4_substrate
mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,179.261,2.3049999999999997,9.2,0.54,,0.33,,,1.9500000000000002,
pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,461.5531,,,,12.0,0.99,,,3.9499999999999997,
naproxen (S-naproxen),C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,230.2616,,,6.0,,0.499,,,0.075,
perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,403.975,,,,,,,,107.0,
acebutolol,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,336.4,,,,,0.175,,,0.63,CYP450_3a4_inhibitor
levodopa,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,197.189,,,,,,,,13.5,
metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,299.8,,,,,0.22,,,3.75,CYP450_3a4_substrate
(S)-mephenytoin,CC[C@@]1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,218.2,1.69,8.51,1.27,,0.3,0.779,,,
azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],277.267,,,,,,,,44.0,
cefpiramide,CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,612.6456,,,,,,,,8.65,
ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437,4.3,,,,0.4955,,,6.25,CYP450_3a4_substrate
quinine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.875,,,1.2,
metformin,CN(C)C(=N)N=C(N)N,129.16,-1.43,11.8,100.0,,,,,3.96,
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,280.413,4.8,,,,0.4575,,,7.35,CYP450_3a4_substrate
metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,267.366,1.9,9.7,,,0.06,,,9.0,CYP450_2d6_inhibitor
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,263.382,3.9,9.7,,,0.47,,,4.5,CYP450_2d6_inhibitor
nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,414.4798,2.9,,,,0.457,,,363.935,
pentopril,CCOC(=O)[C@H](C)C[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C21)C(=O)O,333.3817,,,,,,,,0.79,
tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,270.351,2.34,5.16,109000.0,,0.935,,,0.14,
vancomycin,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,1449.26,,,,,0.205,,,0.79,
colchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,399.44,,12.8,,,0.39,,,54.1,
ceftazidime,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],636.6,,,,,0.1,,,115.0,
lisinopril,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,405.492,,,,,0.0,,,4.2,
azapropazone,CCCC1C(=O)N2C3=C(C=CC(=C3)C)N=C(N2C1=O)N(C)C,300.36,,,,,0.9957499999999999,,,6.1,
nitrendipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,360.364,2.4,,,,0.98,,,1450.0,
trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,290.321,,,,,0.44,,,1.0999999999999999,
phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,252.2718,2.4,8.31,0.02,,0.56,0.0645,,3.5500000000000003,CYP450_3a4_substrate
theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166,-0.02,8.81,7360000.0,4.35,0.3,,,0.42500000000000004,CYP450_3a4_inhibitor
propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,178.273,,11.0,,,0.9854999999999999,,,16.0,
clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,277.1932,,,,,,,,5.515000000000001,
methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,454.445,,,,,0.285,,,1.4500000000000002,
vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,824.966,,,,,,,,3.965,CYP450_3a4_substrate
cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,252.34,0.48,6.9,,3.0,,,,5.15,CYP450_3a4_substrate
flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,,,,,,,,,,
acitretin,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC,326.44,,,,,,,,,
nalidixic acid,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,232.238,,,,,0.9,,,,
gallopamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,484.633,,,,,0.93,,,6.0,
ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,395.4318,,,,,0.479,,,528.5,
lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,321.162,,,,,0.465,,,0.75,
rifampin,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,822.947,,,0.1,12.0,0.75,,,2.55,
amikacin,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,585.604,,,,,0.06,,,0.95,
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,318.87,,,,,0.965,,,5.75,
disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,339.48,,,,,,,,0.8,
bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,325.446,,,,,0.3,,,15.0,CYP450_3a4_substrate
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,314.858,,,,,0.97,,,,CYP450_3a4_substrate
propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,259.347,,,,17.9,,,,10.5,CYP450_2d6_inhibitor
timolol,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,316.42,1.8,9.2,0.269,159.0,0.1,,,4.45,CYP450_2d6_inhibitor
methoxyphenamine,CC(CC1=CC=CC=C1OC)NC,,2.6,10.45,,,,,,,
doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,451.48,,,,,0.99,,,2.1,
famotidine,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N,337.43,0.2,9.29,0.001,,0.175,,,13.0,
cefpodoxime,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,427.4603,,,,,,,,164.95,
clorazepate,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,314.727,,,,,0.975,,,0.095,CYP450_3a4_substrate
etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,287.357,,,,,0.94,,,0.333,
isoniazid,C1=CN=CC=C1C(=O)NN,137.141,,,100.0,,0.0,,,4.7,
acetylsalicylic acid (aspirin),CC(=O)OC1=CC=CC=C1C(=O)O,180.1582,,,,,0.49,,,5.2,
dronabinol (delta-(9)-tetrahydrocannabinol),CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,314.466,6.0,10.6,,,,,,0.2,CYP450_3a4_substrate
thioridazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,370.5824,5.9,9.5,33.6,,,,,0.565,
cannabidiol,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,314.466,,,,,0.94,,,1111.0,CYP450_3a4_substrate
encainide,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC,352.4752,,,,,0.36,,,10410.0,
cefonicid,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)O)C(=O)O)CSC4=NN=NN4CS(=O)(=O)O,542.572,,,,,0.98,,,1.2,
ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,254.284,,,,,0.99,,,,
chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,274.79,,,,,0.365,,,0.9,
nalbuphine,C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,357.4,,,,,,,,40.85,
SRT2104,CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6,516.6476,,,,,,,,248.3,
tauroursodeoxycholic acid,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,499.7085,3.6,,0.001,,0.985,,,,
methylnaltrexone,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,356.4394,,,,,0.1315,,,,
dextrorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O,257.375,,,,,,,,19.5,
fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,307.4747,,,,,0.997,,,4.3,CYP450_3a4_substrate
tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2,386.4414,,,,,0.84,,,5.65,
celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,,,,,0.97,,,4.225,
desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,310.8,,,,,0.845,,,,
(S)-methamphetamine (metamfetamine),C[C@@H](CC1=CC=CC=C1)NC,149.2355,2.07,9.9,,,0.15,,,,
adavosertib,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,500.607,,,,,,,,23.74,
dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,556.764,7.2,,1.7,0.40349999999999997,0.98,,,140.0,CYP450_3a4_substrate
ezogabine (retigabine),CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,303.335,,3.7,0.05,1.64,0.8,,,0.5,CYP450_3a4_inhibitor
telcagepant,C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,566.5283,,,,,0.9470000000000001,,,,
temafloxacin,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F,417.385,,,,,0.25,,,189.0,
Z-335,C1C(CC2=C1C=CC(=C2)CC(=O)[O-])CNS(=O)(=O)C3=CC=C(C=C3)Cl.[Na+],401.8443,,,,,,,,3.5999999999999996,
mipomersen,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])S[C@H]3C[C@@H](O[C@@H]3COP(=O)([O-])S[C@H]4C[C@@H](O[C@@H]4COP(=O)([O-])S[C@H]5C[C@@H](O[C@@H]5COP(=O)([O-])S[C@H]6C[C@@H](O[C@@H]6COP(=O)([O-])S[C@H]7C[C@@H](O[C@@H]7COP(=O)([O-])S[C@H]8C[C@@H](O[C@@H]8COP(=O)([O-])S[C@H]9C[C@@H](O[C@@H]9COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=O)([O-])S[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=NC2=C1N=C(NC2=O)N)CO)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)SP(=O)([O-])OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=NC1=O)N)C)SP(=O)([O-])OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)SP(=O)([O-])OC[C@H]1[C@@H]([C@@H]([C@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,7594.9,,,,,0.9,,,,CYP450_3a4_substrate
ixazomib,B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,517.12,,,,,0.99,,,1.9,CYP450_3a4_substrate
triclabendazole,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,359.663,,,0.1,,0.9670000000000001,0.641,,53.0,CYP450_3a4_substrate
CTP-499,[2H]C([2H])([2H])[C@@H](C([2H])([2H])CCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,285.3585,,,,,,,,31261.5,
luliconazole,C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl,354.28,,,,,0.99,,,,CYP450_3a4_substrate
mirogabalin,CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN,209.2871,,,,,,,,14.62,
grazoprevir,CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,766.9,,,0.001,,0.988,,,,
fidaxomicin,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,1058.04,6.4,,,,,,,,CYP450_3a4_substrate
bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,239.744,,,,,0.84,,,19.1,CYP450_3a4_substrate
diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,284.7447,,,,,0.49450000000000005,0.257,,0.22,CYP450_3a4_substrate
lisinopril,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,405.492,,,,,0.0,,,4.2,
artemether and lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O.C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)OC)C,,8.7,,0.001,,0.9540000000000001,,0.05,1.59,
tetracycline,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.4376,,,,,0.34,,,0.955,
crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,450.3,4.28,9.4,10.0,,0.91,0.84,,60.0,CYP450_3a4_substrate
mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,295.297,,,,,0.95,,,8.0,
valspodar,C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,1214.6,,,,,,,,2.26,
lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,426.8581,3.3,5.05,0.001,,0.985,,,9.5,CYP450_3a4_substrate
sotrastaurin,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,438.4888,,,,3.3,,,,,
bentysrepinine,CN(C)CCOC1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)CO)NC(=O)C3=CC=CC=C3,489.6,,,,,,,,148.35,
drospirenone,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,366.498,3.08,,0.001,,0.96,,,6.8,CYP450_3a4_substrate
"caffeine (1,3,7-TMX)",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,194.1906,,,,,0.305,,,40.0,
levomepromazine (methotrimeprazine),C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,328.478,,,,,0.9440000000000001,,,,
"zalcitabine (2',3'-dideoxycytidine)",C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N,211.22,,,,,,,,14.0,
firuglipel,CC[C@H](C1=NC(=NO1)C2=CC(=C(C=C2)C(=O)N[C@H](C)CO)F)OC3=CC=C(C=C3)C(=O)C4CC4,467.4944,,,,,,,,5.295,
noramidopyrine,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC,217.27,,,,,,,,2.1750000000000003,
colchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,399.44,,12.8,,,0.39,,,54.1,
galunisertib,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,369.4261,,,,,,,,40.9,
R1663,COC1=CC2=C(C=C1)SC3=CC=CC=C3N2,229.297,,,,,,,,36.5,
ginsenoside C-K,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,622.9,,,,,,,,33.8,
PKI 166,C[C@H](C1=CC=CC=C1)NC2=NC=NC3=C2C=C(N3)C4=CC=C(C=C4)O,,,,,,,,,61.5,
caspofungin,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,1093.32,,,,,0.97,,,11.0,CYP450_3a4_substrate
dihydroartemisinin,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,284.35,,,,,0.615,,,35.5,
KAF-156,CC1(C2=NC(=C(N2CCN1C(=O)CN)NC3=CC=C(C=C3)F)C4=CC=C(C=C4)F)C,411.4537,,,,,,,,18.455,
cinacalcet,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,357.417,,,,3.3,0.95,,,126.5,
risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,410.49,,,,,0.9,,,3.4000000000000004,CYP450_3a4_substrate
itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,705.643,5.66,,,,0.998,,,278.0,CYP450_3a4_substrate
nifurtimox,CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-],287.2947,,,,,0.42,,,,CYP450_3a4_inhibitor
atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,266.34,,9.0,10.0,1.0,0.05,,,,CYP450_3a4_substrate
tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,253.716,1.72,7.49,1.0,,0.3,,,153.5,
linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,337.35,,,,,0.31,,,1.4500000000000002,
liraglutide,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O,3751.2355,,,,,0.98,,,0.7,
tafenoquine,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,463.5,,,,,0.995,,,3.0,
diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,296.152,,,,,0.995,,,2.5500000000000003,
misoprostol acid,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,368.51,,,,,0.85,,,170.0,
xanomeline,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,281.42,,,242.0,4.15,0.95,,,1950.0,CYP450_2d6_inhibitor
tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,279.12,,,,,0.08,,,88.7,
tacrolimus,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,804.024,3.3,1.0,0.00402,,0.87,,,0.0665,CYP450_3a4_substrate
linagliptin,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,472.5502,1.7,1.0,0.9,3.56,0.895,,,70.0,CYP450_3a4_substrate
ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F,522.5742,2.295,12.94,0.016,,0.99,,,14.2,CYP450_3a4_substrate
daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,393.4373,5.28,3.24,0.054,11.5,0.9940000000000001,0.95,0.004,18.9,CYP450_3a4_substrate
oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,,1.1,,,,,,,,
cathinone,C[C@@H](C(=O)C1=CC=CC=C1)N,149.1919,,,,,,,,2104.5,
desmopressin,C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N,1069.23,,,,,,,,6.7,
trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,266.3388,,,,,0.16,,,,
bromazepam,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3,316.157,,,,,0.75,,,45.0,CYP450_3a4_substrate
amikacin,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,585.604,,,,,0.06,,,0.95,
evogliptin,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](CC2=CC(=C(C=C2F)F)F)N,401.4264,,,,,,,,29.5,
monomethyl auristatin E,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC,717.9863,,,,2.0,0.7505000000000002,,,45.9,
ulipristal,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,475.62,,,,,0.94,,,,CYP450_3a4_substrate
boceprevir,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,519.6825,3.0,,1.5,,0.75,,,161.0,CYP450_3a4_substrate
isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,371.391,,,,,0.97,,,5.5,
zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,212.23,,,,,0.39,,,0.13,CYP450_3a4_substrate
"didanosine (2',3'-dideoxyinosine)",C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O,236.23,,,,,0.05,,,11.5,
tacrine,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,198.268,2.71,9.95,217000.0,,0.75,,,,CYP450_3a4_inhibitor
tazarotenic acid,CC1(CCSC2=C1C=C(C=C2)C#CC3=NC=C(C=C3)C(=O)O)C,323.414,,,,,0.99,,,0.0555,
sulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.463,,,0.17,
antofloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=C(C(=C2N4CCN(CC4)C)F)N)C(=O)O,376.3859,,,,,,,,47.01,
(-)-mefloquine,C1CCN[C@H](C1)[C@H](C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,378.314,,,,,,,,0.6759999999999999,
artesunate,C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C,384.4222,,,,,0.93,0.85,,326.5,CYP450_3a4_substrate
aprepitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,534.43,2.4499999999999997,,,,0.95,,,76.0,CYP450_3a4_substrate
timolol,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,316.42,1.8,9.2,0.269,159.0,0.1,,,4.45,CYP450_2d6_inhibitor
ivosidenib,C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,582.96,2.97,1.4,0.001,,0.94,,,4.3,CYP450_3a4_substrate
rifamycin,C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,697.7733,,,,,0.8,,,,CYP450_3a4_substrate
finasteride,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,372.549,,,,,0.9,,,1.5499999999999998,
baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,371.42,,,,,0.5,,,8.9,CYP450_3a4_substrate
trospium,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,392.5,,,628.5,,0.8,,,796.0,CYP450_3a4_substrate
midecamycin acetate (miocamycin),CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C,898.046,,,,,0.47,,,,
sonidegib,C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,681.49,4.26,4.3,,4.58,0.97,0.29,,10.0,CYP450_3a4_substrate
clindamycin,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,424.987,,,,,0.469,,,3.0,
pirenzepine,CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,351.4079,,,,,0.14,,,255.0,
cobimetinib,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,531.3,2.42,8.86,0.72,,0.95,,,13.8,CYP450_3a4_substrate
meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,247.33,,,,,0.335,,,11.0,CYP450_3a4_substrate
nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,539.6327,,,5.0,,,,,1390.0,CYP450_3a4_substrate
pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,356.444,,,,,0.99,0.39,0.0078,1.43,CYP450_3a4_substrate
ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,255.233,,,,,0.015,,,3.1999999999999997,
paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,853.913,,,,,0.94,,,21.5,CYP450_3a4_substrate
ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl,436.8855,,,0.76,,0.9359999999999999,0.7,,11.2,CYP450_3a4_substrate
"L-771,688",COCC1=C([C@@H](N(C(=O)N1)C(=O)NCCCN2CCC(CC2)C3=CC=CC=N3)C4=CC(=C(C=C4)F)F)C(=O)OC,557.6,2.4,,,,,0.95,,,
carteolol,CC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O,292.37,,,,,0.25,,,5.535,
capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,359.352,,,,,0.54,,,145.0,
dimethyl fumarate,COC(=O)/C=C/C(=O)OC,144.13,,,,,0.36,,,,CYP450_3a4_inhibitor
betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,307.43,,,,,0.55,,,4.7,CYP450_2d6_inhibitor
levosimendan,C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,280.2898,,,,,0.98,,,300.0,
citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,9.5,3.3,,0.82,,,2.75,CYP450_3a4_substrate
efavirenz,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,315.68,,,,,0.99625,,,2.15,CYP450_3a4_substrate
omecamtiv mecarbil,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,401.4396,,,,,0.909,,,17.9,
anagliptin,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N,383.4535,,,,,,,,352.2,
netivudine,CC#CC1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,282.2506,,,,,0.88,,,0.605,
diltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,414.523,,,,,0.405,,,7.0,CYP450_3a4_substrate
dalfopristin,CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@@H]([C@@H](/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC3=NC(=CO3)C2=O)O)/C)C)C(C)C,690.854,,,,,0.53,,,15.25,
medroxyprogesterone,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,,,,,,,,,115.0,
fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,360.8,,,,,0.99,,,,CYP450_3a4_substrate
metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,365.839,,,,,,,,7503.9,
zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3,287.36,,,,,0.25,,,11.2,CYP450_3a4_inhibitor
kanamycin,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,484.499,,,,,,,,,
tenoxicam,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,337.3789,1.9,2.21,14100.0,,,,,2.745,
decitabine,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,228.21,,,3.3,,0.01,,,125.0,CYP450_3a4_substrate
ranitidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,314.408,,,,,0.09,,,5.75,
ginsenoside Rd,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,947.1578,,,,,0.003,,,1.3,
vinorelbine,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,778.942,,,,,,,,14.0,
rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.34,,,,,0.4,,,1.2,CYP450_3a4_inhibitor
vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,441.5323,,7.1,0.32,,0.975,0.6,,29.4,CYP450_3a4_substrate
oseltamivir acid,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)O,284.3536,,,,,0.03,,,,
mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,152.181,,,,,0.19,,,7.5,
terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,548.6,,,,,0.2,,,2.0,
pramipexole,CCCN[C@H]1CCC2=C(C1)SC(=N2)N,211.33,,,,,0.15,,,4.8,CYP450_3a4_inhibitor
metrifonate (trichlorfon),COP(=O)(C(C(Cl)(Cl)Cl)O)OC,257.4362,,,,,,,,0.34,
dextromethorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,271.401,,,,,0.65,,,1116.5,
N-desethylamodiaquine,CCNCC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,327.8132,,,,,,,,0.675,
bevirimat,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O,584.8324,,,,,,,,179.85000000000002,
mitiperstat,C[C@H](C1=C(C=CC(=C1)Cl)CN2C3=C(C(=O)NC2=S)NC=C3)N,334.8,,,,,0.65,,,20.1,
lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,293.724,,,,,0.985,,,4.6,
exemestane,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,296.41,3.1,,,,0.9,,,145.0,CYP450_3a4_substrate
zuclopenthixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,400.971,,,0.1,,0.98,,,0.9,
lurasidone,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O,492.6844,5.4,1.0,,,0.99,,,3902.0,CYP450_3a4_substrate
ezetimibe,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,409.43,,,,,0.9,,,,
clazosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,,,,,,,,,36.0,
sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,666.7,,,,,0.96,,,3.55,CYP450_3a4_substrate
talviraline,CC(C)OC(=O)N1[C@H](C(=S)NC2=C1C=C(C=C2)OC)CSC,340.466,2.7,8.31,0.0101,,,,,,
tilidine,CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2,273.3737,3.255,8.6,0.181,,,,,34019.5,
tetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,317.4,,,,,0.835,,,,CYP450_3a4_substrate
streptomycin,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,581.574,,,,,0.46,,,,
rifabutin,C[C@H]1/C=C/C=C(\C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)/C,847.013,3.2,,0.19,,0.365,,,1.4,
fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,501.6559,,,,,0.977,,,2495.0,
neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,557.0511,4.9,7.65,3.3,,0.99,,,216.0,CYP450_3a4_substrate
chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,169.567,,,,,,,,313.5,
stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,224.2148,,,,,,,,5.17,
desloratadine (descarboethoxyloratadine),C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,310.8,,,,,0.845,,,,
fludarabine,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,365.2,,,,,0.24,,,6.6,
asunaprevir,CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,748.3,,,,473.0,0.988,,,183.9,
valacyclovir (L-valacyclovir),CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,324.339,,,,,0.157,,,,
tasimelteon,CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2,245.3201,2.43,15.74,1.1,,0.9,,,1609.5,CYP450_3a4_substrate
levodopa,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,197.189,,,,,,,,13.5,
mirabegron,C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,396.5126,2.1,,,,0.71,,,57.0,CYP450_3a4_substrate
tolterodine,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,325.493,1.83,9.87,12.0,,0.963,0.8,,396.0,CYP450_3a4_substrate
alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,,,,,,0.708,,,,
nisoldipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,388.418,3.1,,,,0.9973000000000001,,,11.0,
milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,211.223,,,,,,,,18.2,
treprostinil,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,412.49,,,,,0.91,,,30.0,
fandosentan,CCC1=C2C(=CC(=C1)C3=C(N(S(=O)(=O)C4=CC=CC=C43)C5=CC=CC=C5C(F)(F)F)C(=O)O)OCO2,517.5,,,,,,,,15.3,
dihydrocodeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O,301.384,,,,,,,,704.5,
eliglustat,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O,404.5474,2.84,8.79,300.0,12.65,0.795,,,92.5,CYP450_3a4_substrate
eplerenone,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,414.5,7.1,,,,0.5,,,10.0,CYP450_3a4_substrate
selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,457.6855,,2.8,1.0,6.88,0.9840000000000001,0.56,,8.8,CYP450_3a4_substrate
mavorixafor,C1C[C@@H](C2=C(C1)C=CC=N2)N(CCCCN)CC3=NC4=CC=CC=C4N3,349.4793,2.4,11.5,70.0,0.8350000000000001,0.94,,,61.5,CYP450_3a4_substrate
alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,330.8,,6.95,,,0.41300000000000003,0.295,,600.0,
mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,179.261,2.3049999999999997,9.2,0.54,,0.33,,,1.9500000000000002,
isoniazid,C1=CN=CC=C1C(=O)NN,137.141,,,100.0,,0.0,,,4.7,
sulfamethizole,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,0.54,1.0,1050000.0,,0.985,,,,
"arformoterol (R,R-formoterol)",C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,344.4086,,,,,,,,,
tocainide,CC1=C(C(=CC=C1)C)NC(=O)C(C)N,,,,,,0.125,,,1.55,
telithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,812.0115,3.0,8.84,300000.0,,0.65,,,14.0,
morphothiadin,CCOC(=O)C1=C(NC(=NC1C2=C(C=C(C=C2)F)Br)C3=NC=CS3)CN4CCOCC4,509.4,2.5,,,,,,,106.0,
itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,358.4354,,,1000.0,,,,,,
safinamide,C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,302.3471,,,288.0,120.0,0.885,,,4.6,CYP450_3a4_substrate
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,314.858,,,,,0.97,,,,CYP450_3a4_substrate
flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,244.264,4.2,,,,0.995,,,0.21999999999999997,
relebactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,348.378,,,,,0.22,,,5.8,
ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,378.106,,,,,,,,37.995,
tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,415.1144,3.99,4.03,0.00269,,,,,0.0111,
cinaciguat,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,565.7061,,,,,,,,0.59,
vancomycin,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,1449.26,,,,,0.205,,,0.79,
artemisinin,C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,282.334,,,,,0.865,,,6.9,
amifostine,C(CN)CNCCSP(=O)(O)O,214.22,,,,,,,,1.115,
indoxyl sulfate,C1=CC=C2C(=C1)C(=CN2)OS(=O)(=O)O,213.212,,,,,0.905,,,,
aplaviroc,CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O,577.7177,,,,,0.93,,,34.6,
zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,236.29,,,0.001,,0.93,,,7.0,
sertraline,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,306.234,,,,,0.985,,,26.0,CYP450_3a4_substrate
osilodrostat,C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F,227.241,1.61,6.9,50.0,6.88,0.364,0.117,,16.4,CYP450_3a4_substrate
gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,263.1989,,,,,,,,28.599999999999998,
nortilidine,CCOC(=O)[C@]1(CCC=C[C@@H]1NC)C2=CC=CC=C2,,,,,,0.138,,,,
eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O,424.519,,,,,0.98,,,,CYP450_3a4_substrate
ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,554.5872,,,,,0.925,,,0.87,
bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,530.446,,,0.053,,0.94,,,38.85,CYP450_3a4_substrate
argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,526.66,,,,,0.54,,,,
acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,225.207,,,,,0.21,,,3.37,
cryptophycin 52,C[C@@H]([C@@H]1C/C=C/C(=O)N[C@@H](C(=O)NCC(C(=O)O[C@H](C(=O)O1)CC(C)C)(C)C)CC2=CC(=C(C=C2)OC)Cl)[C@@H]3[C@H](O3)C4=CC=CC=C4,686.217,,,,,,,,54.9,
hexobarbital,CC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2,236.2694,,,,,,,,164.0,
imipenem and cilastatin,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,,,,,,0.2,,,11.8,
(S)-mephenytoin,CC[C@@]1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,218.2,1.69,8.51,1.27,,0.3,0.779,,,
balipodect,COC1=CN(N=C(C1=O)C2=CC=NN2C3=CC=CC=C3)C4=C(C=C(C=C4)N5C=CC=N5)F,428.4253,,,,,,,,80.3,
macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,588.279,3.7,,,,0.99,,,,CYP450_3a4_substrate
quinupristin,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)C[C@H]3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C,1022.2313,,,,,0.275,,,10.315,
clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,326.829,,,,,0.97,,,3.8499999999999996,CYP450_3a4_substrate
nusinersen,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=S)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]5[C@H]([C@H]([C@@H](O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OC[C@@H]8[C@H]([C@H]([C@@H](O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,7501.0,,,,,0.25,,,,CYP450_3a4_substrate
flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,304.3233,,,,,,,,275.0,
guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,282.55,,,,,0.7,,,414.4,CYP450_3a4_substrate
(R)-omeprazole,CC1=CN=C(C(=C1OC)C)C[S@@](=O)C2=NC3=C(N2)C=C(C=C3)OC,345.4,,9.29,0.36,,0.96,,,0.037,
triamcinolone,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,,,,,,0.708,,,,
nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,309.403,,,,,0.3,,,,
ethosuximide,CCC1(CC(=O)NC1=O)C,141.169,,,,,0.0,,,0.115,
S-3304,CC1=CC=C(C=C1)C#CC2=CC=C(S2)S(=O)(=O)N[C@H](CC3=CNC4=CC=CC=C43)C(=O)O,464.564,,,,,,,,,
CF-1743,CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)CO)O,398.4564,,,,,,,,450.0,
seliciclib (R-roscovitine),CC[C@H](CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,354.455,,,,,0.9,,,,
(-)-epigallocatechin,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,306.269,,,,,,,,715.3,
phenprocoumon,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,280.3,3.62,4.1,100000.0,,,,,,
TAK-272,CC(C)CN([C@H]1C[C@H](CNC1)C(=O)N2CCOCC2)C(=O)C3=NC4=CC=CC=C4N3CCCCOC.Cl,536.1128,,,,,0.8195,,,,
remacemide,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN,268.358,,,,,0.74,,,,
(+)-tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,263.379,,,,,,,,0.49,
quinapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,438.521,,,,,0.97,,,0.6,
dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,487.95,,,,,0.98,,,24.9,CYP450_3a4_substrate
(S)-7-hydroxywarfarin,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(C3=C(C=C(C=C3)O)OC2=O)O,324.3,,,,,,,,51.35,
empagliflozin,C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl,450.91,,,0.001,,0.862,,,10.6,
naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C([C@H]4[C@@]56CCN([C@@H]([C@@]5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,570.6426,3.2,,,,0.935,,,8.34,CYP450_3a4_substrate
isosorbide dinitrate,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-],236.135,,,,,0.2,,,48.5,
quazepam,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,386.799,,,,,0.95,,,,CYP450_3a4_substrate
bedaquiline,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,555.5,,,,,0.99,,,4.8549999999999995,CYP450_3a4_substrate
fluvastatin (acid),CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,411.47,,,101.0,,0.98,0.75,,9.5,CYP450_3a4_substrate
tiopronin,CC(C(=O)NCC(=O)O)S,163.196,,,,,0.8,,,62.0,
cannabidiol,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,314.466,,,,,0.94,,,1111.0,CYP450_3a4_substrate
buprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O,467.646,4.82,,,44.7,0.96,,,6.945,CYP450_3a4_substrate
indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,357.791,,,,,0.9,,,0.7999999999999999,
arbutin,C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,272.0,0.765,,,,,,,,
tirilazad,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,624.8599,6.04,18.26,0.0773,,,,,0.25,
fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)[C@@H]4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,487.3848,,,,,,,,0.40700000000000003,
fluticasone,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)O)C)O)F)C)F,444.511,,,,,0.99,,,1093.0,CYP450_3a4_substrate
temazepam (3-hydroxydiazepam),CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,300.744,,,,,0.96,,,97.1,CYP450_3a4_substrate
cifenline (cibenzoline),C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4,262.354,,,,,,,,5.63,
dotinurad,C1N(C2=CC=CC=C2S1(=O)=O)C(=O)C3=CC(=C(C(=C3)Cl)O)Cl,358.2001,,,,,0.49689999999999995,,,0.45499999999999996,
lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,628.809,5.9,,,,0.985,,,1.2,CYP450_3a4_substrate
acalabrutinib,CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,465.5147,,,100.0,,0.975,,,71.0,CYP450_3a4_substrate
filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,425.5107,,,,,0.57,,,,
aliskiren,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,551.7637,,,,0.2,0.495,,,,CYP450_3a4_substrate
vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,264.32,,,,,0.7120000000000001,,,3.5500000000000003,
teriparatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N,4117.8,18.7,,,,,,,62.0,
anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,293.372,,,,,0.4,,,,CYP450_3a4_substrate
cilazaprilat,C1C[C@@H](C(=O)N2[C@@H](CCCN2C1)C(=O)O)N[C@@H](CCC3=CC=CC=C3)C(=O)O,389.449,,,,,,,,12.3,
velpatasvir,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC,883.0136,,,,,0.995,,,39214.5,CYP450_3a4_substrate
benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],260.2518,,,,,0.52,,,,
netupitant and palonosetron,C/C=C(/C=C)\C1=CC(=NC=C1N(C)C(=O)C(C)(C)C2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)N3CCN(CC3)C.C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5,578.61,,,,,0.995,,,14.75,CYP450_3a4_substrate
setrobuvir,CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C([C@@H]4[C@H]5CC[C@H](C5)[C@@H]4N(C3=O)CC6=CC=C(C=C6)F)O,560.6245,,,,,0.99,,,0.688,
midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,325.773,2.5,5.5,,42.0,0.97,,,4.2,CYP450_3a4_substrate
glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,445.541,,5.9,,,0.9840000000000001,,,0.35,
medigoxin (beta-methyldigoxin),C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)OC,794.9694,,,,,,,,4.0,
elbasvir and grazoprevir,CC(C)[C@@H](C(=O)N1CCC[C@@H]1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5[C@@H](O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)[C@@H]9CCCN9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,766.9,,,0.001,,,,,,CYP450_3a4_substrate
brivaracetam,CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,212.291,,,,,0.2,0.564,,0.817,CYP450_3a4_substrate
fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,411.5823,,,,,0.5,,,,CYP450_3a4_substrate
levofloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.371,,,,,0.31,,,1.485,
carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,236.273,,,,,0.385,,,0.9,CYP450_3a4_substrate
levonorgestrel,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,312.4,,,,,0.955,,,,
atazanavir,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,704.864,,4.7,5.2,5.3,0.86,,,142.0,CYP450_3a4_substrate
lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,406.41,2.45,,0.17,,0.66,,,11.0,CYP450_3a4_substrate
oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,357.491,,,,,,,,5.199999999999999,CYP450_3a4_substrate
prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,367.8744,,,,,0.289,,,317.0,CYP450_3a4_substrate
(R)-acenocoumarol,CC(=O)C[C@H](C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,353.328,,,,,,,,0.915,
AMG 487,CCOC1=CC=C(C=C1)N2C(=O)C3=C(N=CC=C3)N=C2[C@@H](C)N(CC4=CN=CC=C4)C(=O)CC5=CC=C(C=C5)OC(F)(F)F,,,,,,,,,219.5,
fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,437.527,,,,,0.97,,,8.5,
olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,558.59,,,,,0.99,,,,
azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,381.905,,,,,0.83,,,0.365,
ceftaroline,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],684.6939,,,,,,,,5.5,
peramivir,CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C,382.45,,,,,0.18,,,6.78,CYP450_3a4_inhibitor
esketamine,CN[C@@]1(CCCCC1=O)C2=CC=CC=C2Cl,237.728,,,,,0.43,0.637,,89.0,
rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl,435.8862,,13.4,7000.0,,0.935,0.18,,10.0,CYP450_3a4_substrate
iomeprol,CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,777.09,,,,,0.0,,,0.055,
azithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,748.989,,8.1,100.0,,0.07,,,630.0,
desirudin,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H]2C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]3CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)[C@@H](C)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCCCN)C(=O)N6CCC[C@H]6C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC7=CN=CN7)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC8=CC=CC=C8)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N9CCC[C@H]9C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,6963.48,,,,,0.3,,,2.2,
zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,305.34,1.3,,,,0.375,0.55,,9.5,CYP450_3a4_substrate
triamterene,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,253.268,,,,,0.315,,,41.5,
rifampin,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,822.947,,,0.1,12.0,0.75,,,2.55,
eritoran,CCCCCCCCCCCC(=O)CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1OP(=O)(O)O)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC)OP(=O)(O)O)OCC[C@@H](CCCCCCC)OC)NC(=O)CCCCCCCCC/C=C\CCCCCC)O)OCCCCCCCCCC,1313.6644,,,,,,,,0.0293,
dalbavancin,CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)NC(C7=C(C(=CC(=C7)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,1816.71,,,,,0.9259999999999999,,,0.0466,
axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,386.4772,3.5,4.8,1841.0,13.8,,,,21.0,CYP450_3a4_substrate
doxifluridine (5'-dFUrd),C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O,246.19,,,,,,,,836.9,
nafithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)[C@@H](C(=O)O2)/C(=N/O[C@@H](C)C4=NN=C(S4)C5=CC=CC=N5)/N)C,859.0488,,,,,0.419,,,53.9,
rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,323.3692,,,1.7,,0.7,,,47.25,CYP450_3a4_substrate
N-desmethylimatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCNCC3)NC4=NC=CC(=N4)C5=CN=CC=C5,479.6,,,,,0.95,,,,
tapentadol,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,221.34,2.87,9.34,100.0,,0.2,,,853.5,CYP450_3a4_inhibitor
zomepirac,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,291.7326,,,,,,,,3.14,
galantamine,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,287.357,,,,,0.18,,,,CYP450_3a4_substrate
erythromycylamine,CC[C@@H]1[C@@]([C@@H]([C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)N)C)O)(C)O,,,,,,0.225,,,,
ambrisentan,CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,378.42,,,,,0.986,,,38.0,CYP450_3a4_substrate
deferiprone,CC1=C(C(=O)C=CN1C)O,139.15,0.098,1.0,1.0,,0.2,,,31.3,
clofibric acid,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,214.6469,,,,,0.49050000000000005,,,,
sertindole,C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O,440.947,,,,,,,,6.5,CYP450_3a4_substrate
oxycodone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,315.367,0.7,8.53,1.0,,0.45,,,12.3,CYP450_3a4_substrate
vilaprisan,C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C(C(F)(F)F)(F)F)O)C5=CC=C(C=C5)S(=O)(=O)C,544.5781,,,0.001,,,,,15.1,
nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,414.4798,2.9,,,,0.457,,,363.935,
pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,597.49,,,,,0.81,,,91.8,
DNDI-VL-2098,C[C@@]1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)OC(F)(F)F,,,,,,0.9590000000000001,,,,
carfilzomib,CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,719.9183,,,0.001,,0.97,,,207.0,CYP450_3a4_inhibitor
rolapitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4,500.48,,,,,0.998,,,0.96,CYP450_3a4_substrate
enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,320.3223,,,,,,,,11.625,
erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,733.93,,,1.0,,0.435,,,6.6,CYP450_3a4_substrate
diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,296.152,,,,,0.995,,,2.5500000000000003,
terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,387.438,,,,,0.92,,,1.15,
cefsulodin,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,532.552,,,,,,,,81.5,
zomepirac,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,291.7326,,,,,,,,3.14,
isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,371.391,,,,,0.97,,,5.5,
metioprim,COC1=CC(=CC(=C1SC)OC)CC2=CN=C(N=C2N)N,306.3882,,,,,,,,78.3,
pindolol,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,248.32,,,,,0.4,,,,
amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,645.31,,,,,0.49995000000000006,,,1.15,
felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,384.257,3.9,5.07,,,0.499,,,0.8,CYP450_3a4_substrate
cefuroxime,CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,424.388,,,,,0.195,,,0.94,
alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,308.771,,,,,,,,0.44,CYP450_3a4_substrate
mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,378.31,,,,,0.982,,,0.28500000000000003,
imipenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,299.3493,,,,,0.2,,,1.5999999999999999,
mezlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C,539.5875,,,,,,,,19.9,
bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,364.42,,,,,0.97,,,136.5,
alprenolol,CC(C)NCC(COC1=CC=CC=C1CC=C)O,249.352,,,,,0.85,,,,
tenoxicam,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,337.3789,1.9,2.21,14100.0,,,,,2.745,
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,309.45,117.0,9.2,,,0.875,,,63.7,CYP450_3a4_substrate
sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,398.3976,2.5,3.23,,,0.993,,,0.24,
propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,368.494,,,,,,,,79.2,
chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,319.877,,,,,,,,8.35,
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,416.579,,,,,0.9,,,93.0,
temocillin,CC1([C@@H](N2[C@H](S1)[C@@](C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,414.4572,,,,,0.85,,,29.0,
pentazocine,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,285.4283,3.31,8.5,,,0.63,,,741.0,
cephalexin,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,347.393,,,,,0.085,,,2.7,
nizatidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,331.463,,,,,0.35,,,50.0,
sulfamethizole,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,,0.54,1.0,1050000.0,,0.985,,,,
cefotetan,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,575.6263,,,,,0.88,,,1.8,
piperacillin,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,517.56,,,,,0.3,,,14.4,
sulfinpyrazone,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,,2.3,3.25,1.0,,0.494,,,,
flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,453.8763,,,,,0.95,,,67.5,
chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,0.483,,,0.017499999999999998,
bufuralol,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,261.363,,,,,0.9,,,26.0,
dibekacin,C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N,451.5173,,,,,,,,58.45,
carbidopa,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,226.23,,,,,,,,12.5,
dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,248.305,,,,,0.37,,,0.385,
flupentixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,434.523,,,,5.7,0.9840000000000001,,,,
amodiaquine,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,355.867,,,,,,,,35.9,
capreomycin,C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCNC(=N2)N)CNC(=O)C[C@H](CCCN)N.C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N,651.7057,,,,,,,,3.6350000000000002,
gestodene,CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.943,,,,
prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,383.406,,,,,0.48,,,1.65,
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,277.409,,,,,0.478,,,7.45,CYP450_3a4_substrate
(R)-propranolol (dexpropranolol),CC(C)NC[C@H](COC1=CC=CC2=CC=CC=C21)O,259.3469,,,,,,,,2470.5,
procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,235.329,,,,,0.105,,,2.7,
carumonam,C1=C(N=C(S1)N)/C(=N/OCC(=O)O)/C(=O)N[C@H]2[C@H](N(C2=O)S(=O)(=O)O)COC(=O)N,466.4066,,,,,0.18,,,58.050000000000004,
methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,233.309,,,,,0.155,,,4.335,
esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,295.37,,,,,0.55,,,120.0,
piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,331.3,,,,,0.99,,,1.25,CYP450_3a4_substrate
etoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,588.559,,,,,0.48200000000000004,,,2.505,CYP450_3a4_substrate
quinapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,438.521,,,,,0.97,,,0.6,
chlormethiazole,CC1=C(SC=N1)CCCl,161.6552,,,,,0.692,,,185.85000000000002,
ampicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,371.39,,,100.0,,0.28,,,156.9,
codeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,299.368,,,,,0.07,,,6.5,CYP450_3a4_substrate
ethanol,CCO,46.07,,,,,,,,67.0,
aztreonam,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N,435.44,,,,,0.56,,,91.0,
glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,445.541,,5.9,,,0.9840000000000001,,,0.35,
trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,294.4394,,,0.1,,0.91,,,,
norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,319.334,1.03,6.34,0.1,,0.125,,,,
diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,284.7447,,,,,0.49450000000000005,0.257,,0.22,CYP450_3a4_substrate
isotretinoin (13-cis-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,300.44,,,,,0.99,,,6.0,
midecamycin acetate (miocamycin),CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)OC(=O)C)N(C)C)O)CC=O)C)OC(=O)C)C,898.046,,,,,0.47,,,,
probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,285.36,,,0.06,,0.91,,,1.38,
phenacetin,CCOC1=CC=C(C=C1)NC(=O)C,179.22,,,,47.0,,,,,
fluvoxamine,COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F,318.337,3.38,9.16,0.06,,0.77,,,21.4,CYP450_3a4_substrate
amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,408.879,,8.6,1.0,,0.47,,,3.7,CYP450_3a4_substrate
vigabatrin,C=CC(CCC(=O)O)N,129.158,,,,,,,,93.6,
warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,308.331,,5.1,,,0.5,,,0.0345,CYP450_3a4_substrate
diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,255.36,,,,,0.405,,,3.95,CYP450_3a4_substrate
acetaminophen glucuronide,CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,327.287,,,,,,,,1.8,
pefloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,333.361,,,,,0.25,,,3.6,
ethosuximide,CCC1(CC(=O)NC1=O)C,141.169,,,,,0.0,,,0.115,
nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,418.443,,,,,0.98,,,19.0,CYP450_3a4_substrate
lovastatin (lactone),CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,404.543,4.08,13.49,,,0.95,,,11.3,CYP450_3a4_substrate
oxprenolol,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,265.351,,,,,0.8,,,,
ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,254.284,,,,,0.99,,,,
phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,232.2,,,,,0.27,,,0.0375,
flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,414.344,,,,,0.4,,,3.4499999999999997,
ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,263.791,2.9,6.94,100.0,,0.98,,,34.0,
teicoplanin,CCCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@@H](C7=C(C(=CC(=C7)O)OC8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)Cl)CO)O)O,1879.65828,,,,,,,,8.5,
spiramycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,842.05,,,,,,,,1.14,
felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,238.242,,,,,0.235,,,0.315,CYP450_3a4_substrate
cefotaxime,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,455.47,,,,,0.195,,,2.15,
metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],171.155,,,,,0.07,,,0.8,
cefmetazole,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,471.541,,,,,,,,92.14999999999999,
cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1202.62,,,,,0.475,,,12.3,CYP450_3a4_substrate
baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,213.663,,,,,0.21,,,180.0,
clavulanic acid,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O,199.1611,,,,,,,,1.9200000000000002,
tretinoin (all-trans-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,300.44,,,,,0.95,,,,CYP450_3a4_substrate
diosmin,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,608.5458,,,,,,,,0.87,
theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166,-0.02,8.81,7360000.0,4.35,0.3,,,0.42500000000000004,CYP450_3a4_inhibitor
amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,229.63,,,,,0.25,,,,
belotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O,433.505,,,,,,,,3.5500000000000003,
leuprolide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,,,,5.85,CYP450_3a4_substrate
oseltamivir,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,312.407,,,,,0.03,,,2.75,
triclabendazole sulfone,CS(=O)(=O)C1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,391.7,,,,,0.988,,,,
tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,454.8681,4.09,5.9,0.001,2.855,0.99,,,0.75,CYP450_3a4_substrate
benperidol,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,381.449,,,,,0.78,,,,
sulbactam,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,233.2429,,,,,0.38,,,254.0,
PF-05241328,CC1=NN(C2=C1C=C(C=C2)C(=O)NS(=O)(=O)C)C3=CC(=C(N=C3)OCC(C)C)Cl,436.9179,,,,,,,,392.0,
regorafenib N-oxide (M2),CNC(=O)C1=[N+](C=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F)[O-],,,,,,0.998,,,,
erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,733.93,,,1.0,,0.435,,,6.6,CYP450_3a4_substrate
bortezomib,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,384.241,,,,,0.83,,,32.0,
paynantheine,CO/C=C(\[C@H]1C[C@H]2C3=C(CCN2C[C@@H]1C=C)C4=C(N3)C=CC=C4OC)/C(=O)OC,396.4794,,,,,,,0.055,53.45,
cefdinir,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O,395.419,,,,,0.665,,,11.6,
zanamivir,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N,,,,,,0.1,,,1.5499999999999998,
apinocaltamide,C1CC1(C2=CC=C(C=C2)CC(=O)NC3=NN(C=C3)CC4=NC=C(C=C4)C#N)C(F)(F)F,425.4,,,,,,,,,
darifenacin,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,426.557,,,,,0.98,,,40.0,CYP450_3a4_substrate
lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366,2.8,1.0,,,0.97,0.472,,3.915,CYP450_3a4_substrate
metformin,CN(C)C(=N)N=C(N)N,129.16,-1.43,11.8,100.0,,,,,3.96,
dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,504.632,,,,,0.99,,,,
daridorexant,CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,450.9207,3.9,,0.0001,22.6,0.997,0.89,0.12,4.97,CYP450_3a4_substrate
rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,269.35,,,,,0.14,,,6.8500000000000005,CYP450_3a4_inhibitor
alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,482.62,,,,,0.99,,,81.9,CYP450_3a4_substrate
blonanserin,CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F,367.509,,,,,,0.794,,,
progesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,314.5,,,,,0.97,,,,
brecanavir,CC1=NC(=CS1)COC2=CC=C(C=C2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)C3=CC4=C(C=C3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6,703.83,,,,,0.98,,,75.1,
fexinidazole,CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-],279.3187,2.3,1.8,,57.2,0.98,0.12,,99.0,CYP450_3a4_substrate
donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,379.497,,,,,0.4675,,,1.8199999999999998,CYP450_3a4_substrate
3-carboxy-4-methyl-5-propyl-2-furanpropionate,CCCC1=C(C(=C(O1)CCC(=O)O)C(=O)O)C,,,,,,0.995,,,,
CP-724714,CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C,469.5,,,,,,,,29.0,
(R)-bicalutamide,C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,430.37,,,,,0.96,,,,
lomitapide,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,693.7283,8.6,8.2,1.0,,0.998,,,,CYP450_3a4_substrate
lorcaserin,C[C@H]1CNCCC2=C1C=C(C=C2)Cl,195.6916,2.56,9.53,6.0,,0.7,,,26.07,CYP450_3a4_inhibitor
polymyxin B,CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)[C@@H](C)O,2392.9516,,,,,,,,0.54,
lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,581.065,5.1,1.0,,,0.99,,,,CYP450_3a4_substrate
levomepromazine,C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,328.478,,,,,0.9440000000000001,,,,
dalcetrapib,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,389.6005,,,,,,,,41.95,
ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,206.283,,,1.0,,0.99,,,0.475,CYP450_3a4_inhibitor
sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,272.367,,,,,,,,2.6,
baloxavir,C1COC[C@@H]2N1C(=O)C3=C(C(=O)C=CN3N2[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)O,483.5,,,,,0.934,,,10.3,CYP450_3a4_substrate
ledipasvir,CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,889.0116,7.4,1.0,,1.76,0.998,,,,CYP450_3a4_substrate
tiotropium,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,392.5178,,,,,0.72,,,880.0,CYP450_3a4_substrate
tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,308.1193,,,,,0.99,,,0.263,
sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,253.281,0.7949999999999999,1.0,0.001,,0.29,,,0.19,
olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,312.44,0.91,4.69,0.0046,17.37,0.93,0.2367,,25.0,CYP450_2d6_inhibitor
alisporivir,CC[C@H]1C(=O)N([C@@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,1216.6507,3.2,,,8.46,0.92,,,128.0,
amphotericin B,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,924.084,,,,,0.9,,,0.33,
tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],273.243,,,,,0.9990000000000001,,,0.915,CYP450_3a4_substrate
leniolisib,CCC(=O)N1CC[C@@H](C1)NC2=NC=NC3=C2CN(CC3)C4=CC(=C(N=C4)OC)C(F)(F)F,450.4625,2.5,,8.88,1.7,0.945,0.945,,3.51,CYP450_3a4_substrate
vaborbactam,B1([C@H](CC[C@H](O1)CC(=O)O)NC(=O)CC2=CC=CS2)O,297.14,,,,,0.33,,,6.3500000000000005,
tanespimycin,C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)/C)OC)OC(=O)N)\C)C)O)OC,585.6937,,,,,0.0395,,,17.1,
vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,345.4,2.74,9.3,1.0,17.8,0.865,0.491,0.94,97.3,CYP450_3a4_substrate
AFN-1252,CC1=C(OC2=CC=CC=C12)CN(C)C(=O)/C=C/C3=CC4=C(NC(=O)CC4)N=C3,375.4259,,,,,0.953,,,,
istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C,384.4336,2.5,7.8,0.88,32.3,0.98,,,4.6,CYP450_3a4_substrate
D-ribose,C1[C@H]([C@H]([C@H](C(O1)O)O)O)O,150.129,,,,,,,,83.2,
mavacamten,C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C,273.3341,,,0.001,127.7,0.97,0.743,,35.0,CYP450_3a4_substrate
antipyrine (phenazone),CC1=CC(=O)N(N1C)C2=CC=CC=C2,188.229,,,,,,,,39.75,
(R)-cetirizine (levocetirizine),C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.892,,,,,0.46799999999999997,,,23.99,
paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,329.369,2.53,9.51,,,0.95,,,5.9,CYP450_3a4_substrate
selegiline,C[C@H](CC1=CC=CC=C1)N(C)CC#C,187.28,2.7,7.44,100.0,,0.94,,,1500.0,CYP450_3a4_substrate
aplidine,CC[C@H](C)[C@@H]1[C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)N(C)C(=O)[C@@H]3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,,,,,,,,,47.0,
pibrentasvir,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C(=C3)F)[C@H]4CC[C@@H](N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)OC)NC(=O)OC)NC(=O)OC)OC,1113.18,,,0.001,1.0,0.9990000000000001,,,6340.0,
pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,273.2469,,,15.0,,0.28,0.54,,8.5,CYP450_3a4_substrate
suvorexant,C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,450.9277,3.95,0.25,0.117,,0.99,,,4.755,CYP450_3a4_substrate
moxidectin,C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N\OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C,639.825,,,,,0.8,,,2.365,CYP450_3a4_substrate
cephalexin,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,347.393,,,,,0.085,,,2.7,
feprazone,CC(=CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)C,320.39,,5.1,,,,,,3.6,
enalaprilat,C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O,348.397,,,,,,,,14.365,
6-mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,152.181,,,,,0.19,,,7.5,
glycoobeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)NCC(=O)O)C)C)O,477.6765,,,,,0.9976999999999999,,,,
dihydroergotamine,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,583.685,,,,,0.93,,,1.5,CYP450_3a4_substrate
vamorolone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@]1(C(=O)CO)O)C)C,356.46,4.39,,0.038,11.23,0.8809999999999999,,,58.0,CYP450_3a4_substrate
niraparib,C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,320.394,,,,,0.83,,,16.2,CYP450_3a4_substrate
phenacetin,CCOC1=CC=C(C=C1)NC(=O)C,179.22,,,,47.0,,,,,
norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,319.334,1.03,6.34,0.1,,0.125,,,,
trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,294.4394,,,0.1,,0.91,,,,
dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl,408.87,,,,,0.91,,,,
cavosonstat,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,299.712,,,,,,,,17.2,
papaverine,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,339.389,,,,,0.94,,,,
acamprosate,CC(=O)NCCCS(=O)(=O)O,181.211,,,,,,,,8.25,
itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,553.5217,1.6,,,,0.304,,,136.35,
AZD1981,CC1=C(C2=C(C=CC=C2N1CC(=O)O)NC(=O)C)SC3=CC=C(C=C3)Cl,388.8733,,,,,0.9714,,,,
tozasertib,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,464.5952,,,,,0.9309999999999999,,,,
danusertib,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)[C@@H](C5=CC=CC=C5)OC,474.562,,,,,0.6629999999999999,,,,
deramciclane,C[C@@]12CC[C@@H](C1(C)C)C[C@@]2(C3=CC=CC=C3)OCCN(C)C,301.471,,,,,,,,0.16999999999999998,
methylarbutin,COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.278,0.36,,,,,,,,
azilsartan medoxomil,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)OCC6=C(OC(=O)O6)C,568.5396,,,0.001,,,,,,CYP450_2c9_inhibitor
p-aminosalicylate,C1=CC(=C(C=C1N)[O-])C(=O)O,153.135,,,,,0.15,,,,
deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,373.4,,,,,0.99,,,2.1999999999999997,
hydroxyurea,C(=O)(N)NO,76.0546,,,,,0.775,,,153.2,
cipargamin,C[C@H]1CC2=C([C@]3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,390.2436,,,,,,,,2.5500000000000003,
hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,297.742,,,,,0.375,,,3.0,
nitrendipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,360.364,2.4,,,,0.98,,,1450.0,
SNF472,C1(C(C(C(C(C1OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-])OP(=O)(O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,,,,6100.0,
dolasetron,C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54,324.378,,,,,,,,11.5,CYP450_3a4_substrate
dexlansoprazole,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366,,,0.16,,0.975,,,11.4,
flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,,,,,,,,,,
glecaprevir and pibrentasvir,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C(=C3)F)[C@H]4CC[C@@H](N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)OC)NC(=O)OC)NC(=O)OC)OC.CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87,,,,,0.9990000000000001,,,1150.0,CYP450_3a4_substrate
quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,302.237,,,,,,,,35300.0,
buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,385.509,,,,,0.95,,,19.3,CYP450_3a4_substrate
ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,467.42,4.53,6.31,,,0.4999,0.064,,11.7,CYP450_3a4_substrate
alfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,416.523,,,,,,,,4.55,
probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,285.36,,,0.06,,0.91,,,1.38,
finerenone,CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,378.4298,,4.3,0.001,10.65,0.9167000000000001,0.9,,25.63,CYP450_3a4_substrate
procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,235.329,,,,,0.105,,,2.7,
ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,204.312,,,,,0.18,,,4.7,
20(R)-protopanaxadiol,CC(=CCC[C@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O)C,,,,,,,,,314.5,
lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4([C@]35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,412.5342,,,,,,,,17.7,
tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,270.351,2.34,5.16,109000.0,,0.935,,,0.14,
amenamevir,CC1=C(C(=CC=C1)C)N(CC(=O)NC2=CC=C(C=C2)C3=NOC=N3)C(=O)C4CCS(=O)(=O)CC4,482.5584,,,,,0.75,,,15.344999999999999,
dulaglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC6=CNC=N6)N,63000.0,,,,,,,,0.107,
cefetamet,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,397.435,,,,,0.22,,,192.5,
censavudine,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@](O2)(CO)C#C,248.2368,,,,,,,,10330.5,
nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,253.3431,,,,,0.73,,,3.96,
murepavadin,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC4=CNC5=CC=CC=C54)[C@@H](C)O)CO)C)CCN)CCN)CC6=CNC7=CC=CC=C76)CCN)CCN)CCCN)CCN,1553.8258,,,,,,,,91.0,
abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,506.59,,,5.0,,0.48699999999999993,,,26.0,CYP450_3a4_substrate
sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,398.4793,5.2,8.95,25.0,,0.95,,,48.0,
bromfenac,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O,334.16,,,,,0.99,,,6.9,
didesmethylcitalopram,C1C2=C(C=CC(=C2)C#N)C(O1)(CCCN)C3=CC=C(C=C3)F,,,,,,0.78,,,,
febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,316.379,3.66,3.08,0.001,,0.99,,,,CYP450_3a4_substrate
rifapentine,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C,877.031,,,,,0.977,,,,
tenofovir,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,287.2146,,,,,0.01,,,1.75,
enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,464.4414,2.98,7.0,100.0,31.0,0.975,,,0.675,CYP450_3a4_substrate
indisulam,C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)S(=O)(=O)N)NC=C2Cl,385.851,,,,,0.997,,,2.3,
dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,493.5813,4.3,,,44.2,0.9990000000000001,,,,
trapidil,CCN(CC)C1=CC(=NC2=NC=NN12)C,205.264,,,,,,,,175.0,
tadalafil,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,389.41,2.89,15.17,0.001,,0.94,,,2.5,CYP450_3a4_substrate
trofosfamide,C1CN(P(=O)(OC1)N(CCCl)CCCl)CCCl,323.586,,,,,,,,3603.0,
tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,247.274,,,,,0.12,,,,
orlistat,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,495.75,,,,,0.99,,,,
chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,319.877,,,,,,,,8.35,
gestodene,CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.943,,,,
momelotinib,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,414.4668,2.96,1.4,467.1,30.4,0.91,0.362,0.815,103.0,CYP450_3a4_substrate
bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,551.621,3.1,5.46,1.0,,,,,4.0,
zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,307.395,,,,,0.92,,,2.6,CYP450_3a4_substrate
(-)-epicatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,442.374,,,,,,,,329.15,
warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,308.331,,5.1,,,0.5,,,0.0345,CYP450_3a4_substrate
toremifene,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3,405.966,,,,,0.997,,,1.9,CYP450_3a4_substrate
quinine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.875,,,1.2,
cefotiam,CN(C)CCN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O,525.637,,,,,,,,11.8,
buprenorphine glucuronide,C[C@@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)O4)CC8CC8)OC)(C(C)(C)C)O,,,,,,,,,1414.0,
doxapram,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,378.513,,,,,0.56,,,,
plazomicin,C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H](CC=C(O3)CNCCO)N)N)NC(=O)[C@H](CCN)O)O,592.6862,,,,,0.2,,,2.7,
aranidipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,388.374,,,,,,,,0.6,
amphetamine,CC(CC1=CC=CC=C1)N,135.21,1.8,9.9,,,0.16,,,,
umeclidinium,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5,428.5926,,,,,0.89,,,244.0,
paritaprevir,CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,765.8877,4.7,2.64,,8.25,0.978,,,,
norbuprenorphine glucuronide,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN[C@@H]3CC6=C5C(=C(C=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)O4)OC)(C(C)(C)C)O,589.6777,,,,,,,,107.0,
raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,444.42,,,,,0.83,,,,
nilvadipine,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,385.374,,,,,0.98,,,54.3,
terbinafine,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,327.9,5.715,7.1,0.63,,0.99,,,,CYP450_3a4_substrate
nelfinavir,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,567.79,5.7,,1.0,,0.985,,,9.6,CYP450_3a4_substrate
aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,546.1986,,,0.001,3.75,0.9940000000000001,,,0.291,
artemether,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,298.376,,,0.001,,0.9540000000000001,,0.05,1.59,
antipyrine,CC1=CC(=O)N(N1C)C2=CC=CC=C2,188.229,,,,,,,,39.75,
varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,361.35,,,,,0.15,,,,
amifampridine,C1=CN=CC(=C1N)N,109.131,,,,,0.10400000000000001,,,171.4,CYP450_3a4_inhibitor
elagolix,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,631.595,1.8,1.0,0.89,,0.8,,,123.0,CYP450_3a4_substrate
tesamorelin,CC/C=C/CC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N,5135.9,,,,,,,,40.97,
fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,524.6864,4.455,6.3,100.0,9.005,0.95,0.77,,13.0,CYP450_3a4_substrate
ipratropium,CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,332.461,,,,,0.045,,,2.0,
teduglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC5=CN=CN5)N,3752.0,,,,,,,,123.0,
fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,580.46,0.6,1.7,0.3,,,,,,CYP450_3a4_substrate
cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,369.46,,,,,0.965,,,,
nabumetone,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,228.289,,,,,0.99,,,,
chiglitazar,C1=CC=C2C(=C1)C3=CC=CC=C3N2CCOC4=CC=C(C=C4)C[C@@H](C(=O)O)NC5=CC=CC=C5C(=O)C6=CC=C(C=C6)F,572.6331,,,,,,,,5.15,
miglitol,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O,207.2,,,,,0.04,,,,
pretomanid,C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,359.2588,,,0.016,,0.8640000000000001,0.2,,2.35,CYP450_3a4_substrate
thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,258.232,,,,,0.6,,,1.3,
fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,309.33,,,,,0.945,,,8.25,CYP450_3a4_substrate
granisetron,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,312.4,,,,,0.37,,,10.0,CYP450_3a4_substrate
rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,359.4479,,,,,0.4865,0.249,,283.0,CYP450_3a4_substrate
ravtansine,C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)\C)OC)(NC(=O)O2)O,780.4,,,,,0.9937999999999999,,,13.8,
cefotetan,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,575.6263,,,,,0.88,,,1.8,
lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)[C@@H]3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,638.829,4.7,2.8,0.001,,0.99,0.43,,50.0,CYP450_3a4_substrate
treosulfan,CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,278.3,,,7.0,,,,,15.83,CYP450_3a4_substrate
oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,252.3,1.31,5.449999999999999,,,0.76,,,67.4,CYP450_3a4_substrate
bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,288.432,,,,,0.48,,,4.949999999999999,
lanopepden,CC1=NC(=C(C(=N1)N2CCN3CCOC[C@@H]3C2)F)NNC(=O)[C@H](CC4CCCC4)CN(C=O)O,479.5536,,,,,,,,8.45,
brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,584.1011,,,355.2,,0.91,0.72,,8.8,CYP450_3a4_substrate
ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,261.087,,,,,,,,4.05,CYP450_3a4_substrate
ixabepilone,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,506.7,,,,,0.72,,,35.3,CYP450_3a4_substrate
dronabinol (delta-(9)-tetrahydrocannabinol),CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,314.466,6.0,10.6,,,,,,0.2,CYP450_3a4_substrate
palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,447.54,0.99,7.4,4.0,,0.853,,,63.1,CYP450_3a4_substrate
tofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,,4.0600000000000005,2.2,0.00239,,,,,,
keto-darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C,,,,,,0.998,,,,
codeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,299.368,,,,,0.07,,,6.5,CYP450_3a4_substrate
glasdegib,CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,374.4458,,1.0,1.7,,0.91,,,6.45,CYP450_3a4_substrate
fidaxomicin metabolite OP-1118,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)O)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,987.9,4.8,,,,,,,,
dimemorfan,CC1=CC2=C(C[C@H]3[C@@H]4[C@]2(CCCC4)CCN3C)C=C1,255.402,,,,,,,,1.0725,
doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,451.48,,,,,0.99,,,2.1,
acetylsalicylic acid (aspirin),CC(=O)OC1=CC=CC=C1C(=O)O,180.1582,,,,,0.49,,,5.2,
dichlorvos,COP(=O)(OC)OC=C(Cl)Cl,220.975,,,,,,,,465.59000000000003,
azimilide,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)/N=C/C3=CC=C(O3)C4=CC=C(C=C4)Cl,457.959,,,,,0.94,,,0.15,
iclepertin,C[C@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2C[C@@H]3C[C@@]3(C2)C4=NOC(=C4)C(F)(F)F,512.4,,,,,,,,95.7,
stiripentol,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O,234.29,,,,,0.99,,,4.125,CYP450_3a4_substrate
sitafloxacin,C1CC12CN(C[C@H]2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)[C@@H]5C[C@@H]5F)F,409.818,,,,,0.5,,,306.5,
zoledronic acid,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,290.1,,,,,0.22,,,,
hesperetin,COC1=C(C=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O,302.281,,,,,,,,1179.465,
risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,401.4717,,,,350.0,0.89,,,2.1,CYP450_3a4_substrate
etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,287.357,,,,,0.94,,,0.333,
imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OC[C@@H]3[C@H](C[C@@H](O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=CC(=NC1=O)N)NP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)N)S)O,4610.2379,,,,,0.94,,,0.97,
riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,234.2005,,,,,0.98,,,3.2,
dolutegravir,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,419.3821,,,,,0.9890000000000001,,,1.0,CYP450_3a4_substrate
azlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,461.497,,,,,0.17,,,15.45,
insulin degludec,CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CC5=CC=CC=C5)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)N[C@@H](CC7=CC=C(C=C7)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N8CCC[C@H]8C(=O)N[C@@H](CCCCNC(=O)CC[C@@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCC(=O)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)[C@@H](C)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CN,6103.97,,,,,0.99,,,0.03,
bleomycin,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1415.56,,,,,,,,28.049999999999997,
perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,403.975,,,,,,,,107.0,
amoxicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,365.408,,,,,0.18,,,1.5,
grepafloxacin,CC1CN(CCN1)C2=C(C(=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)C)F,359.399,,,,,0.5,,,0.295,
pasireotide,C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,1047.206,0.01,1.0,100.0,,0.88,,,6.7,
pilsicainide,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3,308.85,,,,,0.1485,,,159.0,
losigamone,COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O,254.668,,,,,0.5,,,,
candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,440.461,,,,,0.998,,,0.39,CYP450_3a4_substrate
revexepride,CC1(CC2=C(O1)C(=CC(=C2N)Cl)C(=O)NC[C@@H]3CCN(C[C@H]3O)CCCOC)C,425.9538,,,,,,0.999,,32.5,
naloxone,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,327.378,,,,,,,,22.0,
iptakalim,CC(C)C(C)(C)NC(C)C,143.2719,,,,,,,,20.56,
elvitegravir,CC(C)[C@@H](CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,447.8877,,,,,0.985,,,,
telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,514.63,7.7,3.62,0.001,4.82,0.995,,,800.0,CYP450_3a4_inhibitor
mycophenolic acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,320.339,,,,,0.975,,,1.45,CYP450_3a4_substrate
morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,285.341,,,,,0.185,,,17.0,CYP450_3a4_substrate
lobaplatin,CC(C(=O)[O-])[O-].C1CC(C1CN)CN.[Pt+4],399.348,,,,,,,,12.3,
anidulafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O,1140.3,,,,,0.84,,,1.0,CYP450_3a4_inhibitor
ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,306.4,0.0305,4.3,100.0,21.5,0.97,,,17.7,CYP450_3a4_substrate
daidzein,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,254.24,,,,,0.015,,,9.45,
ceftazidime,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],636.6,,,,,0.1,,,115.0,
cefpodoxime,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,427.4603,,,,,,,,164.95,
nitrazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3,281.2699,,,,,0.067,,,30.965,
abiraterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,349.5,,,,,0.9934999999999999,,,990.0,CYP450_3a4_substrate
pyrazinamide,C1=CN=C(C=N1)C(=O)N,123.115,-0.6,-0.5,4000.0,,0.1,,,1.25,
perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,277.492,,,,,0.9,,,,
semagacestat,C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O,361.4393,,,,4.0,,,,21.2,
cilomilast,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,343.4,,,,,0.9940000000000001,,,2.0,
dexloxiglumide,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl,461.383,,,,,0.9790000000000001,,,0.125,
eribulin,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O,729.9,,,,,0.555,,,1.73,CYP450_3a4_substrate
atropine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,289.373,,,,,0.18,,,6.0,
estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,294.744,,,,,0.93,,,,CYP450_3a4_substrate
cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,252.34,0.48,6.9,,3.0,,,,5.15,CYP450_3a4_substrate
ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,260.3786,,,,,0.4,,,8.1,CYP450_3a4_inhibitor
apricitabine,C1[C@@H](S[C@@H](O1)CO)N2C=CC(=NC2=O)N,229.2589,,,,,,,,13.100000000000001,
cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1202.62,,,,,0.475,,,12.3,CYP450_3a4_substrate
trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,290.321,,,,,0.44,,,1.0999999999999999,
exenatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC9=CNC=N9)N,4186.6,,,,,,,,6.0,
cilastatin,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,358.4564,,,,,0.4,,,115.05,
benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,424.087,,,,,,,,42.0,
roxithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,837.05,,,,,0.9,,,1.85,
acitretin,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C)C)C)OC,326.44,,,,,,,,,
frovatriptan,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,243.308,,,,,0.15,,,,CYP450_3a4_inhibitor
semaxinib,CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C,238.289,,,,,0.49700000000000005,,,10.5,
samidorphan,C1CC1CN2CC[C@]34CC(=O)CC[C@]3([C@H]2CC5=C4C(=C(C=C5)C(=O)N)O)O,370.4,2.4,8.3,200.0,18.77,0.28,0.0593,,40.0,CYP450_3a4_substrate
amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,645.31,,,,,0.49995000000000006,,,1.15,
flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,453.8763,,,,,0.95,,,67.5,
pregabalin,CC(C)C[C@@H](CC(=O)O)CN,159.227,,,,,,,,56.5,
vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,475.3596,4.7,5.2,0.001,9.385,0.94,,0.1,13.2,CYP450_3a4_substrate
edaravone (norantipyrine),CC1=NN(C(=O)C1)C2=CC=CC=C2,174.202,,,,,0.92,,,52619.4,CYP450_3a4_inhibitor
methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,374.474,1.9,,,,0.405,,,3.5500000000000003,CYP450_3a4_substrate
eletriptan,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,382.525,,,,,0.85,,,3.9,CYP450_3a4_substrate
tolfenamic acid,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,261.7068,,,,,0.997,,,,
givosiran,C[C@@H]1C[C@H](CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCO[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)NC(=O)C)O,16300.34,,,,,0.9,,,35.1,CYP450_3a4_inhibitor
fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,426.4133,,,,,,,,44.96,
lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,234.341,2.44,8.01,,,,,,5.8,
avitriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC,458.584,,,4.0,,0.6459999999999999,,,6.4,
pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,181.214,,,,,,,,6.5,
panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO,349.43,3.0,,1.017,0.8,0.9,,,181.0,CYP450_3a4_substrate
betulin,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO,442.7,,,,,0.9990000000000001,,,,
netupitant,CC1=CC=CC=C1C2=CC(=NC=C2N(C)C(=O)C(C)(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C,578.6,6.8,,,,0.995,,,14.75,CYP450_3a4_substrate
ketobemidone,CCC(=O)C1(CCN(CC1)C)C2=CC(=CC=C2)O,247.336,,,,,,,,115.5,
gemifloxacin,CO/N=C/1\CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,389.385,,,,,0.65,,,,
oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,152.1126,,,,,0.17,,,9.95,
armodafinil (R-modafinil),C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N,273.354,,,,3.48,,,,33.0,
lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,371.824,,,,,0.997,,,2.45,
daptomycin,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)[C@H](C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,1620.68,,,,,0.915,,,5.3,
indole-3-acetic acid,C1=CC=C2C(=C1)C(=CN2)CC(=O)O,175.18,,,,,0.94,,,,
cefsulodin,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)S(=O)(=O)O)C(=O)[O-])C[N+]4=CC=C(C=C4)C(=O)N,532.552,,,,,,,,81.5,
arbekacin,C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O)N)N,552.622,,,,,,,,65.75,
furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,330.75,,3.9,0.001,,0.495,,,1.1199999999999999,
halofantrine,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O,500.429,8.86,,,,,,,0.42,
lithium,[Li],6.941,,,,,0.0,,,0.22999999999999998,
sulfadoxine and pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.9,,,,
sulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,341.4,,,,,,,,249.5,
cefixime,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O,453.454,,,,,0.34,,,0.75,
p-aminohippuric acid (PAH),C1=CC(=CC=C1C(=O)NCC(=O)O)N,194.189,,,,,,,,338.5,
quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.45,,,3.25,
thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,201.252,2.47,4.64,50000.0,,,,,,
zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],267.244,,,,,0.38,,,1.1,
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,217.288,,,,,0.25,,,12.0,
methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,374.474,1.9,,,,0.405,,,3.5500000000000003,CYP450_3a4_substrate
hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,297.742,,,,,0.375,,,3.0,
nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,479.53,3.82,,,,0.9875,,,6.75,
propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,341.448,,8.8,1.0,,0.9,,,12.5,
naloxone,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,327.378,,,,,,,,22.0,
miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,416.134,5.3,,,,,,,,
fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,309.33,,,,,0.945,,,8.25,CYP450_3a4_substrate
ceforanide,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3CN)C(=O)O)CSC4=NN=NN4CC(=O)O,519.5609,,,,,0.81,,,30.8,
flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,304.3233,,,,,,,,275.0,
"theophylline (1,3-DMX)",CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166,-0.02,8.81,7360000.0,4.35,0.3,,,0.42500000000000004,CYP450_3a4_inhibitor
thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,258.232,,,,,0.6,,,1.3,
hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,160.179,,,,,0.87,,,34.5,
digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,780.943,,,,1.0,0.15,,,77.5,CYP450_3a4_substrate
Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,398.3976,2.5,3.23,,,0.993,,,0.24,
roxithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,837.05,,,,,0.9,,,1.85,
"caffeine (1,3,7-TMX)",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,194.1906,,,,,0.305,,,40.0,
ramipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,416.515,,,90.0,,0.375,,,23.0,
aminoglutethimide,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,232.281,,,1.0,,0.25,,,3.75,
nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,309.403,,,,,0.3,,,,
ethinylestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,296.408,3.7649999999999997,10.33,3.0,,0.97,,,2.079,
sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,253.281,0.7949999999999999,1.0,0.001,,0.29,,,0.19,
amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,229.63,,,,,0.25,,,,
amoxicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,365.408,,,,,0.18,,,1.5,
clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,315.715,,,,,0.4325,,,0.915,CYP450_3a4_substrate
diltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,414.523,,,,,0.405,,,7.0,CYP450_3a4_substrate
cifenline (cibenzoline),C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4,262.354,,,,,,,,5.63,
omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42,2.2,,0.2,,0.95,0.71,0.03,550.0,CYP450_3a4_substrate
ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,255.233,,,,,0.015,,,3.1999999999999997,
acetaminophen (paracetamol),CC(=O)NC1=CC=C(C=C1)O,151.16,,,,,0.2,,,0.08,CYP450_3a4_substrate
lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,259.2637,,,,,,,,240.0,
opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],413.172,,,1.0,3.5,0.99,,,,
risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,305.1,,,,,0.24,,,122.0,
astemizole,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,458.578,,,,,0.615,,,90.0,
esuberaprost,CC#CC[C@H](C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,398.496,,,,,,,,79.5,
p-aminohippuric acid (PAH),C1=CC(=CC=C1C(=O)NCC(=O)O)N,194.189,,,,,,,,338.5,
sulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,341.4,,,,,,,,249.5,
SPR741,C[C@H]([C@H]1C(=O)NCC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCN)CCN)CC(C)C)CC2=CC=CC=C2)CCN)NC(=O)[C@@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)C)O,,,,,,,,,2.65,
trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,416.358,,,,,0.85,,,0.81,
digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,780.943,,,,1.0,0.15,,,77.5,CYP450_3a4_substrate
odanacatib,CC(C)(C[C@@H](C(=O)NC1(CC1)C#N)N[C@@H](C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,525.5643,,,,,,,,0.8,
carbidopa,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,226.23,,,,,,,,12.5,
desmethylcitalopram,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,,,,,0.74,,,,
atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,,,,,,0.9990000000000001,,,0.12,
ezetimibe glucuronide,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,0.9,,,,
pyrazoloacridine,CN(C)CCCN1C2=C3C(=C(C=C2)[N+](=O)[O-])NC4=C(C3=N1)C=C(C=C4)OC,367.4069,,,,,,,,1654.5,
BIBF 1120,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,539.6327,,,,,,,,16.0,
cilengitide,CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,588.662,,,,,,,,61.5,
fenebrutinib,C[C@H]1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,664.8066,3.3,1.0,,15.1,,,,80.0,
hydromorphone,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,285.341,,,,,0.071,,,11.1,CYP450_3a4_substrate
silodosin,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,495.53,,,,3.007,0.97,,,10.0,CYP450_3a4_substrate
olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,434.46,1.49,1.25,0.13,2.005,0.82,0.973,0.089,5.65,CYP450_3a4_substrate
talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,363.499,2.89,15.17,0.25,,,,,613.5,
atomoxetine,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,291.82,,,27.8,,0.98,,,0.373,
ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,263.791,2.9,6.94,100.0,,0.98,,,34.0,
furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,330.75,,3.9,0.001,,0.495,,,1.1199999999999999,
GLPG0259,CC(C)(C)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(N4C3=NC=N4)C5=COC(=C5)C(=O)N,458.5234,,,,,,,,8.89,
acenocoumarol,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,353.3285,,,,,0.987,,,,
epirubicin,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.522,,,,,0.77,,,28.5,CYP450_3a4_substrate
brofaromine,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br,310.189,,,,,,,,8.4,
pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,226.2742,,,,,0.05,,,,
lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,528.9478,8.7,,,,0.997,,,0.63,
cefuroxime axetil,CC(OC(=O)C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CC=CO3)COC(=O)N,,,,,,0.195,,,0.94,
delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,456.568,,,,,0.976,,,12.05,CYP450_3a4_substrate
penbutolol,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O,291.432,,,,,0.89,,,,
phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,232.2,,,,,0.27,,,0.0375,
ulifloxacin,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCNCC4,349.379943,,,,,0.23,,,103.55,
oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,293.32,,,,,0.99,,,,
peficitinib,C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O,326.3978,,,0.1,,0.76,,,59.78,
acebutolol,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,336.4,,,,,0.175,,,0.63,CYP450_3a4_inhibitor
topotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,421.451,,,,,,,,16.35,CYP450_3a4_substrate
omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42,2.2,,0.2,,0.95,0.71,0.03,550.0,CYP450_3a4_substrate
modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,273.354,1.7,,1.0,,0.6,,,0.525,
etoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,588.559,,,,,0.48200000000000004,,,2.505,CYP450_3a4_substrate
netilmicin,CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N,475.5829,,,,,,,,38.57,
piperacillin,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,517.56,,,,,0.3,,,14.4,
O(6)-benzylguanine,C1=CC=C(C=C1)COC2=NC(=NC3=C2NC=N3)N,241.253,,9.35,,,,0.75,,330.5,
allitinib,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,448.8767,,,,,,,,5130.0,
digitoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5CC[C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)C)C)C)O)O,764.944,,,,,0.484,,,0.0295,
asenapine,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,285.7724,,8.6,3.7,,0.013000000000000001,,,51.9,CYP450_3a4_substrate
torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,348.425,,7.1,,,0.99,,,33.5,
manidipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,610.7072,5.18,,,,0.99,,,,
AZD5069,C[C@H]([C@H](CO)O)OC1=NC(=NC(=C1)NS(=O)(=O)N2CCC2)SCC3=C(C(=CC=C3)F)F,476.5179,,,,,0.99,,,9.0,
senkyunolide I,CCC/C=C\1/C2=C([C@@H]([C@H](CC2)O)O)C(=O)O1,224.2544,,,,,,,,0.422,
roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,352.3444,3.13,2.75,,,0.99,,,1.1,
fusidic acid,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C,516.714,,,,,0.998,,,0.5,
canagliflozin,CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,444.5205,,,,,,,,1.425,CYP450_3a4_substrate
desidustat,C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,332.308,,,,,,,,1388.458,
clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,242.701,,,,,0.49050000000000005,,,0.1,
rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,314.36,,,,,0.87,,,1.7,
(S)-cetirizine,C1CN(CCN1CCOCC(=O)O)[C@@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.9,,,,,0.43550000000000005,,,53.879999999999995,
ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,293.37,,,,,0.375,,,4.25,CYP450_3a4_substrate
naftopidil,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,392.496,,,,,,,,95.55,
midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,290.7,,,,,,,,385.0,
levorphanol,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,257.375,,,,,0.215,,,,
fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,606.8,,,,,0.99,,,11.8,CYP450_3a4_substrate
siponimod,CCC1=C(C=CC(=C1)/C(=N/OCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)/C)CN4CC(C4)C(=O)O,516.6005,,,,,0.9990000000000001,,,3.11,CYP450_3a4_substrate
dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO,396.4922,,,,,0.858,,,,
cocaine,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,,,,,,0.91,,,19.0,
avibactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N,265.2449,,,,,,,,9.88,
alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,249.096,,,,,0.78,,,,
deleobuvir,CN1C2=C(C=CC(=C2)C(=O)NC3(CCC3)C4=NC5=C(N4C)C=C(C=C5)/C=C/C(=O)O)C(=C1C6=NC=C(C=N6)Br)C7CCCC7,653.5777,,,,,,,,319.0,
thiopental,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,,,,,,0.445,,,2.55,
escitalopram,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,,,,0.56,,,24.549999999999997,CYP450_3a4_substrate
propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,341.448,,8.8,1.0,,0.9,,,12.5,
glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87,,,,1.4,0.975,,,1150.0,
erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,393.441,,,,,0.9,,,4.795,
"theophylline (1,3-DMX)",CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166,-0.02,8.81,7360000.0,4.35,0.3,,,0.42500000000000004,CYP450_3a4_inhibitor
eszopiclone,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133,,,,,0.555,,,,CYP450_3a4_substrate
clopidogrel carboxylic acid,C1CN(CC2=C1SC=C2)C(C3=CC=CC=C3Cl)C(=O)O,307.792,,,,,,,,4.975,
ABT-510,CCC[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]([C@@H](C)CC)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CN(C)C(=O)C,994.2417,,,,,,,,17.7,
carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,406.479,4.19,7.47,,1.94,0.95,,,5.199999999999999,CYP450_3a4_substrate
elbasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,882.02,,,0.001,,0.9990000000000001,,,,
etelcalcetide,C[C@H](C(=O)N[C@H](CCCN=C(N)N)C(=O)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@@H](C(=O)O)N)NC(=O)C,1048.2637,,,,,0.47,,,7.66,CYP450_3a4_substrate
ciprofibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,289.1566,,,,,0.99,,,,
KW-7158,C[C@](C(=O)NC1=C2C(=CC=C1)S(=O)(=O)CC3=C(C2=O)SC=C3)(C(F)(F)F)O,,,,,,,,,15.2,
chlormethiazole,CC1=C(SC=N1)CCCl,161.6552,,,,,0.692,,,185.85000000000002,
midostaurin,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,570.646,5.5,,0.001,2.0,0.998,,,3.4,CYP450_3a4_substrate
cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,501.5,,,0.001,,0.997,,,4.4,CYP450_3a4_substrate
felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,238.242,,,,,0.235,,,0.315,CYP450_3a4_substrate
etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,358.848,,,,,0.92,,,36.0,
bunazosin,CCCC(=O)N1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,373.4543,,,,,0.97,,,,
entacapone,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,305.289,,,,,0.98,,,6.0200000000000005,
obeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)O)C)C)O,420.63,5.11,4.76,7.0,8.0,0.99,,,,CYP450_3a4_substrate
clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,456.3197,,,,,0.995,,,0.142,
busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,246.303,,,,,0.08349999999999999,,,2.7,
oxprenolol,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,265.351,,,,,0.8,,,,
morinidazole,CC1=NC=C(N1CC(CN2CCOCC2)O)[N+](=O)[O-],270.139,,,,,,,,0.82,
hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,335.8764,,9.67,100.0,,,,,96.0,
chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,304.215,,,,,0.99,,,1.3,
paliperidone (9-hydroxyrisperidone),CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,426.489,,,,,0.74,,,53.0,CYP450_3a4_substrate
cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,261.087,,,,,0.13,,,0.9,CYP450_3a4_substrate
carbazeran,CCNC(=O)OC1CCN(CC1)C2=NN=CC3=CC(=C(C=C32)OC)OC,360.412,1.83,8.6,,,,0.98,,,
lovastatin acid,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,422.558,3.5,,,,0.95,,,,
cyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,0.66,,,,
chlormadinone acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)OC(=O)C,404.931,,,,,0.98,,,,
pilocarpine,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,208.2594,,,,,,,,,
ACT-451840,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)CN([C@@H](CC3=CC=CC=C3)C(=O)N4CCN(CC4)CC5=CC=C(C=C5)C#N)C(=O)/C=C/C6=CC=C(C=C6)C(C)(C)C,750.9826,5.2,,7.0,,,,,,
diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,250.199,,,0.001,,0.99,,,4.2,
rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N,366.4,4.32,1.0,0.001,12.0,0.997,,,11.8,CYP450_3a4_substrate
clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,230.097,,,,,0.2,,,2.15,
21-desacetyl deflazacort,CC1=N[C@@]2([C@H](O1)C[C@@H]3[C@@]2(C[C@@H]([C@H]4[C@H]3CCC5=CC(=O)C=C[C@]45C)O)C)C(=O)CO,399.4841,,,,,0.4,,,54.2,CYP450_3a4_substrate
yohimbine,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,354.447,2.73,,277000.0,,0.972,,,6075.5,
valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,314.36,,,,,0.98,,,6.0,
palovarotene,CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C,414.5,6.8,4.31,21.4,,0.9875,,0.01,13.22,CYP450_3a4_substrate
venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,277.405,,,,,0.145,,,16.0,CYP450_3a4_substrate
losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,422.918,1.19,5.5,,,,,,4.95,CYP450_3a4_substrate
eluxadoline,CC1=CC(=CC(=C1C[C@@H](C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)[C@@H](C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,569.65,0.9,1.0,1.0,,0.81,,,7536.36,CYP450_3a4_inhibitor
afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,485.9,,,50.0,2.0,0.95,,,1070.0,CYP450_3a4_inhibitor
ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,392.4962,3.13,11.08,0.05,,0.99,,,12.850000000000001,CYP450_3a4_substrate
dicloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,470.331,,,,,0.48,,,0.9500000000000001,
nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,565.98,4.9,2.1,2.8,2.0,0.98,,,29.0,CYP450_3a4_substrate
haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,375.869,,,0.01,,0.47,,,7.3500000000000005,CYP450_3a4_substrate
migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,163.1717,,,,,,,,12.5,
cefmetazole,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O,471.541,,,,,,,,92.14999999999999,
threohydrobupropion,CC(C(C1=CC(=CC=C1)Cl)O)NC(C)(C)C,,,,,,0.42,,,,
tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)[C@H]4[C@@H](C(=O)NC4=O)C5=CNC6=CC=CC=C65,369.4,3.6550000000000002,9.72,0.00745,,,,,9.43,
sepantronium,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4,363.3951,,,,,,,,34.5,
nefiracetam,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,246.308,,,,,,,,7.050000000000001,
pranlukast,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,481.51,,,,,0.99,,,,
5-fluorouracil,C1=C(C(=O)NC(=O)N1)F,130.078,,,,,0.1,,,11.5,
fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,306.275,,,,,0.115,,,0.17,
fluvoxamine,COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F,318.337,3.38,9.16,0.06,,0.77,,,21.4,CYP450_3a4_substrate
dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,135.21,,,,,,,,,
hydroxybupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)CO,255.74,,,,,0.84,,,,
mesna,C(CS(=O)(=O)[O-])S.[Na+],164.18,,,,,0.72,,,1.23,
mangiferin,C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,422.3402,,,,,,,,1.05,
enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,376.45,,,,,0.55,,,3.2,CYP450_3a4_inhibitor
speciogynine,CC[C@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.4953,,,,,,,0.057,28.200000000000003,
doxycycline,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.438,,,,,0.465,,,0.355,
fosdagrocorat,CC1=C(C=CC=N1)NC(=O)C2=CC3=C(C=C2)[C@@]4(CC[C@@](C[C@H]4CC3)(C(F)(F)F)OP(=O)(O)O)CC5=CC=CC=C5,574.533,,,,,0.00028000000000000003,,,,
ibogaine,CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC,310.4384,,,,,,,,,
ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,434.55,,,,,0.7,0.78,,25.5,CYP450_3a4_substrate
etonogestrel,CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.9670000000000001,,,,
amprenavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,505.633,,,0.04,,,,,5.1,
ceftaroline fosamil,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],762.7603,,,,,0.2125,,,9.6,CYP450_3a4_substrate
(S)-ibuprofen,C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O,206.2832,,,,,,,,45.550000000000004,
prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,373.9496,,,,,0.86,,,,
cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,243.22,,,,,0.13,,,13.0,
flunarizine,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,404.501,1.97,1.0,0.1,,0.991,,,301.2,
nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,346.337,2.2,13.0,0.001,,0.485,,,4.4,CYP450_3a4_substrate
tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,263.379,1.35,9.41,200.0,,0.2,,,5.9,CYP450_2d6_inhibitor
fosfluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)OP(=O)(O)O,386.254,,,,,,,,0.8065,
pentostatin,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O,268.27,,,100.0,,0.04,,,68.0,
norbuprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN[C@@H]3CC6=C5C(=C(C=C6)O)O4)OC)(C(C)(C)C)O,413.5545,,,,,,,,343.0,
pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,281.4177,,,,,0.3,,,271.5,
cefotaxime,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,455.47,,,,,0.195,,,2.15,
almorexant,CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC,512.5689,,,,,0.998,,,43.0,
ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,255.272,,,,,0.4965,,,0.325,
hydrocodone,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,299.368,,,,,,,,7.335,CYP450_3a4_substrate
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,309.45,117.0,9.2,,,0.875,,,63.7,CYP450_3a4_substrate
triclabendazole sulfoxide,CS(=O)C1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,375.7,,,,,0.9840000000000001,,,,
vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,379.36,,,1.0,,0.98,,,38.27,CYP450_2d6_inhibitor
terlipressin,C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,1227.3856,,10.0,100.0,,,,,27.4,
methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,454.445,,,,,0.285,,,1.4500000000000002,
PPI 2458,CC(C)[C@H](C(=O)N)NC(=O)O[C@@H]1CC[C@]2(CO2)[C@H]([C@@H]1OC)[C@@]3([C@H](O3)CC=C(C)C)C,424.5344,,,,,,,,353.0,
nicotine,CN1CCC[C@H]1C2=CN=CC=C2,162.2346,,,,,0.0385,,,11.95,
piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,331.3,,,,,0.99,,,1.25,CYP450_3a4_substrate
pergolide,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC,314.494,,,,,,,,457.0,
cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,776.0347,,,,,0.975,,,14.0,CYP450_3a4_substrate
ledipasvir and sofosbuvir,C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3.CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,889.0116,7.4,1.0,,,0.63,,,871.64,
liquiritigenin,C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O,256.256,,,,,,,,401.16,
pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,461.5531,,,,12.0,0.99,,,3.9499999999999997,
zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133,,,,,0.555,,,21.0,CYP450_3a4_substrate
spiramycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,842.05,,,,,,,,1.14,
temsirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,1030.2943,,,,,,,,16.2,CYP450_3a4_substrate
retagliptin,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,464.3642,,,,,,,,162.7,
(R)-propranolol (dexpropranolol),CC(C)NC[C@H](COC1=CC=CC2=CC=CC=C21)O,259.3469,,,,,,,,2470.5,
moxifloxacin,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,401.436,,,,,0.209,,,7.0,
vicriviroc,C[C@H]1CN(CCN1[C@@H](COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C,533.6352,,,,,,,,21.0,
naproxen (S-naproxen),C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,230.2616,,,6.0,,0.499,,,0.075,
dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,488.01,,,,,0.96,,,,CYP450_3a4_substrate
dibekacin,C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N)N)N,451.5173,,,,,,,,58.45,
flibanserin,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,390.41,3.3,,0.008,3.19,,,,555.0,CYP450_3a4_substrate
belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO,318.35,,,,5.9,0.9434999999999999,,,1240.0,CYP450_3a4_substrate
venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,868.44,,,,1.0,0.9990000000000001,,,429.0,CYP450_3a4_substrate
apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,459.5035,,,,,0.87,,,3.3,CYP450_3a4_substrate
butorphanol,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,327.465,,,,,0.815,,,25.0,
sacubitril,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,411.4951,,,,,0.97,,,,
regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,500.83,,,0.001,75.1,0.995,,,,CYP450_3a4_substrate
ospemifene (deamino-hydroxytoremifene),C1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\C3=CC=C(C=C3)OCCO)/CCCl,378.9,,,,,0.99,,,9.16,CYP450_3a4_substrate
trifluridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,296.2,,,,,0.96,,,2.93,
BMS-823778,CC(C)(C1=CC=CN2C1=NN=C2C3(CC3)C4=CC=C(C=C4)Cl)O,327.808,2.76,3.5,,5.24,,0.414,0.15,85.0,
phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,252.2718,2.4,8.31,0.02,,0.56,0.0645,,3.5500000000000003,CYP450_3a4_substrate
topiramate,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,339.4,0.57,8.61,9.8,,0.28,,,25.0,
roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,403.2106,3.99,,0.001,,0.9890000000000001,,,9.6,CYP450_3a4_substrate
rufloxacin,CN1CCN(CC1)C2=C(C=C3C4=C2SCCN4C=C(C3=O)C(=O)O)F,363.4112,,,,,0.6,,,35.35,
ponesimod,CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C,460.9795,,,0.0009,9.93,0.98765,,,3.8,CYP450_3a4_substrate
promazine,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,284.425,,,,,0.84,,,,
linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,421.5017,,,,,,,,42.57,
mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,265.3581,,,,,0.85,,,5.13,CYP450_3a4_substrate
gadolinium,[Gd],1061.1735,,,,,,,,53.5,
upadacitinib,CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,380.3721,,,,,0.52,,,26.77,CYP450_3a4_substrate
felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,384.257,3.9,5.07,,,0.499,,,0.8,CYP450_3a4_substrate
sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,914.179,,,,,0.92,,,111.5,CYP450_3a4_substrate
clopidogrel,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,321.826,,5.3,,,0.98,,,,
ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,331.346,,,,,0.4,,,4.2,
lersivirine,CCC1=C(C(=NN1CCO)CC)OC2=CC(=CC(=C2)C#N)C#N,310.3552,,,,,,,,122.0,
cangrelor,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,776.3615,,,,,0.975,,,53.0,
basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,325.7727,,,,,0.99,,,19.45,
ivermectin,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,1736.1704,,,,,0.46649999999999997,,,1.435,
enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,473.3793,,,74.0,17.9,0.985,,,0.7,CYP450_3a4_substrate
vildagliptin,C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,301.43,,,,,,,,30.4,
brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C,370.3821,,,,,,,,14.7,
phenylephrine,CNC[C@@H](C1=CC(=CC=C1)O)O,167.2,,,,,,,,98.30000000000001,
troglitazone,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,441.545,,,0.001,,0.99,,,172.0,
benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,424.494,,,,,0.97,,,0.35,
idarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,497.497,,,,,0.97,,,19.5,
praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,312.411,,,,4.4,0.825,,,139.5,
2-(1-piperazinyl)pyrimidine,C1CN(CCN1)C2=NC=CC=N2,164.21,,,,,0.32049999999999995,,,524.9,
tebipenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O,383.4909,,,,,,,,39.1,
gemigliptin,C1CC(CN(C1=O)C[C@H](CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,489.4,,,,,0.2,,,64.9,
clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,747.957,,,,,0.46,,,4.6,
voclosporin,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1214.62,5.87,,0.001,,0.97655,,,63.6,CYP450_3a4_substrate
prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,373.446,,,0.001,,,,,139.0,CYP450_3a4_substrate
PF-05089771,C1=CC(=C(C=C1Cl)C2=C(NN=C2)N)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=CSC=N4)F,500.3608,,,,,,,,45.0,
cefodizime,CC1=C(SC(=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O)CC(=O)O,584.677,,,,,,,,1.43,
gallic acid,C1=C(C=C(C(=C1O)O)O)C(=O)O,170.1194,,,,,0.893,,,83.0,
azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],277.267,,,,,,,,44.0,
vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,824.966,,,,,,,,3.965,CYP450_3a4_substrate
"3,4-dihydroxybenzoic acid",C1=CC(=C(C=C1C(=O)O)O)O,154.12,,,,,,,,236.0,
albiglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC6=CNC=N6)N,72970.0,,,,,,,,67.0,
(-)-epigallocatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,458.373,,,,,,,,220.05,
telbivudine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,242.229,,,,,,,,15.85,
quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,383.5,,,,,0.83,,,19.0,CYP450_3a4_substrate
(R)-citalopram,CN(C)CCC[C@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,,,,,,,0.16,
repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,452.591,,,,,0.9740000000000001,,,8.05,CYP450_3a4_substrate
nizatidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,331.463,,,,,0.35,,,50.0,
voriconazole,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,349.3,,,,,0.58,,,3.8,CYP450_3a4_substrate
lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,256.095,,,,,0.56,,,0.495,
naloxegol,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O,742.0,-1.0,,,0.7,0.042,,,115.5,CYP450_3a4_substrate
disufenton sodium,CC(C)(C)/[N+](=C/C1=C(C=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])/[O-].[Na+].[Na+],381.336,,,,,0.33,,,2.4,
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl,331.865,,,,,,,,4.4,
sacubitril,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,411.4951,,,,,0.97,,,,
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,309.45,117.0,9.2,,,0.875,,,63.7,CYP450_3a4_substrate
zavegepant,CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,638.8,,4.8,100.0,,0.9,,,266.0,CYP450_3a4_substrate
methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,233.309,,,,,0.155,,,4.335,
duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,297.42,,,1.0,,0.015,,,94.5,CYP450_1a2_substrate
astemizole,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,458.578,,,,,0.615,,,90.0,
azithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,748.989,,8.1,100.0,,0.07,,,630.0,
cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1202.62,,,,,0.475,,,12.3,CYP450_3a4_substrate
bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,239.744,,,,,0.84,,,19.1,CYP450_3a4_substrate
fexofenadine (terfenadine carboxylate),CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663,,,,,0.65,,,6.800000000000001,
capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,412.4263,1.2,0.9,1.0,24.5,0.96,,,24.0,CYP450_3a4_substrate
quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.45,,,3.25,
vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,345.4,2.74,9.3,1.0,17.8,0.865,0.491,0.94,97.3,CYP450_3a4_substrate
terbinafine,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,327.9,5.715,7.1,0.63,,0.99,,,,CYP450_3a4_substrate
paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,329.369,2.53,9.51,,,0.95,,,5.9,CYP450_3a4_substrate
ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,467.42,4.53,6.31,,,0.4999,0.064,,11.7,CYP450_3a4_substrate
prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,358.4,,,168.2,,0.385,,,2.2,CYP450_3a4_substrate
enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,376.45,,,,,0.55,,,3.2,CYP450_3a4_inhibitor
rifampin,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,822.947,,,0.1,12.0,0.75,,,2.55,
famotidine,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N,337.43,0.2,9.29,0.001,,0.175,,,13.0,
dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,135.21,,,,,,,,,
tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,253.716,1.72,7.49,1.0,,0.3,,,153.5,
clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,747.957,,,,,0.46,,,4.6,
remdesivir,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,602.5815,-2.31,,,,0.9079999999999999,0.8,,65058.7,CYP450_3a4_substrate
trofinetide,C[C@]1(CCCN1C(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)O,315.32,2.93,8.61,100.0,,0.06,,0.9525,11.8,CYP450_3a4_substrate
cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,776.0347,,,,,0.975,,,14.0,CYP450_3a4_substrate
sulfadoxine and pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl.COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.9,,,,
tolterodine,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,325.493,1.83,9.87,12.0,,0.963,0.8,,396.0,CYP450_3a4_substrate
aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,448.38,,7.6,,20.5,0.99,,,0.5,CYP450_3a4_substrate
spiramycin,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,842.05,,,,,,,,1.14,
raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,473.59,,,,,0.95,,,536.5,CYP450_3a4_substrate
zoniporide,C1CC1C2=C(C=NN2C3=CC=CC4=C3C=CC=N4)C(=O)N=C(N)N,320.3544,1.15,,,,,0.56,,11.1,
capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,359.352,,,,,0.54,,,145.0,
remimazolam,CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4,439.3,,,3.3,,0.91,,,64.5,CYP450_3a4_inhibitor
rosuvastatin (acid),CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,481.5,,,,,0.88,,,7.6,CYP450_3a4_substrate
verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,454.607,,,,,0.46,,,10.5,CYP450_3a4_substrate
ethanol,CCO,46.07,,,,,,,,67.0,
zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,305.34,1.3,,,,0.375,0.55,,9.5,CYP450_3a4_substrate
bempedoic acid,CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)O)O)C(=O)O,344.5,0.8,4.88,5.0,11.5,0.993,0.0204,,11.2,CYP450_3a4_inhibitor
roxithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,837.05,,,,,0.9,,,1.85,
lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,426.8581,3.3,5.05,0.001,,0.985,,,9.5,CYP450_3a4_substrate
crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,450.3,4.28,9.4,10.0,,0.91,0.84,,60.0,CYP450_3a4_substrate
rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl,435.8862,,13.4,7000.0,,0.935,0.18,,10.0,CYP450_3a4_substrate
tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,263.379,1.35,9.41,200.0,,0.2,,,5.9,CYP450_2d6_inhibitor
ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437,4.3,,,,0.4955,,,6.25,CYP450_3a4_substrate
idelalisib,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,415.42,,1.6,0.1,,0.84,0.7,,14.9,CYP450_3a4_substrate
simvastatin (lactone),CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,418.7,,,,,0.95,,,7.6,CYP450_3a4_substrate
lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,256.095,,,,,0.56,,,0.495,
erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,733.93,,,1.0,,0.435,,,6.6,CYP450_3a4_substrate
ezetimibe,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,409.43,,,,,0.9,,,,
fidaxomicin,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,1058.04,6.4,,,,,,,,CYP450_3a4_substrate
cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,252.34,0.48,6.9,,3.0,,,,5.15,CYP450_3a4_substrate
atomoxetine,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,291.82,,,27.8,,0.98,,,0.373,
clopidogrel,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,321.826,,5.3,,,0.98,,,,
cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,501.5,,,0.001,,0.997,,,4.4,CYP450_3a4_substrate
probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,285.36,,,0.06,,0.91,,,1.38,
dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,471.5,,4.0,,,0.35,,,1748.0,
tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,492.5802,4.0,9.5,,,0.98,,,23.8,CYP450_3a4_substrate
vancomycin,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,1449.26,,,,,0.205,,,0.79,
rifamycin,C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,697.7733,,,,,0.8,,,,CYP450_3a4_substrate
balovaptan,CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1,409.9186,,,,,0.87,,,9.15,
eslicarbazepine,C1[C@@H](C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,254.2876,,,0.1,,0.4,,,,
amifostine,C(CN)CNCCSP(=O)(O)O,214.22,,,,,,,,1.115,
loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,477.045,5.5,1.0,,,,,,,
monomethyl auristatin E,CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC,717.9863,,,,2.0,0.7505000000000002,,,45.9,
saxagliptin,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N,333.43,,,,,0.38,,,350.0,CYP450_3a4_substrate
dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl,408.87,,,,,0.91,,,,
obeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)O)C)C)O,420.63,5.11,4.76,7.0,8.0,0.99,,,,CYP450_3a4_substrate
nefazodone,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,470.014,4.3,,1.0,,0.99,,,,CYP450_3a4_substrate
lenacapavir,CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)[C@H](CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C([C@H]7C[C@H]7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C,968.3,5.1,6.8,0.1,0.3,0.985,,,55.0,CYP450_3a4_substrate
ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,392.4962,3.13,11.08,0.05,,0.99,,,12.850000000000001,CYP450_3a4_substrate
desmethylcitalopram,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,,,,,0.74,,,,
rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,314.36,,,,,0.87,,,1.7,
efavirenz,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,315.68,,,,,0.99625,,,2.15,CYP450_3a4_substrate
dalbavancin,CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)NC(C7=C(C(=CC(=C7)O)O[C@@H]8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,1816.71,,,,,0.9259999999999999,,,0.0466,
pimobendan,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,334.3772,,,,,0.89,,,,
donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,379.497,,,,,0.4675,,,1.8199999999999998,CYP450_3a4_substrate
abrocitinib,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,323.4138,1.66,5.3,12.7,,0.64,0.53,0.36,50.56,CYP450_3a4_substrate
melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,305.203,0.33,2.5,,,0.725,,,8.0,
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,312.37,1.15,5.07,100.0,0.01,0.4,,,21931.4,CYP450_3a4_substrate
docetaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,807.885,,,,,0.94,,,15.15,CYP450_3a4_substrate
dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,488.01,,,,,0.96,,,,CYP450_3a4_substrate
doxycycline,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.438,,,,,0.465,,,0.355,
lorlatinib,C[C@@H]1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,406.41,2.45,,0.17,,0.66,,,11.0,CYP450_3a4_substrate
capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,412.4263,1.2,0.9,1.0,24.5,0.96,,,24.0,CYP450_3a4_substrate
mangiferin,C1=C2C(=CC(=C1O)O)OC3=C(C2=O)C(=C(C(=C3)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,422.3402,,,,,,,,1.05,
lenabasum (ajulemic acid),CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,400.5554,1.84,5.13,400.0,8.17,0.99,0.51,,5.1,
bitopertin,C[C@@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2CCN(CC2)C3=C(C=C(C=N3)C(F)(F)F)F,543.458,3.03,2.0,,3.5,,0.9,,1.17,
raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,473.59,,,,,0.95,,,536.5,CYP450_3a4_substrate
arbidol,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,531.8962,,,,,,,,66.5,
anagrelide,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3,256.091,,,,,,,,688.5,
omarigliptin,CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N,398.432,,,,,,,,1.6,
amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,369.483,,5.0,0.001,,0.275,,,31.2,CYP450_3a4_substrate
riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,422.42,,,0.001,,,,,1.8,CYP450_3a4_substrate
ticarcillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C,384.431,,,,,0.45,,,62.1,
ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,558.14,,,11.9,0.167,0.972,0.9,,89.0,CYP450_3a4_substrate
cefpiramide,CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,612.6456,,,,,,,,8.65,
almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,469.56,,,,,0.35,,,24.0,CYP450_3a4_substrate
emixustat,C1CCC(CC1)COC2=CC=CC(=C2)[C@@H](CCN)O,263.3785,,,,,,,,363.0,
sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,279.85,30.9,,2.9,,0.97,,,1750.0,CYP450_3a4_substrate
enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,4500.0,,,,,,,,21.75,
aminoglutethimide,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,232.281,,,1.0,,0.25,,,3.75,
indacaterol,CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,392.49,2.33,7.3,0.23,0.36000000000000004,0.9565,,,21.05,CYP450_3a4_substrate
pelubiprofen,CC(C1=CC=C(C=C1)/C=C/2\CCCCC2=O)C(=O)O,258.315,,,,,,,,138.10000000000002,
methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,233.309,,,,,0.155,,,4.335,
sulfinpyrazone,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,,2.3,3.25,1.0,,0.494,,,,
mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,444.485,,,,,0.97,,,10.5,
deupirfenidone,[2H]C([2H])([2H])C1=CN(C(=O)C=C1)C2=CC=CC=C2,188.2403,,,,,,,,17.55,
dimethyl fumarate,COC(=O)/C=C/C(=O)OC,144.13,,,,,0.36,,,,CYP450_3a4_inhibitor
procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,235.329,,,,,0.105,,,2.7,
sulfinpyrazone,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,,2.3,3.25,1.0,,0.494,,,,
genistein,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,270.239,,,,,0.0085,,,12.0,
perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,277.492,,,,,0.9,,,,
procyclidine,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,287.444,,,,,0.9259999999999999,,,,
telavancin,CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)C,1755.6474,,,,,0.897,,,13.1,
eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,442.5,,,,,0.99,,,,CYP450_3a4_substrate
teicoplanin,CCCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)N[C@@H](C7=C(C(=CC(=C7)O)OC8[C@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)C9=C(C=CC(=C9)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)[C@H](C(=O)N[C@H](CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)NC(=O)C)Cl)CO)O)O,1879.65828,,,,,,,,8.5,
istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C,384.4336,2.5,7.8,0.88,32.3,0.98,,,4.6,CYP450_3a4_substrate
selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,445.4996,,,,,,,,2180.0,
fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,411.5823,,,,,0.5,,,,CYP450_3a4_substrate
filociclovir,C1/C(=C/N2C=NC3=C2N=C(NC3=O)N)/C1(CO)CO,263.2557,,,,1.0,,,,,
acetaminophen glucuronide,CC(=O)NC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O,327.287,,,,,,,,1.8,
sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,398.4793,5.2,8.95,25.0,,0.95,,,48.0,
sepantronium,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4,363.3951,,,,,,,,34.5,
rosuvastatin (acid),CC(C)C1=NC(=NC(=C1/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,481.5,,,,,0.88,,,7.6,CYP450_3a4_substrate
falnidamol,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,387.8481,1.83,2.83,,,,0.97,,,
mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,265.3581,,,,,0.85,,,5.13,CYP450_3a4_substrate
metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,299.8,,,,,0.22,,,3.75,CYP450_3a4_substrate
flupentixol,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,434.523,,,,5.7,0.9840000000000001,,,,
dextromethorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,271.401,,,,,0.65,,,1116.5,
avitriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC,458.584,,,4.0,,0.6459999999999999,,,6.4,
uridine triacetate,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C,370.3122,,,,,,,,,
tipranavir,CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,602.671,6.9,5.96,0.000205,,0.99,,,1.15,CYP450_3a4_substrate
levodopa,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,197.189,,,,,,,,13.5,
ivermectin,CC[C@H](C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C,1736.1704,,,,,0.46649999999999997,,,1.435,
rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,269.35,,,,,0.14,,,6.8500000000000005,CYP450_3a4_inhibitor
panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO,349.43,3.0,,1.017,0.8,0.9,,,181.0,CYP450_3a4_substrate
migalastat,C1[C@@H]([C@H]([C@H]([C@H](N1)CO)O)O)O,163.1717,,,,,,,,12.5,
acetylsalicylic acid (aspirin),CC(=O)OC1=CC=CC=C1C(=O)O,180.1582,,,,,0.49,,,5.2,
linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,421.5017,,,,,,,,42.57,
blonanserin,CCN1CCN(CC1)C2=NC3=C(CCCCCC3)C(=C2)C4=CC=C(C=C4)F,367.509,,,,,,0.794,,,
dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,441.57,0.93,3.96,,,0.64,,,2.765,
mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,295.297,,,,,0.95,,,8.0,
varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,361.35,,,,,0.15,,,,
etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,435.28,,,0.001,,0.9990000000000001,,,43.7,CYP450_3a4_substrate
cyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,0.66,,,,
sonidegib,C[C@@H]1CN(C[C@@H](O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,681.49,4.26,4.3,,4.58,0.97,0.29,,10.0,CYP450_3a4_substrate
acamprosate,CC(=O)NCCCS(=O)(=O)O,181.211,,,,,,,,8.25,
baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,213.663,,,,,0.21,,,180.0,
sacituzumab govitecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)OC(=O)OCC5=CC=C(C=C5)NC(=O)[C@H](CCCCN)NC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCN6C=C(N=N6)CNC(=O)C7CCC(CC7)CN8C(=O)CC(C8=O)SC[C@@H](C(=O)O)N)C2=NC9=C1C=C(C=C9)O,1601.7836,,,,,,,,0.002,
avibactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N,265.2449,,,,,,,,9.88,
cenobamate,C1=CC=C(C(=C1)[C@H](CN2N=CN=N2)OC(=O)N)Cl,267.675,,,,,0.6,,,0.54,CYP450_3a4_substrate
mizolastine,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,432.5,,,,,0.98,,,6.02,
"arformoterol (R,R-formoterol)",C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O,344.4086,,,,,,,,,
dotinurad,C1N(C2=CC=CC=C2S1(=O)=O)C(=O)C3=CC(=C(C(=C3)Cl)O)Cl,358.2001,,,,,0.49689999999999995,,,0.45499999999999996,
p-aminohippuric acid (PAH),C1=CC(=CC=C1C(=O)NCC(=O)O)N,194.189,,,,,,,,338.5,
elexacaftor,C[C@H]1CC(N(C1)C2=C(C=CC(=N2)N3C=CC(=N3)OCC(C)(C)C(F)(F)F)C(=O)NS(=O)(=O)C4=CN(N=C4C)C)(C)C,597.6596,,,0.1,3.08,0.99,,,0.735,CYP450_3a4_substrate
trofinetide,C[C@]1(CCCN1C(=O)CN)C(=O)N[C@@H](CCC(=O)O)C(=O)O,315.32,2.93,8.61,100.0,,0.06,,0.9525,11.8,CYP450_3a4_substrate
benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,424.494,,,,,0.97,,,0.35,
warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,308.331,,5.1,,,0.5,,,0.0345,CYP450_3a4_substrate
tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,572.7456,2.82,11.64,7.27,12.9,0.88,0.99,,274.0,CYP450_3a4_substrate
nicotinic acid (niacin),C1=CC(=CN=C1)C(=O)O,123.11,,,,,,,,9.8,
cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,645.6753,,,,,0.9,,,1.5150000000000001,
mycophenolic acid,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O,320.339,,,,,0.975,,,1.45,CYP450_3a4_substrate
pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/[C@H]5CCCN5C,583.1,,,,,0.9330000000000002,,,77.45,
troglitazone,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C,441.545,,,0.001,,0.99,,,172.0,
chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,304.215,,,,,0.99,,,1.3,
pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,417.8205,5.1,2.6,2451.0,21.8,0.99,,,5.1,CYP450_3a4_substrate
piperacillin,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,517.56,,,,,0.3,,,14.4,
sofosbuvir and velpatasvir,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC.C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,529.45,,,,,0.995,,,,
deucravacitinib,[2H]C([2H])([2H])NC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,425.459,,3.4,,,0.86,,,40.5,CYP450_3a4_inhibitor
fluticasone propionate,CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF,500.5749,,,,,0.99,,,1093.0,
benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,424.087,,,,,,,,42.0,
clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,230.097,,,,,0.2,,,2.15,
azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],277.267,,,,,,,,44.0,
itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,358.4354,,,1000.0,,,,,,
glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,445.541,,5.9,,,0.9840000000000001,,,0.35,
telaprevir,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,679.8577,3.96,11.86,0.0047,5.7,0.675,,0.41,32.4,CYP450_3a4_substrate
enoximone,CC1=C(NC(=O)N1)C(=O)C2=CC=C(C=C2)SC,248.305,,,,,0.59,,,11.985,
raxatrigine,C1C[C@H](N[C@H]1C2=CC=C(C=C2)OCC3=CC=CC=C3F)C(=O)N,314.3581,,,,,,,,10.8,
scopolamine,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4,303.356,,,,,,,,93.0,
oxfendazole (fenbendazole-sulfoxide),COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,315.34702,,,,,,,,93.5,
dimetindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,292.4236,,,,,0.706,,,19.205,
contezolid,C1CN(C=CC1=O)C2=C(C=C(C(=C2F)F)N3C[C@@H](OC3=O)CNC4=NOC=C4)F,408.3345,,,,,0.9,,,7.3999999999999995,
ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,293.37,,,,,0.375,,,4.25,CYP450_3a4_substrate
clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,277.1932,,,,,,,,5.515000000000001,
deferiprone,CC1=C(C(=O)C=CN1C)O,139.15,0.098,1.0,1.0,,0.2,,,31.3,
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,277.409,,,,,0.478,,,7.45,CYP450_3a4_substrate
valbenazine,CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC,418.57,,,20.0,30.4,0.99,,,7.2,CYP450_3a4_substrate
celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,,,,,,0.97,,,4.225,
bismuth,[Bi],208.98,,,,,0.9,,,,
bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,288.432,,,,,0.48,,,4.949999999999999,
samidorphan,C1CC1CN2CC[C@]34CC(=O)CC[C@]3([C@H]2CC5=C4C(=C(C=C5)C(=O)N)O)O,370.4,2.4,8.3,200.0,18.77,0.28,0.0593,,40.0,CYP450_3a4_substrate
midostaurin,C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,570.646,5.5,,0.001,2.0,0.998,,,3.4,CYP450_3a4_substrate
oteseconazole,C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F,527.3984,4.41,,0.0657,,0.49779,,,0.253,CYP450_3a4_inhibitor
decitabine,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,228.21,,,3.3,,0.01,,,125.0,CYP450_3a4_substrate
simvastatin (lactone),CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,418.7,,,,,0.95,,,7.6,CYP450_3a4_substrate
cevimeline,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1,244.79,,,1000.0,,0.2,,,,
ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,395.4318,,,,,0.479,,,528.5,
ridogrel,C1=CC(=CC(=C1)C(F)(F)F)/C(=N\OCCCCC(=O)O)/C2=CN=CC=C2,366.3373,,,,,0.937,,,,
iberdomide,C1CC(=O)NC(=O)[C@H]1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,449.5043,,,,,,,,13.495,
empagliflozin,C1COC[C@H]1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl,450.91,,,0.001,,0.862,,,10.6,
quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,383.5,,,,,0.83,,,19.0,CYP450_3a4_substrate
ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,331.346,,,,,0.4,,,4.2,
lormetazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl,335.1888,,,,,,,,225.0,
clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,456.3197,,,,,0.995,,,0.142,
ivosidenib,C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,582.96,2.97,1.4,0.001,,0.94,,,4.3,CYP450_3a4_substrate
telcagepant,C1C[C@H](C(=O)N(C[C@@H]1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,566.5283,,,,,0.9470000000000001,,,,
vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,346.8195,,,,,,,,51.7,
aliskiren,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,551.7637,,,,0.2,0.495,,,,CYP450_3a4_substrate
fluvoxamine,COCCCC/C(=N\OCCN)/C1=CC=C(C=C1)C(F)(F)F,318.337,3.38,9.16,0.06,,0.77,,,21.4,CYP450_3a4_substrate
indacaterol,CCC1=C(C=C2CC(CC2=C1)NC[C@@H](C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,392.49,2.33,7.3,0.23,0.36000000000000004,0.9565,,,21.05,CYP450_3a4_substrate
daidzein,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,254.24,,,,,0.015,,,9.45,
atazanavir,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,704.864,,4.7,5.2,5.3,0.86,,,142.0,CYP450_3a4_substrate
atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,266.34,,9.0,10.0,1.0,0.05,,,,CYP450_3a4_substrate
bromfenac,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O,334.16,,,,,0.99,,,6.9,
inclisiran,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4C[C@@H](C[C@H]4COP(=O)(O)O)O)CO)O)O,17284.72,-8.0,,,,0.8740000000000001,,,23.435000000000002,CYP450_3a4_substrate
dolutegravir,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,419.3821,,,,,0.9890000000000001,,,1.0,CYP450_3a4_substrate
gabapentin,C1CCC(CC1)(CC(=O)O)CN,171.238,,,,,0.03,,,0.9500000000000001,
darunavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,593.73,,,,,0.95,,,32.8,CYP450_3a4_substrate
bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,358.2669,,,,,0.95,,,700.0,CYP450_3a4_inhibitor
lopinavir and ritonavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O.CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,,5.9,,,,0.98,,,,
telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,514.63,7.7,3.62,0.001,4.82,0.995,,,800.0,CYP450_3a4_inhibitor
filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,425.5107,,,,,0.57,,,,
pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,185.23,,,22.0,,0.58,0.48,,15.0,CYP450_3a4_inhibitor
pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,461.5531,,,,12.0,0.99,,,3.9499999999999997,
nelfinavir,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,567.79,5.7,,1.0,,0.985,,,9.6,CYP450_3a4_substrate
cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,252.34,0.48,6.9,,3.0,,,,5.15,CYP450_3a4_substrate
delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,456.568,,,,,0.976,,,12.05,CYP450_3a4_substrate
pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,226.2742,,,,,0.05,,,,
nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,253.3431,,,,,0.73,,,3.96,
atorvastatin (acid),CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,558.6,3.66,4.6,0.27,,0.98,,,29.0,CYP450_3a4_substrate
asunaprevir,CC(C)(C)[C@@H](C(=O)N1C[C@@H](C[C@H]1C(=O)N[C@@]2(C[C@H]2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,748.3,,,,473.0,0.988,,,183.9,
morphothiadin,CCOC(=O)C1=C(NC(=NC1C2=C(C=C(C=C2)F)Br)C3=NC=CS3)CN4CCOCC4,509.4,2.5,,,,,,,106.0,
idelalisib,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,415.42,,1.6,0.1,,0.84,0.7,,14.9,CYP450_3a4_substrate
rovatirelin,C[C@@H]1CCCN1C(=O)[C@H](CC2=CSC=N2)NC(=O)[C@@H]3[C@@H](OC(=O)N3)C,366.4398,,,,,,,,36.7,
taletrectinib,C[C@H](COC1=CC=C(C=C1)C2=CN=C3N2N=C(C=C3)N[C@H](C)C4=CC(=CC=C4)F)N.C(CCC(=O)O)CC(=O)O,405.468,,,,,0.951,,,,
prexasertib,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,365.3951,,,,,,,,133.0,
erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,393.441,,,,,0.9,,,4.795,
posaconazole,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,700.8,,,0.79,,,,,7.3,
levodropropizine,C1CN(CCN1C[C@@H](CO)O)C2=CC=CC=C2,236.31,,,,,,,,54.635,
pacritinib,C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,472.5858,3.8,,,15.5,0.988,,0.69,2.09,CYP450_3a4_substrate
olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,558.59,,,,,0.99,,,,
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,428.537,4.1,,,,0.9,,,1.33,CYP450_3a4_substrate
atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,,,,,,0.9990000000000001,,,0.12,
azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,381.905,,,,,0.83,,,0.365,
letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,285.3,,,,,,,,,
fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,360.8,,,,,0.99,,,,CYP450_3a4_substrate
irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,586.685,,,,,0.49,,,9.4,CYP450_3a4_substrate
enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,464.4414,2.98,7.0,100.0,31.0,0.975,,,0.675,CYP450_3a4_substrate
lamivudine,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,229.2589,,,,,0.36,,,2.85,
macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,588.279,3.7,,,,0.99,,,,CYP450_3a4_substrate
talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,363.499,2.89,15.17,0.25,,,,,613.5,
brotizolam,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl,393.695,,,,,0.92,,,11.5,
osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,596.0,3.7,4.4,3.0,2.0,0.95,,,14.3,CYP450_3a4_substrate
inotersen,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@@H]5[C@H](O[C@H]([C@@H]5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)O[C@@H]8[C@H](O[C@H]([C@@H]8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)O[C@@H]1[C@H](O[C@H]([C@@H]1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,7183.08,,,,,0.94,,,3.185,CYP450_3a4_inhibitor
roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,352.3444,3.13,2.75,,,0.99,,,1.1,
pilocarpine,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,208.2594,,,,,,,,,
etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,358.848,,,,,0.92,,,36.0,
methoxsalen (8-methoxypsoralen),COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,216.191,1.9,,,,,,,,
bunazosin,CCCC(=O)N1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,373.4543,,,,,0.97,,,,
letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,572.55,4.6,,,,0.9840000000000001,,,4.66,CYP450_3a4_substrate
lesinurad,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,404.28,4.7,,,,0.98,,,6.0,CYP450_2c9_inhibitor
ritipenem,C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)COC(=O)N)C(=O)O)O,288.2788,,,,,,,,321.5,
prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,373.9496,,,,,0.86,,,,
encequidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,688.7,,,,,,,,91.5,
lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366,2.8,1.0,,,0.97,0.472,,3.915,CYP450_3a4_substrate
nitrendipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,360.364,2.4,,,,0.98,,,1450.0,
dronabinol (delta-(9)-tetrahydrocannabinol),CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O,314.466,6.0,10.6,,,,,,0.2,CYP450_3a4_substrate
ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,427.54,117.49,7.2,,,0.9,,,557.0,
lurasidone,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O,492.6844,5.4,1.0,,,0.99,,,3902.0,CYP450_3a4_substrate
donafenib,[2H]C([2H])([2H])NC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,467.848,,,,,,,,4.84,
aztreonam,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N,435.44,,,,,0.56,,,91.0,
indoxyl sulfate,C1=CC=C2C(=C1)C(=CN2)OS(=O)(=O)O,213.212,,,,,0.905,,,,
alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,,,,,,0.708,,,,
(-)-epigallocatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,458.373,,,,,,,,220.05,
cefdinir,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O,395.419,,,,,0.665,,,11.6,
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,416.579,,,,,0.9,,,93.0,
V-7404,CCOC(=O)/C=C/[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@H](CC#C)N2C=CC=C(C2=O)NC(=O)C3=NOC(=C3)C,,,,,,,,,1.54,
rimegepant,C1C[C@H](C2=C(C=CC=N2)[C@H]([C@@H]1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6,534.5642,0.8,,1.353,254.5,0.96,,,9.3,CYP450_3a4_substrate
lutetium Lu-177 vipivotide tetraxetan,C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O.[177Lu+3],1216.1,,,,,0.65,,,2.04,CYP450_3a4_substrate
norbuprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN[C@@H]3CC6=C5C(=C(C=C6)O)O4)OC)(C(C)(C)C)O,413.5545,,,,,,,,343.0,
valproic acid,CCCC(CCC)C(=O)O,144.212,,,,,0.47,,,0.065,CYP450_3a4_inhibitor
miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,416.134,5.3,,,,,,,,
avadomide,CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N,286.2896,,,,,0.38,,,40.69,
SUVN-G3031,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4,373.4891,,,,,0.3,,,12.5,
tetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,317.4,,,,,0.835,,,,CYP450_3a4_substrate
melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,232.2814,0.8,16.51,,,0.32,,,0.016,
nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,565.98,4.9,2.1,2.8,2.0,0.98,,,29.0,CYP450_3a4_substrate
quinine,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.875,,,1.2,
hippuric acid,C1=CC=C(C=C1)C(=O)NCC(=O)O,179.17,,,,,0.69,,,,
encorafenib,C[C@@H](CNC1=NC=CC(=N1)C2=CN(N=C2C3=C(C(=CC(=C3)Cl)NS(=O)(=O)C)F)C(C)C)NC(=O)OC,540.0173,2.59,4.51,0.15,71.5,0.86,,,14.0,CYP450_3a4_substrate
vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,488.61,,,,,0.94,,,56.0,CYP450_3a4_substrate
pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,487.5043,2.2,5.7,0.001,11.0,0.9059999999999999,,,10.6,CYP450_3a4_substrate
naproxen (S-naproxen),C[C@@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,230.2616,,,6.0,,0.499,,,0.075,
glyburide (glibenclamide),COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,494.009,,,,,0.998,,,0.9,CYP450_3a4_substrate
mitapivat,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,450.6,,,9.72,18.2,0.977,,0.023,12.95,CYP450_3a4_substrate
arbidol,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,531.8962,,,,,,,,66.5,
ezetimibe,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,409.43,,,,,0.9,,,,
sitafloxacin,C1CC12CN(C[C@H]2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)[C@@H]5C[C@@H]5F)F,409.818,,,,,0.5,,,306.5,
apinocaltamide,C1CC1(C2=CC=C(C=C2)CC(=O)NC3=NN(C=C3)CC4=NC=C(C=C4)C#N)C(F)(F)F,425.4,,,,,,,,,
drospirenone,C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C,366.498,3.08,,0.001,,0.96,,,6.8,CYP450_3a4_substrate
nafithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)[C@@H](C(=O)O2)/C(=N/O[C@@H](C)C4=NN=C(S4)C5=CC=CC=N5)/N)C,859.0488,,,,,0.419,,,53.9,
bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,364.42,,,,,0.97,,,136.5,
capivasertib,C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,428.9,2.5241,6.15,0.19,10.3,0.777,0.54,0.622,38.1,CYP450_3a4_substrate
doxifluridine (5'-dFUrd),C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O,246.19,,,,,,,,836.9,
prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,373.446,,,0.001,,,,,139.0,CYP450_3a4_substrate
ubrogepant,C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6,549.5504,,,0.001,,0.87,,,87.0,CYP450_3a4_substrate
fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)[C@@H](CO4)CC(=O)O)C)OCCCS(=O)(=O)C,524.6,,,,,0.9940000000000001,,,0.75,
repaglinide,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,452.591,,,,,0.9740000000000001,,,8.05,CYP450_3a4_substrate
lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,321.162,,,,,0.465,,,0.75,
dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)/C=C/CN4CCCCC4,487.95,,,,,0.98,,,24.9,CYP450_3a4_substrate
5-hydroxyomeprazole,CC1=C(C(=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)OC)CO)OC,361.4,,,,,,,,2.4,
propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,341.448,,8.8,1.0,,0.9,,,12.5,
hydroxyurea,C(=O)(N)NO,76.0546,,,,,0.775,,,153.2,
rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.34,,,,,0.4,,,1.2,CYP450_3a4_inhibitor
bempedoic acid,CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)O)O)C(=O)O,344.5,0.8,4.88,5.0,11.5,0.993,0.0204,,11.2,CYP450_3a4_inhibitor
imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,589.7,3.5,,0.1,,0.95,,,2.25,CYP450_3a4_substrate
oxymorphone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,337.8,,,,,0.3,,,,CYP450_3a4_substrate
mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,585.6966,4.65,2.5,152.0,15.0,0.49705,0.935,0.63,2.555,CYP450_3a4_substrate
asenapine,CN1C[C@@H]2[C@@H](C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,285.7724,,8.6,3.7,,0.013000000000000001,,,51.9,CYP450_3a4_substrate
cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,369.46,,,,,0.965,,,,
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl,331.865,,,,,,,,4.4,
upadacitinib,CC[C@@H]1CN(C[C@@H]1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,380.3721,,,,,0.52,,,26.77,CYP450_3a4_substrate
trazpiroben,C1CCC(CC1)N2CN(C(=O)C23CCN(CC3)CCCC(=O)C4=CC=CC=C4)CC5=CC(=CC=C5)C(=O)O,517.6591,,,,,,,,371.55,
simurosertib,CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)[C@@H]4CC5CCN4CC5,341.4307,,,100.0,,,,,42.0799,
ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,720.955,3.9,,0.001,,0.985,,,0.8,CYP450_3a4_substrate
trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,693.53,4.99,0.25,0.2,1.0,0.9680000000000001,,,4.285,CYP450_3a4_substrate
SUVN-D4010,CC(C)N1C2=CC=CC=C2C(=N1)C3=NN=C(O3)C4CCN(CC4)CCCOC,383.4873,,,,,,,,21.9,
tolterodine,CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,325.493,1.83,9.87,12.0,,0.963,0.8,,396.0,CYP450_3a4_substrate
phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,252.2718,2.4,8.31,0.02,,0.56,0.0645,,3.5500000000000003,CYP450_3a4_substrate
fluticasone furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,538.5801,,,,,0.996,,,,
betulin,CC(=C)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)CO,442.7,,,,,0.9990000000000001,,,,
nilvadipine,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,385.374,,,,,0.98,,,54.3,
azacitidine,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,244.206,,,,,,,,152.0,
razuprotafib,COC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)NS(=O)(=O)O)C3=CSC(=N3)C4=CC=CS4,586.7114,,,15.0,,,,,,
pretomanid,C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,359.2588,,,0.016,,0.8640000000000001,0.2,,2.35,CYP450_3a4_substrate
pindolol,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,248.32,,,,,0.4,,,,
rifapentine,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C,877.031,,,,,0.977,,,,
zomepirac,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl,291.7326,,,,,,,,3.14,
mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,152.181,,,,,0.19,,,7.5,
lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,371.824,,,,,0.997,,,2.45,
opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],413.172,,,1.0,3.5,0.99,,,,
candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,440.461,,,,,0.998,,,0.39,CYP450_3a4_substrate
opelconazole,CC1=C(C=CC(=C1)N2CCN(CC2)C3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)F)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,682.734,,,,,,,,,
deutenzalutamide,[2H]C([2H])([2H])NC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C2(C)C)C3=CC(=C(C=C3)C#N)C(F)(F)F)F,467.46,,,,,,,,122.13499999999999,
fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,307.4747,,,,,0.997,,,4.3,CYP450_3a4_substrate
anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,293.372,,,,,0.4,,,,CYP450_3a4_substrate
rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,359.4479,,,,,0.4865,0.249,,283.0,CYP450_3a4_substrate
carbidopa,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,226.23,,,,,,,,12.5,
tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(CO[C@@]34[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)C=C2,386.4414,,,,,0.84,,,5.65,
ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,206.283,,,1.0,,0.99,,,0.475,CYP450_3a4_inhibitor
terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,548.6,,,,,0.2,,,2.0,
fusidic acid,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C,516.714,,,,,0.998,,,0.5,
gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,323.4149,,5.8,0.001,,0.94,,,18.95,
stavudine (d4T),CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,224.2148,,,,,,,,5.17,
ravidasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)[C@@H]7CCCN7C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,762.907,,,,,,,,5.62,
tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,480.5296,3.82,1.0599999999999998,18.7,2.19,0.971,0.73,,148.0,CYP450_3a4_substrate
benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],260.2518,,,,,0.52,,,,
ginsenoside Rb1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O)O)O)C,1109.2978,,,,,0.006999999999999999,,,0.9,
pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,597.49,,,,,0.81,,,91.8,
alprenolol,CC(C)NCC(COC1=CC=CC=C1CC=C)O,249.352,,,,,0.85,,,,
peficitinib,C1[C@@H]2CC3(C[C@@H](C2NC4=C5C=CNC5=NC=C4C(=O)N)CC1C3)O,326.3978,,,0.1,,0.76,,,59.78,
pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,273.2469,,,15.0,,0.28,0.54,,8.5,CYP450_3a4_substrate
talazoparib,CN1C(=NC=N1)[C@@H]2[C@H](NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,380.3566,,,17.0,2.49,0.74,,,6.45,CYP450_3a4_inhibitor
linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,337.35,,,,,0.31,,,1.4500000000000002,
nortilidine,CCOC(=O)[C@]1(CCC=C[C@@H]1NC)C2=CC=CC=C2,,,,,,0.138,,,,
tretinoin (all-trans-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,300.44,,,,,0.95,,,,CYP450_3a4_substrate
solifenacin,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5,362.4704,,,100.0,,,,,10.0,CYP450_3a4_substrate
phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,232.2,,,,,0.27,,,0.0375,
thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,258.232,,,,,0.6,,,1.3,
pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,427.55,4.67,8.6,,2.0,0.95,,,25.75,CYP450_3a4_substrate
(S)-7-hydroxywarfarin,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(C3=C(C=C(C=C3)O)OC2=O)O,324.3,,,,,,,,51.35,
prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,358.4,,,168.2,,0.385,,,2.2,CYP450_3a4_substrate
meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,351.4,3.0,4.08,,,0.9940000000000001,,,0.11,
promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,284.425,,,,,0.91,,,5.055499999999999,CYP450_3a4_substrate
ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,263.791,2.9,6.94,100.0,,0.98,,,34.0,
indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,357.791,,,,,0.9,,,0.7999999999999999,
duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,297.42,,,1.0,,0.015,,,94.5,CYP450_1a2_substrate
osilodrostat,C1CC2=CN=CN2[C@H]1C3=C(C=C(C=C3)C#N)F,227.241,1.61,6.9,50.0,6.88,0.364,0.117,,16.4,CYP450_3a4_substrate
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,318.87,,,,,0.965,,,5.75,
cathinone,C[C@@H](C(=O)C1=CC=CC=C1)N,149.1919,,,,,,,,2104.5,
quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,560.6758,2.33,4.75,0.93,,0.9906,0.652,0.985,2.23,CYP450_3a4_substrate
tropifexor,C1C[C@H]2CC(C[C@@H]1N2C3=NC4=C(C=C(C=C4S3)C(=O)O)F)OCC5=C(ON=C5C6=CC=CC=C6OC(F)(F)F)C7CC7,603.5905,,,,,,,,2755.0,
pralsetinib,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,533.6088,3.87,6.71,0.88,5.05,0.971,,,9.1,CYP450_3a4_substrate
tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,308.1193,,,,,0.99,,,0.263,
norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,319.334,1.03,6.34,0.1,,0.125,,,,
leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,270.209,,,,,0.9940000000000001,,,0.012,
urapidil,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,387.481,,,,,0.805,,,200.0,
hydromorphone,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,285.341,,,,,0.071,,,11.1,CYP450_3a4_substrate
mirogabalin,CCC1=C[C@@H]2[C@H](C1)C[C@@]2(CC(=O)O)CN,209.2871,,,,,,,,14.62,
adagrasib,CN1CCC[C@H]1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN([C@H](C6)CC#N)C(=O)C(=C)F,604.1,5.02,3.33,262.0,6.84,0.977,0.72,0.04,37.0,CYP450_3a4_substrate
buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,385.509,,,,,0.95,,,19.3,CYP450_3a4_substrate
cocaine,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,,,,,,0.91,,,19.0,
riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,234.2005,,,,,0.98,,,3.2,
meropenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)N(C)C)C(=O)O)[C@@H](C)O,437.52,,,,,0.02,,,8.95,
nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,266.303,2.5,2.8,,,0.6,,,0.5,CYP450_3a4_substrate
isotretinoin (13-cis-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,300.44,,,,,0.99,,,6.0,
lubiprostone,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@@H]2CCCCCCC(=O)O)O)(F)F,390.46,,,,,0.94,,,,
brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C,370.3821,,,,,,,,14.7,
secnidazole,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],185.18,,,,,0.05,,,25.0,CYP450_3a4_substrate
ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,510.3649,3.7,2.245,30.0,,0.998,,,15.3,CYP450_3a4_substrate
cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,261.087,,,,,0.13,,,0.9,CYP450_3a4_substrate
hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,160.179,,,,,0.87,,,34.5,
thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,201.252,2.47,4.64,50000.0,,,,,,
omecamtiv mecarbil,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,401.4396,,,,,0.909,,,17.9,
nirmatrelvir,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)C(F)(F)F)C(=O)N[C@@H](C[C@@H]3CCNC3=O)C#N)C,499.5265,1.84,,1.21,0.925,0.69,0.99,0.296,66.83,CYP450_3a4_substrate
tetracycline,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,444.4376,,,,,0.34,,,0.955,
vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,475.3596,4.7,5.2,0.001,9.385,0.94,,0.1,13.2,CYP450_3a4_substrate
atogepant,C[C@@H]1[C@@H](C[C@@H](C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(C[C@@]4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F,603.5207,,,0.001,2.85,0.953,,,19.0,CYP450_3a4_substrate
biperiden,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,,,,,0.9,,,,
laropiprant,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CC[C@@H]3CC(=O)O)CC4=CC=C(C=C4)Cl)F,435.9,,,,,0.996,,,,
vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl,774.8,,,,,0.94,,,,
lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,256.095,,,,,0.56,,,0.495,
dexlansoprazole,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,369.366,,,0.16,,0.975,,,11.4,
fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,583.4954,,,250.0,2.0,,,,,CYP450_3a4_substrate
exemestane,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,296.41,3.1,,,,0.9,,,145.0,CYP450_3a4_substrate
olverembatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,532.6,3.6,2.9,,0.08,,,0.0005,0.132,
sulfisoxazole,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,,,,,,0.463,,,0.17,
baicalein,C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O,270.24,,,,,,,,1938.0,
methylnaltrexone,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,356.4394,,,,,0.1315,,,,
ropivacaine,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C,274.405,,,,,0.92,,,6.3,
deoxycholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576,,,,,0.98,,,,
ledipasvir,CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,889.0116,7.4,1.0,,1.76,0.998,,,,CYP450_3a4_substrate
cefotaxime,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,455.47,,,,,0.195,,,2.15,
fludarabine,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N,365.2,,,,,0.24,,,6.6,
sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,666.7,,,,,0.96,,,3.55,CYP450_3a4_substrate
mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,179.261,2.3049999999999997,9.2,0.54,,0.33,,,1.9500000000000002,
selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,525.6099,,3.19,,22.35,0.973,,,6.0,CYP450_3a4_substrate
oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,357.491,,,,,,,,5.199999999999999,CYP450_3a4_substrate
temsavir,CC1=NN(C=N1)C2=NC=C(C3=C2NC=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)OC,473.4907,,,,2.0,0.884,,,17.9,CYP450_3a4_substrate
tenofovir,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,287.2146,,,,,0.01,,,1.75,
voxelotor,CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O,337.3771,,,0.03,,0.998,,,6.7,CYP450_3a4_substrate
enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,320.3223,,,,,,,,11.625,
methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,374.474,1.9,,,,0.405,,,3.5500000000000003,CYP450_3a4_substrate
lithium,[Li],6.941,,,,,0.0,,,0.22999999999999998,
ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,204.312,,,,,0.18,,,4.7,
tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,247.274,,,,,0.12,,,,
binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,441.2305,,,,,0.97,,,20.2,CYP450_3a4_substrate
lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,377.3642,,,,,0.575,,,114.0,CYP450_3a4_substrate
aclidinium,C1C[N+]2(CCC1[C@H](C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5,484.7,,,,,,,,170.0,CYP450_3a4_substrate
avacopan,CC1=C(C(=CC=C1)F)C(=O)N2CCC[C@@H]([C@@H]2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,581.6505,,4.7,0.001,30.7,0.9990000000000001,,,0.22955,CYP450_3a4_substrate
rasagiline,C#CCN[C@@H]1CCC2=CC=CC=C12,171.24,,,,,0.92,,,0.34500000000000003,CYP450_3a4_inhibitor
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,217.288,,,,,0.25,,,12.0,
sotorasib,C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,560.6,,8.06,0.07,11.2,0.89,,,26.2,CYP450_3a4_substrate
tapentadol,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,221.34,2.87,9.34,100.0,,0.2,,,853.5,CYP450_3a4_inhibitor
anidulafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O,1140.3,,,,,0.84,,,1.0,CYP450_3a4_inhibitor
torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,348.425,,7.1,,,0.99,,,33.5,
oliceridine,COC1=C(SC=C1)CNCC[C@]2(CCOC3(C2)CCCC3)C4=CC=CC=N4,386.557,,,3.3,,0.77,0.764,,71.2,CYP450_3a4_substrate
edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,548.065,,,,,0.55,,,22.0,CYP450_3a4_substrate
ampreloxetine,C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F,321.3368,,,,,,,,21.549999999999997,
atomoxetine,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,291.82,,,27.8,,0.98,,,0.373,
etoposide,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,588.559,,,,,0.48200000000000004,,,2.505,CYP450_3a4_substrate
(R)-propranolol (dexpropranolol),CC(C)NC[C@H](COC1=CC=CC2=CC=CC=C21)O,259.3469,,,,,,,,2470.5,
carbazeran,CCNC(=O)OC1CCN(CC1)C2=NN=CC3=CC(=C(C=C32)OC)OC,360.412,1.83,8.6,,,,0.98,,,
ginsenoside Rd,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,947.1578,,,,,0.003,,,1.3,
lusutrombopag,CCCCCCO[C@@H](C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)/C=C(\C)/C(=O)O)Cl,591.5,,,,,0.9990000000000001,,,1.1,CYP450_3a4_substrate
somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)N[C@@H](CCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)N[C@@H](CCCCNC(=O)CSC[C@@H](C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,1310.5475,,6.8,,,0.99,,,0.03,
moclobemide,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,268.742,1.79,6.2,,,0.5,,,83.6,
PF-05241328,CC1=NN(C2=C1C=C(C=C2)C(=O)NS(=O)(=O)C)C3=CC(=C(N=C3)OCC(C)C)Cl,436.9179,,,,,,,,392.0,
trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,266.3388,,,,,0.16,,,,
paliperidone (9-hydroxyrisperidone),CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,426.489,,,,,0.74,,,53.0,CYP450_3a4_substrate
paclitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,853.913,,,,,0.94,,,21.5,CYP450_3a4_substrate
ulimorelin,C[C@@H]1CN[C@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4,538.6601,,,,,0.998,,,3.685,
bortezomib,B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,384.241,,,,,0.83,,,32.0,
flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,,,,,,,,,,
crizotinib,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,450.3,4.28,9.4,10.0,,0.91,0.84,,60.0,CYP450_3a4_substrate
nifurtimox,CC1CS(=O)(=O)CCN1/N=C/C2=CC=C(O2)[N+](=O)[O-],287.2947,,,,,0.42,,,,CYP450_3a4_inhibitor
venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,277.405,,,,,0.145,,,16.0,CYP450_3a4_substrate
carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],373.2666,,,,,0.0,,,0.9,
fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,501.6559,,,,,0.977,,,2495.0,
adinazolam,CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,,,,,,0.65,,,,
lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,293.724,,,,,0.985,,,4.6,
PF-05186462,C1=CC(=C(C=C1C(F)(F)F)C2=CN=NC=C2)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=NN=CS4)F,,,,,,,,,94.0,
argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,526.66,,,,,0.54,,,,
amodiaquine,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,355.867,,,,,,,,35.9,
azlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C,461.497,,,,,0.17,,,15.45,
semaxinib,CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C,238.289,,,,,0.49700000000000005,,,10.5,
mifepristone,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,429.6,5.13,5.0,25.0,15.09,0.992,,,,CYP450_3a4_substrate
risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,401.4717,,,,350.0,0.89,,,2.1,CYP450_3a4_substrate
iclepertin,C[C@H](C(F)(F)F)OC1=C(C=C(C=C1)S(=O)(=O)C)C(=O)N2C[C@@H]3C[C@@]3(C2)C4=NOC(=C4)C(F)(F)F,512.4,,,,,,,,95.7,
(R)-ibuprofen,C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)O,206.2832,,,,,,,,3.45,
doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,451.48,,,,,0.99,,,2.1,
ramipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,416.515,,,90.0,,0.375,,,23.0,
glasdegib,CN1CC[C@H](C[C@@H]1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,374.4458,,1.0,1.7,,0.91,,,6.45,CYP450_3a4_substrate
baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,371.42,,,,,0.5,,,8.9,CYP450_3a4_substrate
teriflunomide,C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O,270.21,2.7,22.0,0.02,,0.96,,,30.5,CYP450_3a4_substrate
bedaquiline,CN(C)CC[C@@](C1=CC=CC2=CC=CC=C21)([C@H](C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,555.5,,,,,0.99,,,4.8549999999999995,CYP450_3a4_substrate
imipenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,299.3493,,,,,0.2,,,1.5999999999999999,
tiotropium,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,392.5178,,,,,0.72,,,880.0,CYP450_3a4_substrate
nalbuphine,C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,357.4,,,,,,,,40.85,
fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,580.46,0.6,1.7,0.3,,,,,,CYP450_3a4_substrate
5-fluorouracil,C1=C(C(=O)NC(=O)N1)F,130.078,,,,,0.1,,,11.5,
cefuroxime,CO/N=C(/C1=CC=CO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,424.388,,,,,0.195,,,0.94,
formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,344.4086,,,,,0.61,,,150.0,
(R)-citalopram,CN(C)CCC[C@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,,,,,,,0.16,
mitragynine,CC[C@@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.5,,,,,,,0.039,186.85,
erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,446.552,,,0.001,,,,,0.362,CYP450_3a4_substrate
amprenavir,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,505.633,,,0.04,,,,,5.1,
larotrectinib,C1C[C@@H](N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CC[C@@H](C4)O)C5=C(C=CC(=C5)F)F,428.4408,1.7,2.0,3.63,,0.7,,,98.0,CYP450_3a4_substrate
dicloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,470.331,,,,,0.48,,,0.9500000000000001,
chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,169.567,,,,,,,,313.5,
promazine,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C31,284.425,,,,,0.84,,,,
esomeprazole,CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42,2.24,9.29,0.36,,0.96,,,5.9,
amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,229.63,,,,,0.25,,,,
zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],267.244,,,,,0.38,,,1.1,
simeprevir,CC1=C(C=CC2=C1N=C(C=C2O[C@@H]3C[C@@H]4[C@@H](C3)C(=O)N(CCCC/C=C\[C@@H]5C[C@]5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,749.94,,,,,,,,,CYP450_3a4_substrate
naloxone,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,327.378,,,,,,,,22.0,
rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,357.432,,,,,0.998,,,0.42000000000000004,CYP450_3a4_inhibitor
flunarizine,C1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,404.501,1.97,1.0,0.1,,0.991,,,301.2,
cyclosporine,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1202.62,,,,,0.475,,,12.3,CYP450_3a4_substrate
tasimelteon,CCC(=O)NC[C@@H]1C[C@H]1C2=C3CCOC3=CC=C2,245.3201,2.43,15.74,1.1,,0.9,,,1609.5,CYP450_3a4_substrate
cannabidiol,CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O,314.466,,,,,0.94,,,1111.0,CYP450_3a4_substrate
flavopiridol (alvocidib),CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,401.844,,,,,0.91,,,6.55,
albuterol (salbutamol),CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,239.31,,,,,,,,6.65,
tenoxicam,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,337.3789,1.9,2.21,14100.0,,,,,2.745,
suvorexant,C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,450.9277,3.95,0.25,0.117,,0.99,,,4.755,CYP450_3a4_substrate
niraparib,C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,320.394,,,,,0.83,,,16.2,CYP450_3a4_substrate
dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,519.57,2.9,6.6,0.001,,0.997,,,34.4,CYP450_3a4_substrate
tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,448.948,5.0,,,,0.98,,,4.7,CYP450_3a4_substrate
bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,239.744,,,,,0.84,,,19.1,CYP450_3a4_substrate
lurbinectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,784.9,,,0.001,,0.99,,,11.0,CYP450_3a4_substrate
ceftazidime,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],636.6,,,,,0.1,,,115.0,
landiolol,CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C,509.596,,,1000.0,,0.1,,,57.0,CYP450_3a4_inhibitor
bufuralol,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O,261.363,,,,,0.9,,,26.0,
dextrorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)O,257.375,,,,,,,,19.5,
alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCC[C@H](C3)N,339.3969,-0.9,8.5,47.0,1.059,0.2,,,14.0,CYP450_3a4_substrate
memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,179.305,,,,,0.45,,,7.5,CYP450_3a4_inhibitor
clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,315.715,,,,,0.4325,,,0.915,CYP450_3a4_substrate
clesacostat,CC(C)N1C2=C(CC3(CCN(CC3)C(=O)C4=CC(=NC(=C4)OC)C5=CC=C(C=C5)C(=O)O)CC2=O)C=N1,502.6,,,,,,,,14.100000000000001,
probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,285.36,,,0.06,,0.91,,,1.38,
minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,209.251,,,,,0.0,,,24.0,
cabotegravir,C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,405.3553,1.58,7.8,1.0,256.0,0.998,0.67,,0.151,
cinacalcet,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,357.417,,,,3.3,0.95,,,126.5,
practolol,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O,266.339,,,,,,,,70.5,
p-cresol,CC1=CC=C(C=C1)O,,,,,,0.935,,,,
velpatasvir,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC,883.0136,,,,,0.995,,,39214.5,CYP450_3a4_substrate
diosmin,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,608.5458,,,,,,,,0.87,
imipenem and cilastatin,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,,,,,,0.2,,,11.8,
bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,430.37,2.49,12.0,5000.0,,0.4,,,0.2115,CYP450_3a4_substrate
bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,470.61,,,,,0.9754999999999999,,,,CYP450_3a4_substrate
treprostinil,CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,412.49,,,,,0.91,,,30.0,
esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,295.37,,,,,0.55,,,120.0,
cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,501.5,,,0.001,,0.997,,,4.4,CYP450_3a4_substrate
valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,435.525,4.4,1.0,1.0,,0.95,,,0.29,CYP450_3a4_substrate
escitalopram,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,,,,0.56,,,24.549999999999997,CYP450_3a4_substrate
vildagliptin,C1C[C@H](N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,301.43,,,,,,,,30.4,
idrocilamide,C1=CC=C(C=C1)/C=C/C(=O)NCCO,191.229,0.9,,,,0.9640000000000001,,,,
mavacamten,C[C@@H](C1=CC=CC=C1)NC2=CC(=O)N(C(=O)N2)C(C)C,273.3341,,,0.001,127.7,0.97,0.743,,35.0,CYP450_3a4_substrate
epirubicin,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.522,,,,,0.77,,,28.5,CYP450_3a4_substrate
TP0463518,C1CN(C(=O)C(=C1O)C(=O)NCC(=O)O)CC2=CN=C(C=C2)OC3=CC=C(C=C3)Cl,,,,,,0.99,,,3.235,
umeclidinium,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5,428.5926,,,,,0.89,,,244.0,
progesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,314.5,,,,,0.97,,,,
bevantolol,CC1=CC(=CC=C1)OCC(CNCCC2=CC(=C(C=C2)OC)OC)O,345.436,,,,,0.95,,,9.0,
granisetron,CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,312.4,,,,,0.37,,,10.0,CYP450_3a4_substrate
apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,477.4405,2.89,9.7,0.01,42.3,0.96,,,1.3,CYP450_3a4_substrate
ampicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,371.39,,,,,0.28,,,156.9,
stiripentol,CC(C)(C)C(/C=C/C1=CC2=C(C=C1)OCO2)O,234.29,,,,,0.99,,,4.125,CYP450_3a4_substrate
clavulanic acid,C1[C@@H]2N(C1=O)[C@H](/C(=C/CO)/O2)C(=O)O,199.1611,,,,,,,,1.9200000000000002,
palovarotene,CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C,414.5,6.8,4.31,21.4,,0.9875,,0.01,13.22,CYP450_3a4_substrate
streptomycin,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,581.574,,,,,0.46,,,,
brofaromine,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br,310.189,,,,,,,,8.4,
azithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,748.989,,8.1,100.0,,0.07,,,630.0,
ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,230.3092,,,,43.0,,,,,
carfilzomib,CC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,719.9183,,,0.001,,0.97,,,207.0,CYP450_3a4_inhibitor
clindamycin,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@H](C)Cl,424.987,,,,,0.469,,,3.0,
regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,500.83,,,0.001,75.1,0.995,,,,CYP450_3a4_substrate
ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,261.087,,,,,,,,4.05,CYP450_3a4_substrate
navtemadlin,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,568.5522,,4.35,,,0.975,,,23.7,
emodepside,C[C@@H]1C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N([C@H](C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C,1119.399,,,,,,,,3.56,
tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,415.1144,3.99,4.03,0.00269,,,,,0.0111,
ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,467.42,4.53,6.31,,,0.4999,0.064,,11.7,CYP450_3a4_substrate
milnacipran,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,246.35,,,,,0.129,,,20.65,CYP450_3a4_substrate
dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO,396.4922,,,,,0.858,,,,
proguanil,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl,253.735,,,,,0.75,,,1.2,
9-cis-UAB30,C/C(=C\C(=O)O)/C=C/C=C(/C)\C=C\1/CCCC2=CC=CC=C21,,,,,,,,,15.05,
pradefovir,C1CO[P@@](=O)(O[C@@H]1C2=CC(=CC=C2)Cl)COCCN3C=NC4=C(N=CN=C43)N,519.897,,,,,,,,192.3,
pindolol,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,248.32,,,,,0.4,,,,
7-ethyl-10-hydroxycamptothecin (SN-38),CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,392.409,,,,,0.95,,,,
bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,325.446,,,,,0.3,,,15.0,CYP450_3a4_substrate
salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,239.31,,,,,,,,6.65,
gepirone,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=NC=CC=N3)C,359.5,,,,,0.389,,,485.3,CYP450_3a4_substrate
salicin,C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.2782,0.44,,,,,,,,
fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,336.476,860.0,8.4,,,0.43,,,0.5,CYP450_3a4_substrate
cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,645.6753,,,,,0.9,,,1.5150000000000001,
tauroobeticholic acid,CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3[C@@H]1O)CC[C@@H]4[C@H](C)CCC(=O)NCCS(=O)(=O)O)C)C)O,527.8,,,,,0.9978,,,,
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,277.409,,,,,0.478,,,7.45,CYP450_3a4_substrate
tauroursodeoxycholic acid (taurursodiol),C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,499.7085,3.6,,0.001,,0.985,,,,
vinflunine,CC[C@@]12C=CCN3[C@@H]1[C@]4(CC3)[C@H]([C@]([C@@H]2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)[C@]6(C[C@H]7C[C@H](CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,816.938,,,,,,,,27.15,
saquinavir,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,670.85,,,,,0.98,,,10.65,CYP450_3a4_substrate
rocuronium,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,529.7807,,,,,0.25,,,4.25,
methoxsalen (8-methoxypsoralen),COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,216.191,1.9,,,,,,,,
benidipine,CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,505.568,,,,,,,,977.18,
lypressin,C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N,1056.2305,,,,,,,,318.0,
sofosbuvir and velpatasvir,C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)[C@@H](C9=CC=CC=C9)NC(=O)OC)COC.C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,529.45,,,,,0.995,,,,
flavopiridol (alvocidib),CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,401.844,,,,,0.91,,,6.55,
azacitidine,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,244.206,,,,,,,,152.0,
fluticasone furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,538.5801,,,,,0.996,,,,
bivalirudin,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N,2180.3,,,,,,,,0.32,
sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,386.557,,,,,0.47,,,7.6,
zoniporide,C1CC1C2=C(C=NN2C3=CC=CC4=C3C=CC=N4)C(=O)N=C(N)N,320.3544,1.15,,,,,0.56,,11.1,
aclidinium,C1C[N+]2(CCC1[C@H](C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5,484.7,,,,,,,,170.0,CYP450_3a4_substrate
omadacycline,CC(C)(C)CNCC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,556.656,,,,,0.2,,,8.8,
scopolamine,CN1[C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4,303.356,,,,,,,,93.0,
dapoxetine,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3,305.419,,8.6,,,0.99,,,20.5,
esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,295.37,,,,,0.55,,,120.0,
CP-724714,CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)/C=C/CNC(=O)COC)C,469.5,,,,,,,,29.0,
neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C,557.0511,4.9,7.65,3.3,,0.99,,,216.0,CYP450_3a4_substrate
disopyramide,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,339.48,,,,,,,,0.8,
cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.892,,,,,0.498,,,0.46499999999999997,
lactitol,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]([C@@H](CO)O)[C@@H]([C@H](CO)O)O)O)O)O)O,344.3106,,,,,,,,,
pefloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,333.361,,,,,0.25,,,3.6,
omaveloxolone,C[C@@]12CC[C@]3(CCC(C[C@H]3[C@H]1C(=O)C=C4[C@]2(CC[C@@H]5[C@@]4(C=C(C(=O)C5(C)C)C#N)C)C)(C)C)NC(=O)C(C)(F)F,554.7,,7.26,0.001,2.325,0.97,,,109.0,CYP450_3a4_substrate
gestodene,CC[C@]12CC[C@H]3[C@H]([C@@H]1C=C[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.943,,,,
ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437,4.3,,,,0.4955,,,6.25,CYP450_3a4_substrate
belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,452.5156,3.8,1.57,0.001,0.19065,0.9990000000000001,0.419,,23.0,CYP450_3a4_substrate
rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl,435.8862,,13.4,7000.0,,0.935,0.18,,10.0,CYP450_3a4_substrate
fluvastatin (acid),CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,411.47,,,101.0,,0.98,0.75,,9.5,CYP450_3a4_substrate
rufinamide,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,238.196,,,,,0.27,,,6.12,CYP450_3a4_inhibitor
eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O,424.519,,,,,0.98,,,,CYP450_3a4_substrate
bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,530.446,,,0.053,,0.94,,,38.85,CYP450_3a4_substrate
budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,430.5,,,0.001,,0.875,,,1.35,CYP450_3a4_substrate
aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,546.1986,,,0.001,3.75,0.9940000000000001,,,0.291,
olodaterol,CC(C)(CC1=CC=C(C=C1)OC)NC[C@@H](C2=C3C(=CC(=C2)O)NC(=O)CO3)O,422.9,,,,,0.6,,,872.0,CYP450_3a4_substrate
avanafil,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl,483.9574,,,0.001,44.6,0.99,,,17.41,CYP450_3a4_substrate
vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,489.93,3.0,7.9,0.001,2.9,0.99,,,31.0,CYP450_3a4_substrate
omzotirome,CC1=CC(=C2CCCC2=C1O)CC3=C(N(N=C3C)CCC(=O)O)C,328.4,,,,,,,,4.22,
selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,457.6855,,2.8,1.0,6.88,0.9840000000000001,0.56,,8.8,CYP450_3a4_substrate
losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,422.918,1.19,5.5,,,,,,4.95,CYP450_3a4_substrate
itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,553.5217,1.6,,,,0.304,,,136.35,
eliglustat,CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O,404.5474,2.84,8.79,300.0,12.65,0.795,,,92.5,CYP450_3a4_substrate
ipragliflozin,C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F,404.4559,3.38,,0.09,5.92,0.9555,,,6.55,
lovastatin (lactone),CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,404.543,4.08,13.49,,,0.95,,,11.3,CYP450_3a4_substrate
amifampridine,C1=CN=CC(=C1N)N,109.131,,,,,0.10400000000000001,,,171.4,CYP450_3a4_inhibitor
topotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,421.451,,,,,,,,16.35,CYP450_3a4_substrate
dexloxiglumide,CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl,461.383,,,,,0.9790000000000001,,,0.125,
dexmethylphenidate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,233.3091,1.8,,100.0,,0.47,,,0.4,
propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,178.273,,11.0,,,0.9854999999999999,,,16.0,
atropine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,289.373,,,,,0.18,,,6.0,
onalespib,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,409.5269,,,,,,,,29.25,
diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,284.7447,,,,,0.49450000000000005,0.257,,0.22,CYP450_3a4_substrate
tacrine,C1CCC2=NC3=CC=CC=C3C(=C2C1)N,198.268,2.71,9.95,217000.0,,0.75,,,,CYP450_3a4_inhibitor
daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,393.4373,5.28,3.24,0.054,11.5,0.9940000000000001,0.95,0.004,18.9,CYP450_3a4_substrate
levonorgestrel,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,312.4,,,,,0.955,,,,
amsacrine,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,393.465,,,,,0.97,,,0.26,
entacapone,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,305.289,,,,,0.98,,,6.0200000000000005,
tirzepatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N4CCC[C@H]4C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C(C)(C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CC=C(C=C8)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=CC=C9)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N,4813.53,,,,,0.99,,,0.0621,
thiotepa,C1CN1P(=S)(N2CC2)N3CC3,189.222,,,,,,,,103.0,
ramelteon,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,259.347,,,1.1,16.3,,,,916.0,CYP450_3a4_substrate
idasanutlin,CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,616.4891,5.6,4.0,,8.0,,,,2.025,
flibanserin,C1CN(CCN1CCN2C3=CC=CC=C3NC2=O)C4=CC=CC(=C4)C(F)(F)F,390.41,3.3,,0.008,3.19,,,,555.0,CYP450_3a4_substrate
glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87,,,,1.4,0.975,,,1150.0,
nemiralisib,CC(C)N1CCN(CC1)CC2=CN=C(O2)C3=C4C=NNC4=CC(=C3)C5=C6C=CNC6=CC=C5,440.5482,4.01,8.47,,,0.9790000000000001,,,10.8,
firuglipel,CC[C@H](C1=NC(=NO1)C2=CC(=C(C=C2)C(=O)N[C@H](C)CO)F)OC3=CC=C(C=C3)C(=O)C4CC4,467.4944,,,,,,,,5.295,
topiramate,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,339.4,0.57,8.61,9.8,,0.28,,,25.0,
salicin,C1=CC=C(C(=C1)CO)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.2782,0.44,,,,,,,,
trospium,C1CC[N+]2(C1)[C@@H]3CC[C@H]2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,392.5,,,628.5,,0.8,,,796.0,CYP450_3a4_substrate
omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42,2.2,,0.2,,0.95,0.71,0.03,550.0,CYP450_3a4_substrate
semagacestat,C[C@@H](C(=O)N[C@H]1C2=CC=CC=C2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O,361.4393,,,,4.0,,,,21.2,
trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,371.87,2.9,6.74,100.0,,0.92,,,1.1,CYP450_3a4_substrate
montelukast,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,586.2,7.7,4.3,,,0.99,,,0.435,CYP450_3a4_substrate
naltrexone,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,341.405,,,,,0.21,,,,CYP450_3a4_substrate
labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,328.41,3.1,,,,0.5,0.366,,33.0,
belzutifan,CS(=O)(=O)C1=C2[C@@H]([C@@H]([C@@H](C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,383.3417,,,0.01,29.299999999999997,0.45,,,7.3,CYP450_3a4_substrate
verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,454.607,,,,,0.46,,,10.5,CYP450_3a4_substrate
garcinia acid,C(C(=O)O)C(C(C(=O)O)O)(C(=O)O)O,208.121,,,,,,,,125.925,
ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,260.3786,,,,,0.4,,,8.1,CYP450_3a4_inhibitor
indinavir,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,613.798,2.8,,,,0.61,,,9.35,CYP450_3a4_substrate
daridorexant,CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,450.9207,3.9,,0.0001,22.6,0.997,0.89,0.12,4.97,CYP450_3a4_substrate
enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,4500.0,,,,,,,,21.75,
gallic acid,C1=C(C=C(C(=C1O)O)O)C(=O)O,170.1194,,,,,0.893,,,83.0,
sirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,914.179,,,,,0.92,,,111.5,CYP450_3a4_substrate
avapritinib,C[C@](C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,498.558,3.2,1.0,3.6,8.0,0.988,0.9,,19.5,CYP450_3a4_substrate
cisplatin,N.N.Cl[Pt]Cl,302.0632,,,,,,,,3.75,
galantamine,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,287.357,,,,,0.18,,,,CYP450_3a4_substrate
finerenone,CCOC1=NC=C(C2=C1[C@@H](C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,378.4298,,4.3,0.001,10.65,0.9167000000000001,0.9,,25.63,CYP450_3a4_substrate
(-)-epicatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,442.374,,,,,,,,329.15,
gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,250.336,,4.7,,,0.99,,,1.05,CYP450_3a4_substrate
durlobactam,CC1=C[C@@H]2CN([C@@H]1C(=O)N)C(=O)N2OS(=O)(=O)O,277.2559,2.0,,100.0,,0.1,,,6.535,CYP450_3a4_substrate
nicotine,CN1CCC[C@H]1C2=CN=CC=C2,162.2346,,,,,0.0385,,,11.95,
cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,776.0347,,,,,0.975,,,14.0,CYP450_3a4_substrate
rifabutin,C[C@H]1/C=C/C=C(\C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)/C,847.013,3.2,,0.19,,0.365,,,1.4,
quinidine,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,324.422,,,,,0.45,,,3.25,
esketamine,CN[C@@]1(CCCCC1=O)C2=CC=CC=C2Cl,237.728,,,,,0.43,0.637,,89.0,
telithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,812.0115,3.0,8.84,300000.0,,0.65,,,14.0,
enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,473.3793,,,74.0,17.9,0.985,,,0.7,CYP450_3a4_substrate
levomepromazine (methotrimeprazine),C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C,328.478,,,,,0.9440000000000001,,,,
piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,331.3,,,,,0.99,,,1.25,CYP450_3a4_substrate
remdesivir metabolite GS-441524,C1=C2C(=NC=NN2C(=C1)[C@]3([C@@H]([C@@H]([C@H](O3)CO)O)O)C#N)N,291.2627,,,,,0.02,,,,
ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,378.106,,,,,,,,37.995,
pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,356.444,,,,,0.99,0.39,0.0078,1.43,CYP450_3a4_substrate
olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,434.46,1.49,1.25,0.13,2.005,0.82,0.973,0.089,5.65,CYP450_3a4_substrate
voclosporin,CC[C@H]1C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1)[C@@H]([C@H](C)C/C=C/C=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,1214.62,5.87,,0.001,,0.97655,,,63.6,CYP450_3a4_substrate
estetrol,C[C@]12CC[C@H]3[C@H]([C@@H]1[C@H]([C@H]([C@@H]2O)O)O)CCC4=C3C=CC(=C4)O,304.3836,,,0.1,1.8,0.48,,,196.0,CYP450_3a4_substrate
almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,469.56,,,,,0.35,,,24.0,CYP450_3a4_substrate
tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,454.8681,4.09,5.9,0.001,2.855,0.99,,,0.75,CYP450_3a4_substrate
7-carboxycannabidiol (cannabidiol-11-oic acid),CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C(=O)O)O,,,,,,0.968,,,,
gadopiclenol,C1CN(CC2=NC(=CC=C2)CN(CCN1C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-].[Gd+3],970.0912,,,,,0.018000000000000002,,,0.1,CYP450_3a4_substrate
aplaviroc,CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O,577.7177,,,,,0.93,,,34.6,
voriconazole,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,349.3,,,,,0.58,,,3.8,CYP450_3a4_substrate
erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,733.93,,,1.0,,0.435,,,6.6,CYP450_3a4_substrate
dapoxetine,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3,305.419,,8.6,,,0.99,,,20.5,
yohimbine,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,354.447,2.73,,277000.0,,0.972,,,6075.5,
selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,496.62,,,,,0.99,,,35.0,CYP450_3a4_substrate
abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)[C@@H]4C[C@@H](C=C4)CO,286.337,,,,,,,,13.4,
inavolisib,C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F,407.37,0.96,3.12,2.41,1.9,0.37,,0.63,8.8,CYP450_3a4_substrate
brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,433.2,0.3,7.8,,,,,,15.600000000000001,CYP450_3a4_substrate
vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,345.4,2.74,9.3,1.0,17.8,0.865,0.491,0.94,97.3,CYP450_3a4_substrate
clopidogrel carboxylic acid,C1CN(CC2=C1SC=C2)C(C3=CC=CC=C3Cl)C(=O)O,307.792,,,,,,,,4.975,
rolapitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC[C@]2(CC[C@]3(CCC(=O)N3)CN2)C4=CC=CC=C4,500.48,,,,,0.998,,,0.96,CYP450_3a4_substrate
haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,375.869,,,0.01,,0.47,,,7.3500000000000005,CYP450_3a4_substrate
alflutinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(N=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OCC(F)(F)F,568.6,,,,,,,,55.95,
brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,584.1011,,,355.2,,0.91,0.72,,8.8,CYP450_3a4_substrate
venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,868.44,,,,1.0,0.9990000000000001,,,429.0,CYP450_3a4_substrate
ombitasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,894.1203,7.9,,0.001,,0.9990000000000001,,,,
tiagabine,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C,375.555,,,,,0.96,,,1.2,CYP450_3a4_substrate
artemisinin,C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C,282.334,,,,,0.865,,,6.9,
dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,135.21,,,,,,,,,
furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,330.75,,3.9,0.001,,0.495,,,1.1199999999999999,
fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,472.4004,,,1.0,,0.7794999999999999,,,2.5639,
pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,432.4,2.05,3.92,,,0.98,0.719,,10.8,CYP450_3a4_substrate
levetiracetam,CC[C@@H](C(=O)N)N1CCCC1=O,170.2106,,,,,0.1,,,0.96,CYP450_3a4_substrate
nizatidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,331.463,,,,,0.35,,,50.0,
lacosamide,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1,250.3,,,,,0.15,,,2.71,CYP450_3a4_substrate
arbutin,C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,272.0,0.765,,,,,,,,
ABI-H0731,C1=CC=C2C(=C1)C(=O)NC3=C(S2(=O)=O)C=CC(=C3)C(=O)NCC4=CN=C(S4)C(F)(F)F,,,,,,,,,4.715,
enalaprilat,C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O,348.397,,,,,,,,14.365,
dihydrocodeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O,301.384,,,,,,,,704.5,
zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,575.683,,,0.001,,0.99,,,6.8,
dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,504.632,,,,,0.99,,,,
fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,524.6864,4.455,6.3,100.0,9.005,0.95,0.77,,13.0,CYP450_3a4_substrate
zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,388.8133,,,,,0.555,,,21.0,CYP450_3a4_substrate
conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,498.583,,,,,0.99,,,15.2,CYP450_3a4_substrate
nacubactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NOCCN,324.3124,,,,,,,,7.16,
flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,276.2129,,,,,0.95,,,280.0,CYP450_3a4_substrate
glycopyrronium,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,318.431,,,,,,,,422.0,
lefamulin,C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CS[C@@H]4CC[C@H](C[C@H]4O)N)C,567.79,4.3,,,,0.948,,,16.47,CYP450_3a4_substrate
enerisant,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3C=C(C=N3)C(=O)N4CCOCC4,398.504,1.92,9.42,,,0.317,,,21.8,
danusertib,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)[C@@H](C5=CC=CC=C5)OC,474.562,,,,,0.6629999999999999,,,,
ribavirin,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,244.206,,,,,0.0,,,3.0,
pemafibrate,CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,490.553,5.04,3.58,,4.9,0.99,0.38,,,
zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,307.395,,,,,0.92,,,2.6,CYP450_3a4_substrate
canagliflozin,CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,444.5205,,,,,,,,1.425,CYP450_3a4_substrate
gisadenafil,CCC1=C2C(=NN1CCOC)C(=O)NC(=N2)C3=C(N=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC,519.6237,,,,,0.44799999999999995,,,,
fosfluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)OP(=O)(O)O,386.254,,,,,,,,0.8065,
roxatidine,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO,306.403,,,,,0.04850000000000001,,,229.5,
fidaxomicin,CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C,1058.04,6.4,,,,,,,,CYP450_3a4_substrate
sertraline,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,306.234,,,,,0.985,,,26.0,CYP450_3a4_substrate
fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,393.39,4.26,2.78,129.9,2.75,0.47659999999999997,,0.05,9.600000000000001,CYP450_3a4_substrate
lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,628.809,5.9,,,,0.985,,,1.2,CYP450_3a4_substrate
phenacetin,CCOC1=CC=C(C=C1)NC(=O)C,179.22,,,,47.0,,,,,
roflumilast N-oxide,C1CC1COC2=C(C=CC(=C2)C(=O)N=C3C(=CN(C=C3Cl)O)Cl)OC(F)F,,,,,,0.97,,,,
quinapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,438.521,,,,,0.97,,,0.6,
amoxicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,365.408,,,,,0.18,,,1.5,
treosulfan,CS(=O)(=O)OC[C@@H]([C@H](COS(=O)(=O)C)O)O,278.3006,2.6,12.99,17.0,,,,,185.0,
sofosbuvir,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,529.4551,1.0,9.3,,,0.63,,,871.64,CYP450_3a4_inhibitor
cobimetinib,C1CCN[C@@H](C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,531.3,2.42,8.86,0.72,,0.95,,,13.8,CYP450_3a4_substrate
vincristine,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,824.966,,,,,,,,3.965,CYP450_3a4_substrate
clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,314.858,,,,,0.97,,,,CYP450_3a4_substrate
ranitidine,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,314.408,,,,,0.09,,,5.75,
casimersen,CN(C)P(=O)(N1CCN(CC1)C(=O)OCCOCCOCCO)OC[C@@H]2CNC[C@@H](O2)N3C=CC(=NC3=O)N,7584.5,,,,,0.2,,,180.0,CYP450_3a4_substrate
etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CC[C@@H]5CC(=O)O)C(F)(F)F,457.5,7.4,4.5,1.38,20.6,0.9790000000000001,0.38,,1.0,CYP450_3a4_substrate
milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,211.223,,,,,,,,18.2,
ambrisentan,CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,378.42,,,,,0.986,,,38.0,CYP450_3a4_substrate
capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,359.352,,,,,0.54,,,145.0,
trilaciclib,CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6,446.556,,,,,,,,158.0,CYP450_3a4_substrate
"3,4-dihydroxybenzoic acid",C1=CC(=C(C=C1C(=O)O)O)O,154.12,,,,,,,,236.0,
buprenorphine,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O,467.646,4.82,,,44.7,0.96,,,6.945,CYP450_3a4_substrate
tamsulosin,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,408.516,2.3,9.93,3.3,,0.965,,,0.46499999999999997,
levofloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.371,,,,,0.31,,,1.485,
nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,405.44,,8.5,0.1,,0.98,,,51.6,CYP450_2d6_inhibitor
naringenin,C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O,272.25,,,,,,,,627.345,
ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)OCCO)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F,522.5742,2.295,12.94,0.016,,0.99,,,14.2,CYP450_3a4_substrate
fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,606.8,,,,,0.99,,,11.8,CYP450_3a4_substrate
dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,556.764,7.2,,1.7,0.40349999999999997,0.98,,,140.0,CYP450_3a4_substrate
valspodar,C/C=C/C[C@@H](C)C(=O)[C@H]1C(=O)N[C@H](C(=O)N(CC(=O)N([C@H](C(=O)N[C@H](C(=O)N([C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,1214.6,,,,,,,,2.26,
sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,398.3976,2.5,3.23,,,0.993,,,0.24,
mezlocillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C,539.5875,,,,,,,,19.9,
tebipenem,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)O)[C@@H](C)O,383.4909,,,,,,,,39.1,
doxapram,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,378.513,,,,,0.56,,,,
ipratropium,CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,332.461,,,,,0.045,,,2.0,
famotidine,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N,337.43,0.2,9.29,0.001,,0.175,,,13.0,
methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,233.309,,,,,0.155,,,4.335,
asciminib,C1CN(C[C@@H]1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,449.8432,,1.975,0.124,22.1,0.973,0.36,,6.7,CYP450_3a4_substrate
ropeginterferon alfa-2b,COCCOC(=O)NCCCCC(CCN1CCC[C@H]1C(=O)O)NC(=O)OCCOC,60000.0,-1.3,,,,,,,3.15,
selegiline,C[C@H](CC1=CC=CC=C1)N(C)CC#C,187.28,2.7,7.44,100.0,,0.94,,,1500.0,CYP450_3a4_substrate
fenebrutinib,C[C@H]1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,664.8066,3.3,1.0,,15.1,,,,80.0,
triamcinolone,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,,,,,,0.708,,,,
abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,506.59,,,5.0,,0.48699999999999993,,,26.0,CYP450_3a4_substrate
diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,255.36,,,,,0.405,,,3.95,CYP450_3a4_substrate
colchicine,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,399.44,,12.8,,,0.39,,,54.1,
trifluridine,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,296.2,,,,,0.96,,,2.93,
ethinylestradiol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,296.408,3.7649999999999997,10.33,3.0,,0.97,,,2.079,
ensartinib,C[C@@H]1CN(C[C@@H](N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)O[C@H](C)C4=C(C=CC(=C4Cl)F)Cl)N,561.4,3.6,,4.21,2.0,0.934,,,42.0,CYP450_3a4_substrate
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,309.45,117.0,9.2,,,0.875,,,63.7,CYP450_3a4_substrate
futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)[C@H]4CCN(C4)C(=O)C=C)OC,418.4485,3.3,3.24,0.685,24.4,0.956,,,19.8,CYP450_3a4_substrate
verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,348.4244,,,,35.8,,,,37.400000000000006,
ipatasertib,C[C@@H]1C[C@H](C2=C1C(=NC=N2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)C4=CC=C(C=C4)Cl)O,458.0028,2.5,9.0,10.0,3.55,,,0.63,2.7,
propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,259.347,,,,17.9,,,,10.5,CYP450_2d6_inhibitor
metformin,CN(C)C(=N)N=C(N)N,129.16,-1.43,11.8,100.0,,,,,3.96,
omadacycline,CC(C)(C)CNCC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,556.656,,,,,0.2,,,8.8,
osthole (Cnidium monnieri),CC(=CCC1=C(C=CC2=C1OC(=O)C=C2)OC)C,244.288,3.95,,,,,,,,
fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,309.33,,,,,0.945,,,8.25,CYP450_3a4_substrate
lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,480.5426,4.15,,,,0.9998999999999999,,,0.8099999999999999,
lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,581.065,5.1,1.0,,,0.99,,,,CYP450_3a4_substrate
degrasyn,CCC[C@@H](C1=CC=CC=C1)NC(=O)/C(=C/C2=NC(=CC=C2)Br)/C#N,384.3,,,,4.9,,,,,
ibrutinib,C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,440.5,3.97,3.74,0.001,57.9,0.973,,,62.0,CYP450_3a4_substrate
apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,459.5035,,,,,0.87,,,3.3,CYP450_3a4_substrate
pergolide,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC,314.494,,,,,,,,457.0,
zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,424.4394,,,,,0.74,,,,
ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,558.14,,,11.9,0.167,0.972,0.9,,89.0,CYP450_3a4_substrate
halofuginone,C1C[C@H]([C@@H](NC1)CC(=O)CN2C=NC3=CC(=C(C=C3C2=O)Cl)Br)O,414.6853,,,,2.5050000000000003,,,,,
GST-HG131,CC(C)(C)[C@@H]1COC2=CC(=C(C=C2C3=CC(=O)C(=CN13)C(=O)O)OC)OCCCOC,,,,,,0.5720000000000001,,,6019.55,
mibefradil,CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,495.635,,,,,,,,6.6,
cefepime,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-],480.5676,,,,,0.2,,,64.0,
amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,369.483,,5.0,0.001,,0.275,,,31.2,CYP450_3a4_substrate
cephalexin,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,347.393,,,,,0.085,,,2.7,
sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,295.405,,,,,0.175,,,13.7,CYP450_3a4_substrate
nemonoxacin,C[C@H]1C[C@@H](CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,371.4345,,,,,0.16,,,12.87,
bleomycin,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,1415.56,,,,,,,,28.049999999999997,
glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,490.622,,,,,0.995,,,47.8,CYP450_2c9_inhibitor
dolasetron,C1[C@@H]2CC(C[C@H]3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54,324.378,,,,,,,,11.5,CYP450_3a4_substrate
nateglinide,CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O,317.4,3.2,,0.001,,0.98,,,,CYP450_3a4_substrate
enalapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,376.45,,,,,0.55,,,3.2,CYP450_3a4_inhibitor
tanshinone IIA,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4(C)C,294.3,,,5.0,,,,,,
cefixime,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O,453.454,,,,,0.34,,,0.75,
nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,346.337,2.2,13.0,0.001,,0.485,,,4.4,CYP450_3a4_substrate
aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,448.38,,7.6,,20.5,0.99,,,0.5,CYP450_3a4_substrate
zavegepant,CC1=CC(=CC2=C1NN=C2)C[C@H](C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,638.8,,4.8,100.0,,0.9,,,266.0,CYP450_3a4_substrate
tolamolol,CC1=CC=CC=C1OCC(CNCCOC2=CC=C(C=C2)C(=O)N)O,344.409,,,,,0.652,,,,
mitiperstat,C[C@H](C1=C(C=CC(=C1)Cl)CN2C3=C(C(=O)NC2=S)NC=C3)N,334.8,,,,,0.65,,,20.1,
abiraterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,349.5,,,,,0.9934999999999999,,,990.0,CYP450_3a4_substrate
darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,398.8521,,,,,0.92,,,116.0,CYP450_3a4_substrate
itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,705.643,5.66,,,,0.998,,,278.0,CYP450_3a4_substrate
vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,264.32,,,,,0.7120000000000001,,,3.5500000000000003,
acalabrutinib,CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,465.5147,,,100.0,,0.975,,,71.0,CYP450_3a4_substrate
diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,296.152,,,,,0.995,,,2.5500000000000003,
triazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,343.216,,,,,0.45799999999999996,,,3.8,CYP450_3a4_substrate
tauroursodeoxycholic acid (taurursodiol),C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,499.7085,3.6,,0.001,,0.985,,,,
citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,324.3969,,9.5,3.3,,0.82,,,2.75,CYP450_3a4_substrate
felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,384.257,3.9,5.07,,,0.499,,,0.8,CYP450_3a4_substrate
encainide,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C3=CC=C(C=C3)OC,352.4752,,,,,0.36,,,10410.0,
triamterene,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,253.268,,,,,0.315,,,41.5,
remdesivir,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@@H]1[C@H]([C@H]([C@](O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,602.5815,-2.31,,,,0.9079999999999999,0.8,,65058.7,CYP450_3a4_substrate
dihydroartemisinin,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)O)C,284.35,,,,,0.615,,,35.5,
sulbactam,CC1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)C,233.2429,,,,,0.38,,,254.0,
bictegravir,C1C[C@@H]2C[C@H]1N3[C@H](O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,471.4,2.1,8.3,0.1,6.2,0.99,,0.25,0.504,CYP450_3a4_substrate
vinorelbine,CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,778.942,,,,,,,,14.0,
guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,282.55,,,,,0.7,,,414.4,CYP450_3a4_substrate
isavuconazole,C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,437.4723,3.5,,,,0.99,,,2500.0,CYP450_3a4_substrate
acetaminophen (paracetamol),CC(=O)NC1=CC=C(C=C1)O,151.16,,,,,0.2,,,0.08,CYP450_3a4_substrate
saquinavir,CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,670.85,,,,,0.98,,,10.65,CYP450_3a4_substrate
doxepin,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,279.4,,8.96,0.0466,9.844999999999999,,,,8.5,CYP450_3a4_substrate
ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@@]34[C@@H]([C@H]([C@@H]([C@@](O3)(CO4)CO)O)O)O)Cl,436.8855,,,0.76,,0.9359999999999999,0.7,,11.2,CYP450_3a4_substrate
temsirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,1030.2943,,,,,,,,16.2,CYP450_3a4_substrate
ceftobiprole,C1CNC[C@@H]1N2CC/C(=C\C3=C(N4[C@@H]([C@@H](C4=O)NC(=O)/C(=N\O)/C5=NSC(=N5)N)SC3)C(=O)O)/C2=O,534.6,,,250.0,,0.5,,,2.781,
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,280.413,4.8,,,,0.4575,,,7.35,CYP450_3a4_substrate
tenofovir disoproxil,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,519.445,,,,,0.006999999999999999,,,,
apatinib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,493.5853,,,,,0.924,0.626,,57.8,
moxifloxacin,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,401.436,,,,,0.209,,,7.0,
sacubitril,CCOC(=O)[C@H](C)C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,411.4951,,,,,0.97,,,,
trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,290.321,,,,,0.44,,,1.0999999999999999,
bromocriptine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,654.602,,,,,,,,5.5,
azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,456.456,2.5,2.5,0.001,,0.99,,,1.5,CYP450_2c9_inhibitor
pramipexole,CCCN[C@H]1CCC2=C(C1)SC(=N2)N,211.33,,,,,0.15,,,4.8,CYP450_3a4_inhibitor
ceftaroline,CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],684.6939,,,,,,,,5.5,
tofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,,4.0600000000000005,2.2,0.00239,,,,,,
raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,473.59,,,,,0.95,,,536.5,CYP450_3a4_substrate
linagliptin,CC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,472.5502,1.7,1.0,0.9,3.56,0.895,,,70.0,CYP450_3a4_substrate
adavosertib,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,500.607,,,,,,,,23.74,
brivaracetam,CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,212.291,,,,,0.2,0.564,,0.817,CYP450_3a4_substrate
paroxetine,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,329.369,2.53,9.51,,,0.95,,,5.9,CYP450_3a4_substrate
telbivudine,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,242.229,,,,,,,,15.85,
cisapride,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,465.95,,,,,0.98,,,4.75,
tolfenamic acid,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,261.7068,,,,,0.997,,,,
riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,422.42,,,0.001,,,,,1.8,CYP450_3a4_substrate
tigecycline,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,585.65,0.8,3.17,14550.0,,0.71,,,23.8,
TERN-101,CN1C=C(C2=C1C=C(C=C2)N3CCC(CC3)OCC4=C(ON=C4C5=C(C=CC=C5Cl)Cl)C6CC6)C(=O)O,540.4443,,,,,,,,7.41,
methylarbutin,COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,286.278,0.36,,,,,,,,
etonogestrel (3-keto-desogestrel),CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,,,,,,0.9670000000000001,,,,
clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,326.829,,,,,0.97,,,3.8499999999999996,CYP450_3a4_substrate
speciociliatine,CC[C@@H]1CN2CCC3=C([C@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.5,,,,7.58,,,0.04,5.72,
ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,254.284,,,,,0.99,,,,
6-mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,152.181,,,,,0.19,,,7.5,
raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,444.42,,,,,0.83,,,,
diltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,414.523,,,,,0.405,,,7.0,CYP450_3a4_substrate
tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,270.351,2.34,5.16,109000.0,,0.935,,,0.14,
chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,274.79,,,,,0.365,,,0.9,
bentysrepinine,CN(C)CCOC1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=CC=C2)CO)NC(=O)C3=CC=CC=C3,489.6,,,,,,,,148.35,
gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,353.4011,,,,,,,,12.5,
belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO,318.35,,,,5.9,0.9434999999999999,,,1240.0,CYP450_3a4_substrate
zuranolone,C[C@]1(CC[C@H]2[C@@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CN5C=C(C=N5)C#N)C)O,409.57,4.5,,0.001,5.6,0.988,,,32.7,CYP450_3a4_substrate
"caffeine (1,3,7-TMX)",CN1C=NC2=C1C(=O)N(C(=O)N2C)C,194.1906,,,,,0.305,,,40.0,
(S)-mephenytoin,CC[C@@]1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,218.2,1.69,8.51,1.27,,0.3,0.779,,,
clofibrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,242.701,,,,,0.49050000000000005,,,0.1,
dienogest,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,311.422,,,,,0.9,,,4.0,
zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,305.34,1.3,,,,0.375,0.55,,9.5,CYP450_3a4_substrate
iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,426.5,,,,30.65,0.97,,,102.0,CYP450_3a4_substrate
amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,645.31,,,,,0.49995000000000006,,,1.15,
isoniazid,C1=CN=CC=C1C(=O)NN,137.141,,,100.0,,0.0,,,4.7,
napabucasin,CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O,240.2132,2.3,,,,,,,,
abiraterone acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,391.6,5.12,5.19,0.001,3.69,,,,,CYP450_3a4_substrate
finasteride,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,372.549,,,,,0.9,,,1.5499999999999998,
lovastatin acid,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,422.558,3.5,,,,0.95,,,,
hesperetin,COC1=C(C=C(C=C1)[C@@H]2CC(=O)C3=C(C=C(C=C3O2)O)O)O,302.281,,,,,,,,1179.465,
zimeldine,CN(C)C/C=C(/C1=CC=C(C=C1)Br)\C2=CN=CC=C2,,,,,,0.667,,,,
remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,507.5318,2.8,4.1,,17.0,,0.003,0.047,205.0,
metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,267.366,1.9,9.7,,,0.06,,,9.0,CYP450_2d6_inhibitor
etavopivat,C1COC2=C(O1)C=C(C=N2)S(=O)(=O)N3CC4=C(C3)CN(C4)C(=O)[C@H](CO)C5=CC=CC=C5,457.4995,,,,,,,,82.8,
desloratadine (descarboethoxyloratadine),C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,310.8,,,,,0.845,,,,
dexmedetomidine,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C,200.28,,,,,0.94,,,0.318,
resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)/C=C/C(=O)NO,349.4091,,,,5.2,,,,,
hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,335.8764,,9.67,100.0,,,,,96.0,
dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,248.305,,,,,0.37,,,0.385,
fexofenadine (terfenadine carboxylate),CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663,,,,,0.65,,,6.800000000000001,
modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,273.354,1.7,,1.0,,0.6,,,0.525,
nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,309.403,,,,,0.3,,,,
sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,592.8,4.26,4.09,1.48,16.5,0.498,0.813,,3.88,CYP450_3a4_substrate
oxaliplatin,C1CC[C@H]([C@@H](C1)[NH-])[NH-].C(=O)(C(=O)[O-])[O-].[Pt+4],395.2728,,,,,0.9,,,52.5,CYP450_3a4_substrate
clopidogrel,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,321.826,,5.3,,,0.98,,,,
alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,308.771,,,,,,,,0.44,CYP450_3a4_substrate
digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CC[C@@H]7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,780.943,,,,1.0,0.15,,,77.5,CYP450_3a4_substrate
pecazine,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,310.4628,,,,16.0,,,,,
tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],273.243,,,,,0.9990000000000001,,,0.915,CYP450_3a4_substrate
betaxolol,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,307.43,,,,,0.55,,,4.7,CYP450_2d6_inhibitor
mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,444.485,,,,,0.97,,,10.5,
esuberaprost,CC#CC[C@H](C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,398.496,,,,,,,,79.5,
ceftazidime and avibactam,CC(C)(C(=O)O)O/N=C(\C1=CSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N,636.6,,,,,0.135,,,6.86,
entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,560.6456,,1.0,42.2,,0.9978,,,19.6,CYP450_3a4_substrate
metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],171.155,,,,,0.07,,,0.8,
xanomeline,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,281.42,,,242.0,4.15,0.95,,,1950.0,CYP450_2d6_inhibitor
mirabegron,C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,396.5126,2.1,,,,0.71,,,57.0,CYP450_3a4_substrate
indisulam,C1=CC2=C(C(=C1)NS(=O)(=O)C3=CC=C(C=C3)S(=O)(=O)N)NC=C2Cl,385.851,,,,,0.997,,,2.3,
quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,302.237,,,,,,,,35300.0,
elagolix,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,631.595,1.8,1.0,0.89,,0.8,,,123.0,CYP450_3a4_substrate
terfenadine,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,471.681,7.1,13.2,96.3,,,,,5.48,
risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,305.1,,,,,0.24,,,122.0,
tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,279.12,,,,,0.08,,,88.7,
valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,314.36,,,,,0.98,,,6.0,
alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,482.62,,,,,0.99,,,81.9,CYP450_3a4_substrate
roxithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,837.05,,,,,0.9,,,1.85,
doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,425.75,3.0,9.47,0.001,25.0,0.76,,,106.0,CYP450_3a4_substrate
lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC\2=C1C3=C(/C2=C/C4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,528.9478,8.7,,,,0.997,,,0.63,
idarubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,497.497,,,,,0.97,,,19.5,
esaxerenone,CC1=C(N(C=C1C(=O)NC2=CC=C(C=C2)S(=O)(=O)C)CCO)C3=CC=CC=C3C(F)(F)F,466.4779,,,,,,,,3.96,
bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,325.446,,,,,0.3,,,15.0,CYP450_3a4_substrate
lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,259.2637,,,,,,,,240.0,
sulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,341.4,,,,,,,,249.5,
prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,383.406,,,,,0.48,,,1.65,
felcisetrag,CC(C)C1=NC2=C(C=CC=C2N1)C(=O)NCC3CCN(CC3)CC4CCN(CC4)C(=O)OC,455.5993,,,,,,0.979,,7.2,
gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,446.908,4.15,1.0,4.0,2.15,0.9,,,2910.0,
toremifene,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3,405.966,,,,,0.997,,,1.9,CYP450_3a4_substrate
ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,361.368,,,,,0.155,,,2.1,
boceprevir,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,519.6825,3.0,,1.5,,0.75,,,161.0,CYP450_3a4_substrate
ursodeoxycholic acid (ursodiol),C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,392.576,,,,,0.7,,,52.0,
(S)-ibuprofen,C[C@@H](C1=CC=C(C=C1)CC(C)C)C(=O)O,206.2832,,,,,,,,45.550000000000004,
oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,152.1126,,,,,0.17,,,9.95,
vidofludimus,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,355.3632,,,,,,,,3.633,
ethanol,CCO,46.07,,,,,,,,67.0,
noramidopyrine,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC,217.27,,,,,,,,2.1750000000000003,
amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,408.879,,8.6,1.0,,0.47,,,3.7,CYP450_3a4_substrate
remimazolam,CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=N[C@H]2CCC(=O)OC)C4=CC=CC=N4,439.3,,,3.3,,0.91,,,64.5,CYP450_3a4_inhibitor
carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,236.273,,,,,0.385,,,0.9,CYP450_3a4_substrate
valemetostat,CC1=CC(=C(C(=O)N1)CNC(=O)C2=CC(=C3C(=C2C)O[C@@](O3)(C)C4CCC(CC4)N(C)C)Cl)C,488.0,,,,,0.945,,,58.1,
(-)-epigallocatechin,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,306.269,,,,,,,,715.3,
cholic acid,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,408.57,,,,,,,,9.44,CYP450_3a4_substrate
pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,437.5257,,1.0,4.0,11.1,0.99,,,0.997,CYP450_3a4_substrate
elbasvir and grazoprevir,CC(C)[C@@H](C(=O)N1CCC[C@@H]1C2N=CC(=N2)C3=CC4=C(C=C3)C5=CC6=C(N5[C@@H](O4)C7=CC=CC=C7)C=CC(=C6)C8=CN=C(N8)[C@@H]9CCCN9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC.CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,766.9,,,0.001,,,,,,CYP450_3a4_substrate
tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,371.5,7.1,9.24,0.00102,,0.98,,,1.4,CYP450_3a4_substrate
pravastatin (acid),CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,424.53,1.6,4.2,0.001,,0.455,,,7.95,CYP450_3a4_substrate
thioridazine,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,370.5824,5.9,9.5,33.6,,,,,0.565,
tilidine,CCOC(=O)[C@@]1(CCC=C[C@H]1N(C)C)C2=CC=CC=C2,273.3737,3.255,8.6,0.181,,,,,34019.5,
vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,421.3026,2.7,3.8,0.99,,0.99,,,0.0434,CYP450_3a4_substrate
artemether,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,298.376,,,0.001,,0.9540000000000001,,0.05,1.59,
lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,554.6428,4.38,2.2,4.61,2.6399999999999997,0.0013,,0.0231,36.4,CYP450_3a4_substrate
flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,414.344,,,,,0.4,,,3.4499999999999997,
methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,454.445,,,,,0.285,,,1.4500000000000002,
benperidol,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,381.449,,,,,0.78,,,,
oxprenolol,CC(C)NCC(COC1=CC=CC=C1OCC=C)O,265.351,,,,,0.8,,,,
trimipramine,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,294.4394,,,0.1,,0.91,,,,
perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,362.9,,3.24,0.47,26.68,,,,12.0,CYP450_3a4_substrate
tranylcypromine,C1[C@H]([C@@H]1N)C2=CC=CC=C2,133.193,,,,,,,,410.5,
nisoldipine,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,388.418,3.1,,,,0.9973000000000001,,,11.0,
roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,403.2106,3.99,,0.001,,0.9890000000000001,,,9.6,CYP450_3a4_substrate
micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,1292.26,,,,,0.99,,,,CYP450_3a4_substrate
vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,379.36,,,1.0,,0.98,,,38.27,CYP450_2d6_inhibitor
ledipasvir and sofosbuvir,C[C@@H](C(=O)OC(C)C)N[P@@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3.CC(C)[C@@H](C(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)[C@@H]9[C@H]1CC[C@H](C1)N9C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,889.0116,7.4,1.0,,,0.63,,,871.64,
vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,426.3854,,4.7,0.001,,0.978,0.6,,1.3,CYP450_3a4_substrate
viloxazine,CCOC1=CC=CC=C1OCC2CNCCO2,237.297,,,78.0,5.04,0.79,,,73.85,CYP450_3a4_inhibitor
dalfampridine (4-aminopyridine),C1=CN=CC=C1N,94.1164,,,,,0.02,,,,CYP450_3a4_substrate
proguanil,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl,253.735,,,,,0.75,,,1.2,
zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,236.29,,,0.001,,0.93,,,7.0,
perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,403.975,,,,,,,,107.0,
ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,237.728,,,,,0.725,,,1.0699999999999998,
mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,246.3518,,,,,0.47600000000000003,,,,
desvenlafaxine (O-desmethylvenlafaxine),CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,263.38,,,,,0.21,,,12.45,CYP450_3a4_substrate
mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,241.2885,,,0.004,,0.9,,,21.13,
gepotidacin,C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)C[C@@H]4CN5C(=O)C=CC6=C5N4C(=O)C=N6,448.5242,0.16,8.83,,,0.33,,,51.2,
mesdopetam,CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F,275.34,,,,,,,,23.2,
eplerenone,C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,414.5,7.1,,,,0.5,,,10.0,CYP450_3a4_substrate
propiverine,CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C,367.4861,,,,,0.925,,,422.0,CYP450_3a4_substrate
daptomycin,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H]3[C@H](OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)[C@H](C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,1620.68,,,,,0.915,,,5.3,
phenylephrine,CNC[C@@H](C1=CC(=CC=C1)O)O,167.2,,,,,,,,98.30000000000001,
sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,386.557,,,,,0.47,,,7.6,
flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,244.264,4.2,,,,0.995,,,0.21999999999999997,
verlukast,CN(C)C(=O)CCS[C@@H](C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O,515.0953,,,,,0.998,,,,
oseltamivir,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,312.407,,,,,0.03,,,2.75,
loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,382.889,5.2,,,,0.97,,,99.5,
maraviroc,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,513.67,5.1,7.3,,,0.76,,,47.599999999999994,CYP450_3a4_substrate
oxandrolone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,306.443,4.2,,,,0.95,,,,
ravtansine,C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C/C=C(/CC3=CC(=C(C(=C3)OC)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)CCC(C)(C)S)C)\C)OC)(NC(=O)O2)O,780.4,,,,,0.9937999999999999,,,13.8,
grazoprevir,CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1,766.9,,,0.001,,0.988,,,,
semaglutide,CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)C(C)(C)NC(=O)[C@H](CC6=CN=CN6)N,4113.6119,,,,,0.99,,,0.05,
pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,248.7,,,,,0.87,,,,
difelikefalin,CC(C)C[C@H](C(=O)N[C@H](CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CC3=CC=CC=C3)N,679.8577,,2.4,100.0,,0.255,,,,CYP450_3a4_substrate
gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,552.7196,,,29.0,,0.94,,0.095,14.85,CYP450_3a4_substrate
abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,397.4287,,,,0.7,,,,,
imeglimin,C[C@@H]1N=C(NC(=N1)N(C)C)N,155.2037,,,,,0.058499999999999996,,,17.5,
basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,325.7727,,,,,0.99,,,19.45,
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,263.382,3.9,9.7,,,0.47,,,4.5,CYP450_2d6_inhibitor
aprepitant,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,534.43,2.4499999999999997,,,,0.95,,,76.0,CYP450_3a4_substrate
cilomilast,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,343.4,,,,,0.9940000000000001,,,2.0,
allopurinol,C1=NNC2=C1C(=O)NC=N2,136.114,,,,,0.02,,,6.15,
lafutidine,C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3,431.554,,,,,,,,7.210000000000001,
"theophylline (1,3-DMX)",CN1C2=C(C(=O)N(C1=O)C)NC=N2,180.166,-0.02,8.81,7360000.0,4.35,0.3,,,0.42500000000000004,CYP450_3a4_inhibitor
bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,551.621,3.1,5.46,1.0,,,,,4.0,
oxycodone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,315.367,0.7,8.53,1.0,,0.45,,,12.3,CYP450_3a4_substrate
ibiglustat,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)O[C@@H]3CN4CCC3CC4,389.4926,,,,,,,,12.0,
nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,539.6327,,,5.0,,,,,1390.0,CYP450_3a4_substrate
PF-05150122,C1=CC(=C(C=C1C(F)(F)F)C2=CN=NC=C2)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=NN=CS4)F,,,,,,,,,295.0,
voxilaprevir,CC[C@@H]1[C@@H]2CN([C@@H]1C(=O)N[C@@]3(C[C@H]3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)[C@@H](NC(=O)O[C@@H]5C[C@H]5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,868.9418,,,,,0.99,,,429788.6,CYP450_3a4_substrate
busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,246.303,,,,,0.08349999999999999,,,2.7,
semaxanib,CC1=CC(=C(N1)/C=C\2/C3=CC=CC=C3NC2=O)C,238.2886,,,,,0.97,,,,
trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,416.358,,,,,0.85,,,0.81,
primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,259.351,,,,,,,,9.24,
medroxyprogesterone,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,,,,,,,,,115.0,
ginsenoside Rg1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C,801.0168,,,,,0.43449999999999994,,,159.4,
acebutolol,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,336.4,,,,,0.175,,,0.63,CYP450_3a4_inhibitor
pregabalin,CC(C)C[C@@H](CC(=O)O)CN,159.227,,,,,,,,56.5,
2-(1-piperazinyl)pyrimidine,C1CN(CCN1)C2=NC=CC=N2,164.21,,,,,0.32049999999999995,,,524.9,
luliconazole,C1[C@H](S/C(=C(\C#N)/N2C=CN=C2)/S1)C3=C(C=C(C=C3)Cl)Cl,354.28,,,,,0.99,,,,CYP450_3a4_substrate
vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,441.5323,,7.1,0.32,,0.975,0.6,,29.4,CYP450_3a4_substrate
notoginsenoside R1,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C,933.131,,,,,0.462,,,121.8,
flumatinib,CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,562.5971,,,,,,,,520.5,
clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,747.957,,,,,0.46,,,4.6,
genistein,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,270.239,,,,,0.0085,,,12.0,
moricizine,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,427.5225,,6.4,,,0.95,,,1.6600000000000001,
dienogest,C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(CC#N)O,311.422,,,,,0.9,,,4.0,
sofosbuvir,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,529.4551,1.0,9.3,,,0.63,,,871.64,CYP450_3a4_inhibitor
reboxetine,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3,313.4,,,,,0.97,,,,
idelalisib,CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,415.42,,1.6,0.1,,0.84,0.7,,14.9,CYP450_3a4_substrate
loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,382.889,5.2,,,,0.97,,,99.5,
hippuric acid,C1=CC=C(C=C1)C(=O)NCC(=O)O,179.17,,,,,0.69,,,,
alprenolol,CC(C)NCC(COC1=CC=CC=C1CC=C)O,249.352,,,,,0.85,,,,
practolol,CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C)O,266.339,,,,,,,,70.5,
prednisone,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,358.4,,,168.2,,0.385,,,2.2,CYP450_3a4_substrate
tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,371.5,7.1,9.24,0.00102,,0.98,,,1.4,CYP450_3a4_substrate
talampanel,C[C@@H]1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,337.377,,,,,0.775,,,,
biperiden,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,,,,,0.9,,,,
SUVN-502,CN1CCN(CC1)CC2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br,478.4026,,,,,,,,1892.0,
amodiaquine,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,355.867,,,,,,,,35.9,
secnidazole,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],185.18,,,,,0.05,,,25.0,CYP450_3a4_substrate
cabotegravir,C[C@H]1CO[C@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,405.3553,1.58,7.8,1.0,256.0,0.998,0.67,,0.151,
rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,357.432,,,,,0.998,,,0.42000000000000004,CYP450_3a4_inhibitor
tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,448.948,5.0,,,,0.98,,,4.7,CYP450_3a4_substrate
selinexor,C1=CN=C(C=N1)NNC(=O)/C=C\N2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,443.3099,,,,,0.95,,,17.9,CYP450_3a4_substrate
teriflunomide,C/C(=C(\C#N)/C(=O)NC1=CC=C(C=C1)C(F)(F)F)/O,270.21,2.7,22.0,0.02,,0.96,,,30.5,CYP450_3a4_substrate
midecamycin,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]1OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC)(C)O)N(C)C)O)CC=O)C)O)C,813.9723,,,,,0.15,,,,
cedazuridine,C1CN(C(=O)N[C@@H]1O)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,268.2146,,,,,0.34,,,4.24,CYP450_3a4_substrate
ropivacaine,CCCN1CCCC[C@H]1C(=O)NC2=C(C=CC=C2C)C,274.405,,,,,0.92,,,6.3,
verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,348.4244,,,,35.8,,,,37.400000000000006,
ramelteon,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,259.347,,,1.1,16.3,,,,916.0,CYP450_3a4_substrate
pimobendan,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,334.3772,,,,,0.89,,,,
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,318.87,,,,,0.965,,,5.75,
letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2[C@H](C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,572.55,4.6,,,,0.9840000000000001,,,4.66,CYP450_3a4_substrate
laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,356.8073,3.7,,,,0.98,,,0.09,
garcinia acid,C(C(=O)O)C(C(C(=O)O)O)(C(=O)O)O,208.121,,,,,,,,125.925,
primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,259.351,,,,,,,,9.24,
diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,255.36,,,,,0.405,,,3.95,CYP450_3a4_substrate
azelnidipine,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,582.65,4.43,1.9,,,0.9,,,,
sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,272.367,,,,,,,,2.6,
AFN-1252,CC1=C(OC2=CC=CC=C12)CN(C)C(=O)/C=C/C3=CC4=C(NC(=O)CC4)N=C3,375.4259,,,,,0.953,,,,
frovatriptan,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,243.308,,,,,0.15,,,,CYP450_3a4_inhibitor
CVN-424,CC(=O)N1CCC2=C(C1)N=C(C(=N2)N3CCC(CC3)OC4=C(C=C(C=C4)F)F)N[C@@H]5CCOC5,473.5156,,,,,,,,8.177,
celiprolol,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,379.498,,,,,0.275,,,,
ginsenoside C-K,CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C,622.9,,,,,,,,33.8,
rezafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)OCC[N+](C)(C)C)O,1226.4,,,,,0.9055,,,0.24,CYP450_3a4_substrate
rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,323.3692,,,1.7,,0.7,,,47.25,CYP450_3a4_substrate
nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,479.53,3.82,,,,0.9875,,,6.75,
sulindac,CC\1=C(C2=C(/C1=C\C3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,356.415,,,,,0.94,,,,
fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,306.275,,,,,0.115,,,0.17,
pyrazinamide,C1=CN=C(C=N1)C(=O)N,123.115,-0.6,-0.5,4000.0,,0.1,,,1.25,
mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,378.314,,,,,0.982,,,0.28500000000000003,
atuliflapon,CC1=CC(=NN1)C2=CC=C(C=C2)C(=O)[C@@H]3CCCC[C@H]3C(=O)NC4=C5C(=O)NCCN5N=C4,446.5,,,,,,,,126.0,
iptacopan,CCO[C@H]1CCN([C@@H](C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,422.5,,,10.78,1.33,0.75,0.5,,1.0,CYP450_3a4_inhibitor
cabazitaxel,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,835.93,,,,,0.905,0.8,,48.5,CYP450_3a4_substrate
sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,253.281,0.7949999999999999,1.0,0.001,,0.29,,,0.19,
ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,434.55,,,,,0.7,0.78,,25.5,CYP450_3a4_substrate
sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,523.32,,,,,0.38,,,697.0,CYP450_3a4_substrate
indole-3-acetic acid,C1=CC=C2C(=C1)C(=CN2)CC(=O)O,175.18,,,,,0.94,,,,
losartan carboxylic acid,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl,436.9009,5.0,,,,0.998,,,50.0,
dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,471.5,,4.0,,,0.35,,,1748.0,
infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,560.4829,4.7,,1.0,1.7,0.968,0.94,,33.1,CYP450_3a4_substrate
zoniporide,C1CC1C2=C(C=NN2C3=CC=CC4=C3C=CC=N4)C(=O)N=C(N)N,320.3544,1.15,,,,,0.56,,11.1,
1'-hydroxymidazolam,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO,341.7717,,,,,0.89,,,,
timolol,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,316.42,1.8,9.2,0.269,159.0,0.1,,,4.45,CYP450_2d6_inhibitor
janagliflozin,C1[C@H]2[C@@H]1CC(C2)OC3=CC=C(C=C3)CC4=C(C=CC(=C4)[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)Cl,460.9511,3.5,,0.07,2.11,,,,0.279,
risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,410.49,,,,,0.9,,,3.4000000000000004,CYP450_3a4_substrate
chlormethiazole,CC1=C(SC=N1)CCCl,161.6552,,,,,0.692,,,185.85000000000002,
glecaprevir and pibrentasvir,C[C@H]([C@@H](C(=O)N1CCC[C@H]1C2=NC3=C(N2)C=C(C(=C3)F)[C@H]4CC[C@@H](N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)OC)NC(=O)OC)NC(=O)OC)OC.CC1(CC1)S(=O)(=O)NC(=O)[C@]2(C[C@H]2C(F)F)NC(=O)[C@@H]3C[C@@H]4CN3C(=O)[C@@H](NC(=O)O[C@@H]5CCC[C@H]5OC/C=C/C(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,838.87,,,,,0.9990000000000001,,,1150.0,CYP450_3a4_substrate
nivasorexant,CC1=CC(=C(C=C1)C(=O)N2CCOC[C@H]2CC3=CC(=CC=C3)N4N=CC=N4)N5N=CC=N5,429.5,,,0.001,,0.99,,,,
daclatasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC,738.885,,,,,,,,4.2,CYP450_3a4_substrate
rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N,366.4,4.32,1.0,0.001,12.0,0.997,,,11.8,CYP450_3a4_substrate
terbinafine,CC(C)(C)C#C/C=C/CN(C)CC1=CC=CC2=CC=CC=C21,327.9,5.715,7.1,0.63,,0.99,,,,CYP450_3a4_substrate
cilastatin,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C,358.4564,,,,,0.4,,,115.05,
doxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,543.5,,,,,0.76,,,502.5,CYP450_3a4_substrate
ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CC[C@@H](C4=CC=C3)NCCO)C#N,404.4676,,,58.0,,0.982,,,192.0,CYP450_3a4_substrate
PF-05089771,C1=CC(=C(C=C1Cl)C2=C(NN=C2)N)OC3=CC(=C(C=C3Cl)S(=O)(=O)NC4=CSC=N4)F,500.3608,,,,,,,,45.0,
rifampin,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C,822.947,,,0.1,12.0,0.75,,,2.55,
flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,453.8763,,,,,0.95,,,67.5,
hydroxybupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)CO,255.74,,,,,0.84,,,,
relebactam,C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,348.378,,,,,0.22,,,5.8,
ritlecitinib,C[C@H]1CC[C@H](CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3,285.34,,,35.6,,0.14,,0.86,92.56,CYP450_3a4_substrate
apararenone,CC1(C(=O)N(C2=C(O1)C=C(C=C2)NS(=O)(=O)C)C3=CC=C(C=C3)F)C,364.3953,,,,,0.9440000000000001,,,,
gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,263.1989,,,,,,,,28.599999999999998,
caspofungin,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,1093.32,,,,,0.97,,,11.0,CYP450_3a4_substrate
cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,243.22,,,,,0.13,,,13.0,
molibresib,CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,423.9,2.38,,,,0.8,,,,
paritaprevir,CC1=CN=C(C=N1)C(=O)N[C@H]2CCCCC/C=C\[C@@H]3C[C@]3(NC(=O)[C@@H]4C[C@H](CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,765.8877,4.7,2.64,,8.25,0.978,,,,
minocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,457.48,,,,,0.76,,,0.65,
elbasvir,CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC4=C(C=C3)N5[C@@H](OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)[C@@H]8CCCN8C(=O)[C@H](C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,882.02,,,0.001,,0.9990000000000001,,,,
desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,266.386,,,,,,,,0.7450000000000001,CYP450_2d6_substrate
paynantheine,CO/C=C(\[C@H]1C[C@H]2C3=C(CCN2C[C@@H]1C=C)C4=C(N3)C=CC=C4OC)/C(=O)OC,396.4794,,,,,,,0.055,53.45,
repotrectinib,C[C@H]1CNC(=O)C2=C3N=C(C=CN3N=C2)N[C@@H](C4=C(O1)C=CC(=C4)F)C,355.37,3.49,,0.008,,0.9540000000000001,,0.046,15.9,CYP450_3a4_substrate
lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,452.41,4.4,,,,0.99,,,2.38,CYP450_3a4_substrate
fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,437.527,,,,,0.97,,,8.5,
etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,287.357,,,,,0.94,,,0.333,
hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,297.742,,,,,0.375,,,3.0,
fluticasone,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)SCF)O)C)O)F)C)F,444.511,,,,,0.99,,,1093.0,CYP450_3a4_substrate
clofibric acid,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,214.6469,,,,,0.49050000000000005,,,,
givosiran,C[C@@H]1C[C@H](CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCO[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)NC(=O)C)O,16300.34,,,,,0.9,,,35.1,CYP450_3a4_inhibitor
levothyroxine (thyroxine),C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,776.855,,2.2,,,,,,,
axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,386.4772,3.5,4.8,1841.0,13.8,,,,21.0,CYP450_3a4_substrate
oxaprozin,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,293.32,,,,,0.99,,,,
maribavir,CC(C)NC1=NC2=CC(=C(C=C2N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O)Cl)Cl,376.24,2.86,5.2,1.49,5.6,0.98,0.664,0.73,2.85,CYP450_3a4_substrate
dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,493.5813,4.3,,,44.2,0.9990000000000001,,,,
keto-darolutamide,C[C@@H](CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=CC(=NN3)C(=O)C,,,,,,0.998,,,,
alvimopan,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,460.6,,,,,0.8,,,245.5,
isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,371.391,,,,,0.97,,,5.5,
amphotericin B,C[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,924.084,,,,,0.9,,,0.33,
lisinopril,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,405.492,,,,,0.0,,,4.2,
fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663,,,,,0.65,,,6.800000000000001,
carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,406.479,4.19,7.47,,1.94,0.95,,,5.199999999999999,CYP450_3a4_substrate
MAK-683,CC1=C(C=CC=N1)C2=CN=C(N3C2=NN=C3)NCC4=C(C=CC5=C4CCO5)F,376.387,,,19.0,2.8,0.0013,,,,
lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,234.341,2.44,8.01,,,,,,5.8,
cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,463.9,2.2355,4.1025,0.1,2.2150000000000003,0.94,,,,CYP450_3a4_substrate
GSK269984A,C1=CC(=NC(=C1)C(=O)[O-])CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F.[Na+],428.216,,,,,0.9990000000000001,,,9.81,
speciogynine,CC[C@H]1CN2CCC3=C([C@@H]2C[C@@H]1/C(=C\OC)/C(=O)OC)NC4=C3C(=CC=C4)OC,398.4953,,,,,,,0.057,28.200000000000003,
eletriptan,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,382.525,,,,,0.85,,,3.9,CYP450_3a4_substrate
nabumetone,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,228.289,,,,,0.99,,,,
evogliptin,CC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](CC2=CC(=C(C=C2F)F)F)N,401.4264,,,,,,,,29.5,
fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,336.476,860.0,8.4,,,0.43,,,0.5,CYP450_3a4_substrate
palonosetron,C1C[C@@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5,296.412,,,,,0.62,,,160.0,CYP450_3a4_substrate
almorexant,CNC(=O)[C@@H](C1=CC=CC=C1)N2CCC3=CC(=C(C=C3[C@@H]2CCC4=CC=C(C=C4)C(F)(F)F)OC)OC,512.5689,,,,,0.998,,,43.0,
volasertib,CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,618.822,,,,,0.855,,,,
eluxadoline,CC1=CC(=CC(=C1C[C@@H](C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)[C@@H](C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,569.65,0.9,1.0,1.0,,0.81,,,7536.36,CYP450_3a4_inhibitor
amikacin,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,585.604,,,,,0.06,,,0.95,
clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,300.7437,,,1.0,,0.85,0.181,,2.2199999999999998,CYP450_3a4_substrate
(S)-methamphetamine (metamfetamine),C[C@@H](CC1=CC=CC=C1)NC,149.2355,2.07,9.9,,,0.15,,,,
rivipansel,C[C@H]1[C@H]([C@H]([C@@H]([C@@H](O1)O[C@@H]2[C@H](C[C@H](C[C@H]2O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@@H](CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,1447.4316,,,,,0.6,,,0.6020000000000001,
danazol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,337.4603,,,,,,,,59.0,
beclomethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C,408.9191,,,,,,,,163.4,
lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,426.8581,3.3,5.05,0.001,,0.985,,,9.5,CYP450_3a4_substrate
temocillin,CC1([C@@H](N2[C@H](S1)[C@@](C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,414.4572,,,,,0.85,,,29.0,
tezacaftor,CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,520.5013,99.0,13.99,0.0124,,0.99,,,0.86,CYP450_3a4_substrate
desidustat,C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,332.308,,,,,,,,1388.458,
antazoline,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3,265.3581,,,,,0.44,,,1.35,
vorapaxar,CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@@H]3[C@H]([C@H]2/C=C/C4=NC=C(C=C4)C5=CC(=CC=C5)F)[C@H](OC3=O)C,492.5877,,,,,,,,2.22,CYP450_3a4_substrate
midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,325.773,2.5,5.5,,42.0,0.97,,,4.2,CYP450_3a4_substrate
safinamide,C[C@@H](C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,302.3471,,,288.0,120.0,0.885,,,4.6,CYP450_3a4_substrate
febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,316.379,3.66,3.08,0.001,,0.99,,,,CYP450_3a4_substrate
sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,464.829,,,,,0.99,,,,
palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,447.54,0.99,7.4,4.0,,0.853,,,63.1,CYP450_3a4_substrate
ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,255.272,,,,,0.4965,,,0.325,
antipyrine (phenazone),CC1=CC(=O)N(N1C)C2=CC=CC=C2,188.229,,,,,,,,39.75,
tirbanibulin,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,431.5331,,,1.0,,0.88,,,,CYP450_3a4_substrate
morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,285.341,,,,,0.185,,,17.0,CYP450_3a4_substrate
CUDC-101,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,434.4934,,,,,0.9790000000000001,,,,
oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,252.3,1.31,5.449999999999999,,,0.76,,,67.4,CYP450_3a4_substrate
codeine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,299.368,,,,,0.07,,,6.5,CYP450_3a4_substrate
vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,306.7,,,0.001,2.0,0.995,,,1.68,
tadalafil,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,389.41,2.89,15.17,0.001,,0.94,,,2.5,CYP450_3a4_substrate
edaravone (norantipyrine),CC1=NN(C(=O)C1)C2=CC=CC=C2,174.202,,,,,0.92,,,52619.4,CYP450_3a4_inhibitor
nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,414.4798,2.9,,,,0.457,,,363.935,
prednisolone,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,360.4,,,,,0.925,,,0.58,
amphetamine,CC(CC1=CC=CC=C1)N,135.21,1.8,9.9,,,0.16,,,,
tazobactam,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,300.294,,,,,0.3,,,251.0,
bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,348.483,,,,,0.99,,,,
sulfaphenazole,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,,1.52,6.82,1500000.0,,,,,,
delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,440.76,,,,,0.84,,,11.67,
glucarpidase,[Zn+2].[Zn+2].[Zn+2].[Zn+2],83000.0,,,,,,,,4.35,CYP450_3a4_substrate
ixazomib,B([C@H](CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,517.12,,,,,0.99,,,1.9,CYP450_3a4_substrate
temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,194.15,,,,,0.15,,,5.5,
naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,335.47,,,,,0.295,,,6.6,CYP450_3a4_substrate
liquiritigenin,C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O,256.256,,,,,,,,401.16,
hydrocodone,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,299.368,,,,,,,,7.335,CYP450_3a4_substrate
ruxolitinib,C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,306.4,0.0305,4.3,100.0,21.5,0.97,,,17.7,CYP450_3a4_substrate
zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3,287.36,,,,,0.25,,,11.2,CYP450_3a4_inhibitor
zanubrutinib,C=CC(=O)N1CCC(CC1)[C@@H]2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,471.5509,4.2,3.3,0.247,0.9,0.94,,0.0582,182.0,CYP450_3a4_substrate
7-ethyl-10-hydroxycamptothecin (SN-38),CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,392.409,,,,,0.95,,,,
tramadol,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,263.379,1.35,9.41,200.0,,0.2,,,5.9,CYP450_2d6_inhibitor
tyramine,C1=CC(=CC=C1CCN)O,137.179,,,,,,,,171.5,
olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,312.44,0.91,4.69,0.0046,17.37,0.93,0.2367,,25.0,CYP450_2d6_inhibitor
afatinib,CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4,485.9,,,50.0,2.0,0.95,,,1070.0,CYP450_3a4_inhibitor
deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,373.4,,,,,0.99,,,2.1999999999999997,
leuprolide,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6,,,,,,,,,5.85,CYP450_3a4_substrate
ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,532.56,2.78,6.5,1.0,8.0,,0.52,,35.9,CYP450_3a4_substrate
entecavir,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N,295.3,,,,,0.13,,,,
O(6)-benzylguanine,C1=CC=C(C=C1)COC2=NC(=NC3=C2NC=N3)N,241.253,,9.35,,,,0.75,,330.5,
"zalcitabine (2',3'-dideoxycytidine)",C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N,211.22,,,,,,,,14.0,
praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,312.411,,,,4.4,0.825,,,139.5,
astemizole,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F,458.578,,,,,0.615,,,90.0,
"didanosine (2',3'-dideoxyinosine)",C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O,236.23,,,,,0.05,,,11.5,
ezetimibe glucuronide,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O,,,,,,0.9,,,,
alpelisib,CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,441.4758,2.96,3.26,0.02,3.84,0.89,,,9.2,CYP450_3a4_substrate
nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,418.443,,,,,0.98,,,19.0,CYP450_3a4_substrate
romidepsin,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,540.7024,,,,,0.93,,,16.05,CYP450_3a4_substrate
tedizolid,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4C[C@@H](OC4=O)CO)F,370.3425,,,,,0.8,,,8.4,
reboxetine,CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3,313.4,,,,,0.97,,,,
diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,250.199,,,0.001,,0.99,,,4.2,
vilaprisan,C[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(C(C(F)(F)F)(F)F)O)C5=CC=C(C=C5)S(=O)(=O)C,544.5781,,,0.001,,,,,15.1,
domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,425.918,3.96,7.89,,6.19,0.92,,,,
lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4([C@]35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,412.5342,,,,,,,,17.7,
everolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,958.232,,,,0.975,0.74,,,23.299999999999997,CYP450_3a4_substrate
pimecrolimus,CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C,810.4592,,,,,,,,48.5,
chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,319.877,,,,,,,,8.35,
ASP4345,CN(CC1=NC2=C(N1)C=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(C=CC(=C4)Cl)OC3=O,,,,,,0.99,,,4.1,
polymyxin B,CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)[C@@H](C)O,2392.9516,,,,,,,,0.54,
lemborexant,CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,410.422,3.7,3.5,,8.799,0.94,,,22.7,CYP450_3a4_substrate
acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,225.207,,,,,0.21,,,3.37,
albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,265.336,,,,,0.7,,,,
metopimazine,CS(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)C(=O)N,445.6053,,,,,0.727,,,,
fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,583.4954,,,250.0,2.0,,,,,CYP450_3a4_substrate
fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,501.663,,,,,0.65,,,6.800000000000001,
flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,414.344,,,,,0.4,,,3.4499999999999997,
aztreonam,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N,435.44,,,,,0.56,,,91.0,
tiagabine,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C,375.555,,,,,0.96,,,1.2,CYP450_3a4_substrate
imipenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,299.3493,,,,,0.2,,,1.5999999999999999,
GSK269984A,C1=CC(=NC(=C1)C(=O)[O-])CC2=C(C=CC(=C2)Cl)OCC3=C(C=C(C=C3)Cl)F.[Na+],428.216,,,,,0.9990000000000001,,,9.81,
urapidil,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,387.481,,,,,0.805,,,200.0,
famotidine,C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N,337.43,0.2,9.29,0.001,,0.175,,,13.0,
PF-06282999,COC1=C(C=C(C=C1)Cl)C2=CC(=O)NC(=S)N2CC(=O)N,325.7748,,,,,,,,114.5,
amocarzine,CN1CCN(CC1)C(=S)NC2=CC=C(C=C2)NC3=CC=C(C=C3)[N+](=O)[O-],371.463,1.9,6.8,14000.0,,,,,,
miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,416.134,5.3,,,,,,,,
melphalan,C1=CC(=CC=C1C[C@@H](C(=O)O)N)N(CCCl)CCCl,305.203,0.33,2.5,,,0.725,,,8.0,
bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,430.37,2.49,12.0,5000.0,,0.4,,,0.2115,CYP450_3a4_substrate
oxfendazole (fenbendazole-sulfoxide),COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,315.34702,,,,,,,,93.5,
etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,435.28,,,0.001,,0.9990000000000001,,,43.7,CYP450_3a4_substrate
rotigotine,CCCN(CCC1=CC=CS1)[C@H]2CCC3=C(C2)C=CC=C3O,315.48,,,,,0.895,,,,CYP450_3a4_inhibitor
alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,308.771,,,,,,,,0.44,CYP450_3a4_substrate
metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],171.155,,,,,0.07,,,0.8,
N-desmethylclobazam,C1C(=O)NC2=C(C=C(C=C2)Cl)N(C1=O)C3=CC=CC=C3,,,,,,0.7,0.675,,,
nemonoxacin,C[C@H]1C[C@@H](CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,371.4345,,,,,0.16,,,12.87,
plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,502.7906,,,,,0.58,,,,
ceftazidime and avibactam,CC(C)(C(=O)O)O/N=C(\C1=CSC(=N1)N)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-].C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)N,636.6,,,,,0.135,,,6.86,
telavancin,CCCCCCCCCCNCCN[C@]1(C[C@@H](O[C@H]([C@H]1O)C)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)C,1755.6474,,,,,0.897,,,13.1,
morphine-6-glucuronide,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O,461.464,,,,,,,,111.10000000000001,
esomeprazole,CC1=CN=C(C(=C1OC)C)C[S@](=O)C2=NC3=C(N2)C=C(C=C3)OC,345.42,2.24,9.29,0.36,,0.96,,,5.9,
eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,442.5,,,,,0.99,,,,CYP450_3a4_substrate
zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,424.4394,,,,,0.74,,,,
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,280.413,4.8,,,,0.4575,,,7.35,CYP450_3a4_substrate
(R)-ibuprofen,C[C@H](C1=CC=C(C=C1)CC(C)C)C(=O)O,206.2832,,,,,,,,3.45,
fosdevirine,CC1=CC(=CC(=C1)[P@@](=O)(C2=C(NC3=C2C=C(C=C3)Cl)C(=O)N)OC)/C=C/C#N,413.794,,,,,0.998,,,29.35,
1'-hydroxymidazolam,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO,341.7717,,,,,0.89,,,,
5-hydroxyomeprazole,CC1=C(C(=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)OC)CO)OC,361.4,,,,,,,,2.4,
pentazocine,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,285.4283,3.31,8.5,,,0.63,,,741.0,
(S)-ornidazole,CC1=NC=C(N1C[C@@H](CCl)O)[N+](=O)[O-],219.627,,,,,,,,1.255,
adinazolam,CN(C)CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,,,,,,0.65,,,,
labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,328.41,3.1,,,,0.5,0.366,,33.0,
trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,371.87,2.9,6.74,100.0,,0.92,,,1.1,CYP450_3a4_substrate
sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)SC)O)O)O)Cl,424.94,3.2,,0.001,,0.938,,,315.0,CYP450_3a4_substrate
mifepristone,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,429.6,5.13,5.0,25.0,15.09,0.992,,,,CYP450_3a4_substrate
rufinamide,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,238.196,,,,,0.27,,,6.12,CYP450_3a4_inhibitor
pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,432.4,2.05,3.92,,,0.98,0.719,,10.8,CYP450_3a4_substrate
idasanutlin,CC(C)(C)C[C@H]1[C@]([C@H]([C@@H](N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,616.4891,5.6,4.0,,8.0,,,,2.025,
ribavirin,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,244.206,,,,,0.0,,,3.0,
ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,395.4318,,,,,0.479,,,528.5,
cevimeline,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1,244.79,,,1000.0,,0.2,,,,
temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,194.15,,,,,0.15,,,5.5,
N-desmethylselegiline,C[C@H](CC1=CC=CC=C1)NCC#C,173.2575,2.46,9.8,,,0.53,,,,
metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,267.366,1.9,9.7,,,0.06,,,9.0,CYP450_2d6_inhibitor
moclobemide,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,268.742,1.79,6.2,,,0.5,,,83.6,
tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,,,,,,,,,1.54,
cisapride,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,465.95,,,,,0.98,,,4.75,
ritipenem,C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)COC(=O)N)C(=O)O)O,288.2788,,,,,,,,321.5,
salicylamide,C1=CC=C(C(=C1)C(=O)N)O,137.1373,,,3.3,,,,,,
iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,426.5,,,,30.65,0.97,,,102.0,CYP450_3a4_substrate
quinupristin and dalfopristin,CC[C@@H]1C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)N3C[C@H](C(=O)CC3C(=O)N[C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CS[C@@H]6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C.CCN(CC)CCS(=O)(=O)[C@@H]1CCN2[C@H]1C(=O)O[C@@H]([C@@H](/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC3=NC(=CO3)C2=O)O)/C)C)C(C)C,,,,,,,,,10.315,
cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,388.892,,,,,0.498,,,0.46499999999999997,
ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,237.728,,,,,0.725,,,1.0699999999999998,
eslicarbazepine,C1[C@@H](C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,254.2876,,,0.1,,0.4,,,,
tezacaftor and ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,520.5,99.0,13.99,0.0124,,0.99,,,0.86,
ethionamide,CCC1=NC=CC(=C1)C(=S)N,166.244,,,,,0.3,,,,
(d)-nebivolol,C1CC2=C(C=CC(=C2)F)O[C@H]1[C@@H](CNC[C@H]([C@@H]3CCC4=C(O3)C=CC(=C4)F)O)O,,,,,,0.9113,,,,
pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,437.5257,,1.0,4.0,11.1,0.99,,,0.997,CYP450_3a4_substrate
mizolastine,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,432.5,,,,,0.98,,,6.02,
posaconazole,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,700.8,,,0.79,,,,,7.3,
isotretinoin (13-cis-retinoic acid),CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,300.44,,,,,0.99,,,6.0,
ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@H]3CO[C@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,531.437,4.3,,,,0.4955,,,6.25,CYP450_3a4_substrate
naringenin,C1C(OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O,272.25,,,,,,,,627.345,
cefiderocol,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-],752.21,,,,,0.5,,,3.0349999999999997,
micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)[C@@H](CC(=O)N)O)C)O)O)O,1292.26,,,,,0.99,,,,CYP450_3a4_substrate
clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,300.7437,,,1.0,,0.85,0.181,,2.2199999999999998,CYP450_3a4_substrate
tazobactam,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,300.294,,,,,0.3,,,251.0,
lovastatin (lactone),CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,404.543,4.08,13.49,,,0.95,,,11.3,CYP450_3a4_substrate
prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,383.406,,,,,0.48,,,1.65,
